1	Deletion	deletion	NN	_	4	SBJ
2	at	at	IN	_	1	NMOD
3	ITPR1	itpr0	NNP	_	2	PMOD
4	Underlies	underlie	VBZ	_	0	ROOT
5	Ataxia	ataxia	NN	_	4	OBJ
6	in	in	IN	_	5	LOC
7	Mice	mouse	NNS	_	6	PMOD
8	and	and	CC	_	5	COORD
9	Spinocerebellar	spinocerebellar	JJ	_	10	NMOD
10	Ataxia	ataxia	NN	_	8	CONJ
11	15	0	CD	_	10	NMOD
12	in	in	IN	_	10	LOC
13	Humans	human	NNS	_	12	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	observed	observe	VBD	_	0	ROOT
3	a	a	DT	_	8	NMOD
4	severe	severe	JJ	_	8	NMOD
5	autosomal	autosomal	JJ	_	8	NMOD
6	recessive	recessive	JJ	_	8	NMOD
7	movement	movement	NN	_	8	NMOD
8	disorder	disorder	NN	_	2	OBJ
9	in	in	IN	_	2	LOC
10	mice	mouse	NNS	_	9	PMOD
11	used	use	VBN	_	10	NMOD
12	within	within	IN	_	11	LOC
13	our	our	PRP$	_	14	NMOD
14	laboratory	laboratory	NN	_	12	PMOD
15	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	pursued	pursue	VBD	_	0	ROOT
3	a	a	DT	_	4	NMOD
4	series	series	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	experiments	experiment	NNS	_	5	PMOD
7	to	to	TO	_	2	PRP
8	define	define	VB	_	7	IM
9	the	the	DT	_	11	NMOD
10	genetic	genetic	JJ	_	11	NMOD
11	lesion	lesion	NN	_	8	OBJ
12	underlying	underlie	VBG	_	11	NMOD
13	this	this	DT	_	14	NMOD
14	disorder	disorder	NN	_	12	OBJ
15	and	and	CC	_	7	COORD
16	to	to	TO	_	15	CONJ
17	identify	identify	VB	_	16	IM
18	a	a	DT	_	20	NMOD
19	cognate	cognate	JJ	_	20	NMOD
20	disease	disease	NN	_	17	OBJ
21	in	in	IN	_	17	LOC
22	humans	human	NNS	_	21	PMOD
23	with	with	IN	_	22	NMOD
24	mutation	mutation	NN	_	23	PMOD
25	at	at	IN	_	24	LOC
26	the	the	DT	_	28	NMOD
27	same	same	JJ	_	28	NMOD
28	locus	locus	NN	_	25	PMOD
29	.	.	.	_	2	P

1	Through	through	IN	_	7	MNR
2	linkage	linkage	NN	_	5	NMOD
3	and	and	CC	_	2	COORD
4	sequence	sequence	NN	_	3	CONJ
5	analysis	analysis	NN	_	1	PMOD
6	we	we	PRP	_	7	SBJ
7	show	show	VBP	_	0	ROOT
8	here	here	RB	_	7	ADV
9	that	that	IN	_	7	OBJ
10	this	this	DT	_	11	NMOD
11	disorder	disorder	NN	_	12	SBJ
12	is	be	VBZ	_	9	SUB
13	caused	cause	VBN	_	12	VC
14	by	by	IN	_	13	LGS
15	a	a	DT	_	23	NMOD
16	homozygous	homozygous	JJ	_	23	NMOD
17	in	in	IN	_	23	NMOD
18	-	-	HYPH	_	17	P
19	frame	frame	NN	_	17	PMOD
20	18	0	CD	_	22	NMOD
21	-	-	HYPH	_	20	P
22	bp	bp	NN	_	23	NMOD
23	deletion	deletion	NN	_	14	PMOD
24	in	in	IN	_	23	LOC
25	Itpr1	itpr0	NN	_	24	PMOD
26	(	(	-LRB-	_	30	P
27	Itpr1	itpr0	NN	_	30	NMOD
28	Δ18	δ0	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	Δ18	δ0	NN	_	25	PRN
31	)	)	-RRB-	_	30	P
32	,	,	,	_	23	P
33	encoding	encode	VBG	_	23	NMOD
34	inositol	inositol	NN	_	42	NMOD
35	1	0	CD	_	39	NMOD
36	,	,	,	_	39	P
37	4	0	CD	_	39	NMOD
38	,	,	,	_	39	P
39	5	0	CD	_	41	NMOD
40	-	-	HYPH	_	39	P
41	triphosphate	triphosphate	NN	_	42	NMOD
42	receptor	receptor	NN	_	33	OBJ
43	1	0	CD	_	42	NMOD
44	.	.	.	_	7	P

1	A	a	DT	_	6	NMOD
2	previously	previously	RB	_	3	AMOD
3	reported	report	VBN	_	6	NMOD
4	spontaneous	spontaneous	JJ	_	6	NMOD
5	Itpr1	itpr0	NN	_	6	NMOD
6	mutation	mutation	NN	_	9	SBJ
7	in	in	IN	_	6	LOC
8	mice	mouse	NNS	_	7	PMOD
9	causes	cause	VBZ	_	0	ROOT
10	a	a	DT	_	11	NMOD
11	phenotype	phenotype	NN	_	9	OBJ
12	identical	identical	JJ	_	11	NMOD
13	to	to	IN	_	12	AMOD
14	that	that	DT	_	13	PMOD
15	observed	observe	VBN	_	14	NMOD
16	here	here	RB	_	15	ADV
17	.	.	.	_	9	P

1	In	in	IN	_	10	LOC
2	both	both	DT	_	3	NMOD
3	models	model	NNS	_	1	PMOD
4	in	in	IN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	frame	frame	NN	_	7	NMOD
7	deletion	deletion	NN	_	10	SBJ
8	within	within	IN	_	7	LOC
9	Itpr1	itpr0	NN	_	8	PMOD
10	leads	lead	VBZ	_	0	ROOT
11	to	to	IN	_	10	ADV
12	a	a	DT	_	13	NMOD
13	decrease	decrease	NN	_	11	PMOD
14	in	in	IN	_	13	NMOD
15	the	the	DT	_	18	NMOD
16	normally	normally	RB	_	17	AMOD
17	high	high	JJ	_	18	NMOD
18	level	level	NN	_	14	PMOD
19	of	of	IN	_	18	NMOD
20	Itpr1	itpr0	NN	_	21	NMOD
21	expression	expression	NN	_	19	PMOD
22	in	in	IN	_	21	LOC
23	cerebellar	cerebellar	JJ	_	25	NMOD
24	Purkinje	purkinje	NNP	_	25	NMOD
25	cells	cell	NNS	_	22	PMOD
26	.	.	.	_	10	P

1	Spinocerebellar	spinocerebellar	JJ	_	2	NMOD
2	ataxia	ataxia	NN	_	5	NMOD
3	15	0	CD	_	2	NMOD
4	(	(	-LRB-	_	5	P
5	SCA15	sca0	NN	_	12	NMOD
6	)	)	-RRB-	_	12	P
7	,	,	,	_	12	P
8	a	a	DT	_	12	NMOD
9	human	human	JJ	_	12	NMOD
10	autosomal	autosomal	JJ	_	12	NMOD
11	dominant	dominant	JJ	_	12	NMOD
12	disorder	disorder	NN	_	14	SBJ
13	,	,	,	_	14	P
14	maps	map	VBZ	_	29	DEP
15	to	to	IN	_	14	ADV
16	the	the	DT	_	18	NMOD
17	genomic	genomic	JJ	_	18	NMOD
18	region	region	NN	_	15	PMOD
19	containing	contain	VBG	_	18	NMOD
20	ITPR1	itpr0	NN	_	19	OBJ
21	;	;	:	_	29	P
22	however	however	RB	_	29	ADV
23	,	,	,	_	29	P
24	to	to	IN	_	29	TMP
25	date	date	NN	_	24	PMOD
26	no	no	DT	_	28	NMOD
27	causal	causal	JJ	_	28	NMOD
28	mutations	mutation	NNS	_	29	SBJ
29	had	have	VBD	_	0	ROOT
30	been	be	VBN	_	29	VC
31	identified	identify	VBN	_	30	VC
32	.	.	.	_	29	P

1	Because	because	IN	_	13	PRP
2	ataxia	ataxia	NN	_	3	SBJ
3	is	be	VBZ	_	1	SUB
4	a	a	DT	_	6	NMOD
5	prominent	prominent	JJ	_	6	NMOD
6	feature	feature	NN	_	3	PRD
7	in	in	IN	_	6	LOC
8	Itpr1	itpr0	NN	_	10	NMOD
9	mutant	mutant	NN	_	10	NMOD
10	mice	mouse	NNS	_	7	PMOD
11	,	,	,	_	13	P
12	we	we	PRP	_	13	SBJ
13	performed	perform	VBD	_	0	ROOT
14	a	a	DT	_	15	NMOD
15	series	series	NN	_	13	OBJ
16	of	of	IN	_	15	NMOD
17	experiments	experiment	NNS	_	16	PMOD
18	to	to	TO	_	13	PRP
19	test	test	VB	_	18	IM
20	the	the	DT	_	21	NMOD
21	hypothesis	hypothesis	NN	_	19	OBJ
22	that	that	IN	_	21	NMOD
23	mutation	mutation	NN	_	26	SBJ
24	at	at	IN	_	23	NMOD
25	ITPR1	itpr0	NN	_	24	PMOD
26	may	may	MD	_	22	SUB
27	be	be	VB	_	26	VC
28	the	the	DT	_	29	NMOD
29	cause	cause	NN	_	27	PRD
30	of	of	IN	_	29	NMOD
31	SCA15	sca0	NN	_	30	PMOD
32	.	.	.	_	13	P

1	We	we	PRP	_	2	SBJ
2	show	show	VBP	_	0	ROOT
3	here	here	RB	_	2	ADV
4	that	that	IN	_	2	OBJ
5	heterozygous	heterozygous	JJ	_	6	NMOD
6	deletion	deletion	NN	_	36	SBJ
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	11	NMOD
9	5	0	CD	_	11	NMOD
10	′	′	SYM	_	9	P
11	part	part	NN	_	7	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	ITPR1	itpr0	NN	_	15	NMOD
15	gene	gene	NN	_	12	PMOD
16	,	,	,	_	11	P
17	encompassing	encompass	VBG	_	11	NMOD
18	exons	exon	NNS	_	19	NMOD
19	1	0	CD	_	17	OBJ
20	–	–	SYM	_	21	P
21	10	0	CD	_	19	NMOD
22	,	,	,	_	19	P
23	1	0	CD	_	19	CONJ
24	–	–	SYM	_	25	P
25	40	0	CD	_	23	NMOD
26	,	,	,	_	23	P
27	and	and	CC	_	23	COORD
28	1	0	CD	_	27	CONJ
29	–	–	SYM	_	30	P
30	44	0	CD	_	28	NMOD
31	in	in	IN	_	17	ADV
32	three	three	CD	_	34	NMOD
33	studied	study	VBN	_	34	NMOD
34	families	family	NNS	_	31	PMOD
35	,	,	,	_	36	P
36	underlies	underlie	VBZ	_	4	SUB
37	SCA15	sca0	NN	_	36	OBJ
38	in	in	IN	_	36	LOC
39	humans	human	NNS	_	38	PMOD
40	.	.	.	_	2	P

1	Author	author	NN	_	2	NMOD
2	Summary	summary	NN	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	identified	identify	VBN	_	2	VC
4	a	a	DT	_	10	NMOD
5	spontaneous	spontaneous	JJ	_	10	NMOD
6	in	in	IN	_	10	NMOD
7	-	-	HYPH	_	6	P
8	frame	frame	NN	_	6	PMOD
9	deletion	deletion	NN	_	10	NMOD
10	mutation	mutation	NN	_	3	OBJ
11	in	in	IN	_	10	LOC
12	the	the	DT	_	14	NMOD
13	gene	gene	NN	_	14	NMOD
14	Itpr1	itpr0	NN	_	11	PMOD
15	that	that	WDT	_	16	SBJ
16	causes	cause	VBZ	_	10	NMOD
17	a	a	DT	_	20	NMOD
18	recessive	recessive	JJ	_	20	NMOD
19	movement	movement	NN	_	20	NMOD
20	disorder	disorder	NN	_	16	OBJ
21	in	in	IN	_	16	LOC
22	mice	mouse	NNS	_	21	PMOD
23	.	.	.	_	2	P

1	In	in	IN	_	14	ADV
2	an	an	DT	_	3	NMOD
3	attempt	attempt	NN	_	1	PMOD
4	to	to	TO	_	3	NMOD
5	define	define	VB	_	4	IM
6	whether	whether	IN	_	5	OBJ
7	any	any	DT	_	9	NMOD
8	similar	similar	JJ	_	9	NMOD
9	disease	disease	NN	_	10	SBJ
10	occurs	occur	VBZ	_	6	SUB
11	in	in	IN	_	10	LOC
12	humans	human	NNS	_	11	PMOD
13	we	we	PRP	_	14	SBJ
14	performed	perform	VBD	_	0	ROOT
15	a	a	DT	_	17	NMOD
16	literature	literature	NN	_	17	NMOD
17	search	search	NN	_	14	OBJ
18	for	for	IN	_	17	NMOD
19	diseases	disease	NNS	_	18	PMOD
20	linked	link	VBN	_	19	NMOD
21	to	to	IN	_	20	ADV
22	the	the	DT	_	25	NMOD
23	human	human	JJ	_	25	NMOD
24	chromosomal	chromosomal	JJ	_	25	NMOD
25	region	region	NN	_	21	PMOD
26	containing	contain	VBG	_	25	NMOD
27	ITPR1	itpr0	NN	_	26	OBJ
28	.	.	.	_	14	P

1	We	we	PRP	_	2	SBJ
2	identified	identify	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	disease	disease	NN	_	6	NMOD
5	spinocerebellar	spinocerebellar	JJ	_	6	NMOD
6	ataxia	ataxia	NN	_	2	OBJ
7	15	0	CD	_	6	NMOD
8	as	as	IN	_	2	ADV
9	linked	link	VBN	_	8	PMOD
10	to	to	IN	_	9	AMOD
11	this	this	DT	_	12	NMOD
12	region	region	NN	_	10	PMOD
13	.	.	.	_	2	P

1	High	high	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	density	density	NN	_	5	NMOD
4	genomic	genomic	JJ	_	5	NMOD
5	analysis	analysis	NN	_	12	SBJ
6	of	of	IN	_	5	NMOD
7	affected	affect	VBN	_	8	NMOD
8	members	member	NNS	_	6	PMOD
9	from	from	IN	_	8	NMOD
10	three	three	CD	_	11	NMOD
11	families	family	NNS	_	9	PMOD
12	revealed	reveal	VBD	_	0	ROOT
13	that	that	IN	_	12	OBJ
14	disease	disease	NN	_	18	SBJ
15	in	in	IN	_	14	LOC
16	these	these	DT	_	17	NMOD
17	patients	patient	NNS	_	15	PMOD
18	was	be	VBD	_	13	SUB
19	caused	cause	VBN	_	18	VC
20	by	by	IN	_	19	LGS
21	deletion	deletion	NN	_	20	PMOD
22	of	of	IN	_	21	NMOD
23	a	a	DT	_	25	NMOD
24	large	large	JJ	_	25	NMOD
25	portion	portion	NN	_	22	PMOD
26	of	of	IN	_	25	NMOD
27	the	the	DT	_	28	NMOD
28	region	region	NN	_	26	PMOD
29	containing	contain	VBG	_	28	NMOD
30	ITPR1	itpr0	NN	_	29	OBJ
31	.	.	.	_	12	P

1	We	we	PRP	_	2	SBJ
2	show	show	VBP	_	0	ROOT
3	here	here	RB	_	2	ADV
4	that	that	IN	_	2	OBJ
5	this	this	DT	_	6	NMOD
6	mutation	mutation	NN	_	7	SBJ
7	results	result	VBZ	_	4	SUB
8	in	in	IN	_	7	ADV
9	a	a	DT	_	11	NMOD
10	dramatic	dramatic	JJ	_	11	NMOD
11	reduction	reduction	NN	_	8	PMOD
12	in	in	IN	_	11	NMOD
13	ITPR1	itpr0	NN	_	12	PMOD
14	in	in	IN	_	7	LOC
15	cells	cell	NNS	_	14	PMOD
16	from	from	IN	_	15	NMOD
17	these	these	DT	_	18	NMOD
18	patients	patient	NNS	_	16	PMOD
19	.	.	.	_	2	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	show	show	VBP	_	0	ROOT
4	convincingly	convincingly	RB	_	3	ADV
5	that	that	IN	_	3	OBJ
6	ITPR1	itpr0	NN	_	7	NMOD
7	deletion	deletion	NN	_	8	SBJ
8	underlies	underlie	VBZ	_	5	SUB
9	spinocerebellar	spinocerebellar	JJ	_	10	NMOD
10	ataxia	ataxia	NN	_	8	OBJ
11	15	0	CD	_	10	NMOD
12	in	in	IN	_	8	LOC
13	humans	human	NNS	_	12	PMOD
14	.	.	.	_	3	P

1	Introduction	introduction	NN	_	0	ROOT

1	The	the	DT	_	2	NMOD
2	use	use	NN	_	15	SBJ
3	of	of	IN	_	2	NMOD
4	forward	forward	JJ	_	5	NMOD
5	genetics	genetics	NNS	_	3	PMOD
6	to	to	TO	_	2	NMOD
7	define	define	VB	_	6	IM
8	novel	novel	JJ	_	9	NMOD
9	loci	locus	NNS	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	interest	interest	NN	_	10	PMOD
12	in	in	IN	_	9	NMOD
13	human	human	JJ	_	14	NMOD
14	disease	disease	NN	_	12	PMOD
15	has	have	VBZ	_	0	ROOT
16	become	become	VBN	_	15	VC
17	increasingly	increasingly	RB	_	18	AMOD
18	viable	viable	JJ	_	16	PRD
19	with	with	IN	_	16	ADV
20	the	the	DT	_	21	NMOD
21	implementation	implementation	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	large	large	JJ	_	25	NMOD
24	-	-	HYPH	_	23	P
25	scale	scale	NN	_	27	NMOD
26	mutagenesis	mutagenesis	NN	_	27	NMOD
27	programs	program	NNS	_	22	PMOD
28	.	.	.	_	15	P

1	Prior	prior	RB	_	2	PMOD
2	to	to	IN	_	7	TMP
3	these	these	DT	_	4	NMOD
4	initiatives	initiative	NNS	_	2	PMOD
5	this	this	DT	_	6	NMOD
6	work	work	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	carried	carry	VBN	_	7	VC
9	out	out	RP	_	8	PRT
10	in	in	IN	_	8	ADV
11	part	part	JJ	_	10	PMOD
12	by	by	IN	_	8	MNR
13	the	the	DT	_	14	NMOD
14	investigation	investigation	NN	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	spontaneous	spontaneous	JJ	_	17	NMOD
17	mutations	mutation	NNS	_	15	PMOD
18	that	that	WDT	_	19	SBJ
19	cause	cause	VBP	_	17	NMOD
20	disorders	disorder	NNS	_	19	OBJ
21	in	in	IN	_	19	LOC
22	mouse	mouse	NN	_	24	NMOD
23	breeding	breeding	NN	_	24	NMOD
24	colonies	colony	NNS	_	21	PMOD
25	.	.	.	_	7	P

1	Careful	careful	JJ	_	2	NMOD
2	observation	observation	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	these	these	DT	_	6	NMOD
5	serendipitous	serendipitous	JJ	_	6	NMOD
6	events	event	NNS	_	3	PMOD
7	has	have	VBZ	_	0	ROOT
8	led	lead	VBN	_	7	VC
9	to	to	IN	_	8	ADV
10	the	the	DT	_	11	NMOD
11	establishment	establishment	NN	_	9	PMOD
12	and	and	CC	_	11	COORD
13	study	study	NN	_	12	CONJ
14	of	of	IN	_	11	NMOD
15	many	many	JJ	_	19	NMOD
16	in	in	FW	_	17	AMOD
17	vivo	vivo	FW	_	19	NMOD
18	disease	disease	NN	_	19	NMOD
19	models	model	NNS	_	14	PMOD
20	[	[	-LRB-	_	21	P
21	3	0	CD	_	8	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	7	P

1	During	during	IN	_	11	TMP
2	the	the	DT	_	3	NMOD
3	generation	generation	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	a	a	DT	_	7	NMOD
6	knockout	knockout	NN	_	7	NMOD
7	line	line	NN	_	4	PMOD
8	of	of	IN	_	7	NMOD
9	mice	mouse	NNS	_	8	PMOD
10	we	we	PRP	_	11	SBJ
11	noted	note	VBD	_	0	ROOT
12	an	an	DT	_	15	NMOD
13	early	early	JJ	_	15	NMOD
14	movement	movement	NN	_	15	NMOD
15	disorder	disorder	NN	_	11	OBJ
16	that	that	WDT	_	17	SBJ
17	was	be	VBD	_	15	NMOD
18	inherited	inherit	VBN	_	17	VC
19	independently	independently	RB	_	18	ADV
20	of	of	IN	_	19	AMOD
21	targeting	target	VBG	_	22	NMOD
22	vector	vector	NN	_	23	NMOD
23	transmission	transmission	NN	_	20	PMOD
24	.	.	.	_	11	P

1	We	we	PRP	_	2	SBJ
2	embarked	embark	VBD	_	0	ROOT
3	on	on	IN	_	2	ADV
4	a	a	DT	_	5	NMOD
5	series	series	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	experiments	experiment	NNS	_	6	PMOD
8	to	to	TO	_	2	PRP
9	identify	identify	VB	_	8	IM
10	the	the	DT	_	12	NMOD
11	genetic	genetic	JJ	_	12	NMOD
12	lesion	lesion	NN	_	9	OBJ
13	underlying	underlie	VBG	_	12	NMOD
14	this	this	DT	_	16	NMOD
15	movement	movement	NN	_	16	NMOD
16	disorder	disorder	NN	_	13	OBJ
17	and	and	CC	_	8	COORD
18	to	to	TO	_	17	CONJ
19	identify	identify	VB	_	18	IM
20	a	a	DT	_	22	NMOD
21	cognate	cognate	JJ	_	22	NMOD
22	disease	disease	NN	_	19	OBJ
23	and	and	CC	_	22	COORD
24	corresponding	correspond	VBG	_	25	NMOD
25	mutation	mutation	NN	_	23	CONJ
26	in	in	IN	_	19	LOC
27	humans	human	NNS	_	26	PMOD
28	.	.	.	_	2	P

1	Here	here	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	describe	describe	VBP	_	0	ROOT
4	this	this	DT	_	5	NMOD
5	effort	effort	NN	_	3	OBJ
6	and	and	CC	_	5	COORD
7	the	the	DT	_	8	NMOD
8	discovery	discovery	NN	_	6	CONJ
9	of	of	IN	_	8	NMOD
10	deletion	deletion	NN	_	9	PMOD
11	at	at	IN	_	10	LOC
12	the	the	DT	_	14	NMOD
13	ITPR1	itpr0	NN	_	14	NMOD
14	locus	locus	NN	_	11	PMOD
15	as	as	IN	_	3	ADV
16	a	a	DT	_	17	NMOD
17	cause	cause	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	this	this	DT	_	20	NMOD
20	disorder	disorder	NN	_	18	PMOD
21	in	in	IN	_	20	LOC
22	mice	mouse	NNS	_	21	PMOD
23	and	and	CC	_	18	COORD
24	of	of	IN	_	23	CONJ
25	spinocerebellar	spinocerebellar	JJ	_	26	NMOD
26	ataxia	ataxia	NN	_	29	NMOD
27	15	0	CD	_	26	NMOD
28	(	(	-LRB-	_	29	P
29	SCA15	sca0	NN	_	24	PMOD
30	)	)	-RRB-	_	29	P
31	in	in	IN	_	29	LOC
32	humans	human	NNS	_	31	PMOD
33	.	.	.	_	3	P

1	Results	result	NNS	_	3	NMOD
2	/	/	HYPH	_	1	P
3	Discussion	discussion	NN	_	0	ROOT

1	During	during	IN	_	16	TMP
2	the	the	DT	_	3	NMOD
3	generation	generation	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	a	a	DT	_	6	NMOD
6	line	line	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	mice	mouse	NNS	_	7	PMOD
9	with	with	IN	_	8	NMOD
10	knockout	knockout	NN	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	13	NMOD
13	gene	gene	NN	_	14	NMOD
14	Park7	park0	NN	_	11	PMOD
15	we	we	PRP	_	16	SBJ
16	noted	note	VBD	_	0	ROOT
17	an	an	DT	_	20	NMOD
18	early	early	JJ	_	20	NMOD
19	movement	movement	NN	_	20	NMOD
20	disorder	disorder	NN	_	16	OBJ
21	that	that	WDT	_	22	SBJ
22	was	be	VBD	_	20	NMOD
23	inherited	inherit	VBN	_	22	VC
24	independently	independently	RB	_	23	ADV
25	of	of	IN	_	24	AMOD
26	targeting	targeting	NN	_	27	NMOD
27	vector	vector	NN	_	28	NMOD
28	transmission	transmission	NN	_	25	PMOD
29	.	.	.	_	16	P

1	Our	our	PRP$	_	3	NMOD
2	initial	initial	JJ	_	3	NMOD
3	observations	observation	NNS	_	4	SBJ
4	suggested	suggest	VBD	_	0	ROOT
5	the	the	DT	_	7	NMOD
6	affected	affect	VBN	_	7	NMOD
7	mice	mouse	NNS	_	8	SBJ
8	suffered	suffer	VBD	_	4	OBJ
9	from	from	IN	_	8	ADV
10	an	an	DT	_	14	NMOD
11	apparently	apparently	RB	_	12	AMOD
12	paroxysmal	paroxysmal	JJ	_	14	NMOD
13	movement	movement	NN	_	14	NMOD
14	disorder	disorder	NN	_	9	PMOD
15	,	,	,	_	14	P
16	often	often	RB	_	17	ADV
17	induced	induce	VBN	_	14	NMOD
18	by	by	IN	_	17	MNR
19	touch	touch	NN	_	18	PMOD
20	.	.	.	_	4	P

1	The	the	DT	_	3	NMOD
2	abnormal	abnormal	JJ	_	3	NMOD
3	movements	movement	NNS	_	4	SBJ
4	occurred	occur	VBD	_	0	ROOT
5	predominantly	predominantly	RB	_	4	ADV
6	below	below	IN	_	4	LOC
7	the	the	DT	_	9	NMOD
8	cervical	cervical	JJ	_	9	NMOD
9	level	level	NN	_	6	PMOD
10	,	,	,	_	4	P
11	and	and	CC	_	4	COORD
12	the	the	DT	_	13	NMOD
13	disorder	disorder	NN	_	14	SBJ
14	appeared	appear	VBD	_	11	CONJ
15	progressive	progressive	JJ	_	14	OPRD
16	.	.	.	_	4	P

1	At	at	IN	_	16	TMP
2	initial	initial	JJ	_	3	NMOD
3	examination	examination	NN	_	1	PMOD
4	,	,	,	_	16	P
5	a	a	DT	_	9	NMOD
6	human	human	JJ	_	8	NMOD
7	movement	movement	NN	_	8	NMOD
8	disorder	disorder	NN	_	9	NMOD
9	specialist	specialist	NN	_	16	SBJ
10	(	(	-LRB-	_	14	P
11	K.	k.	NNP	_	14	NMOD
12	G.	g.	NNP	_	14	NMOD
13	-	-	HYPH	_	12	P
14	H.	h.	NNP	_	9	PRN
15	)	)	-RRB-	_	14	P
16	likened	liken	VBD	_	0	ROOT
17	the	the	DT	_	18	NMOD
18	disorder	disorder	NN	_	16	OBJ
19	to	to	IN	_	16	ADV
20	episodic	episodic	JJ	_	22	NMOD
21	intermittent	intermittent	JJ	_	22	NMOD
22	ataxia	ataxia	NN	_	19	PMOD
23	or	or	CC	_	22	COORD
24	kinesiogenic	kinesiogenic	JJ	_	26	NMOD
25	paroxysmal	paroxysmal	JJ	_	26	NMOD
26	dystonia	dystonia	NN	_	23	CONJ
27	and	and	CC	_	16	COORD
28	predicted	predict	VBD	_	27	CONJ
29	the	the	DT	_	30	NMOD
30	involvement	involvement	NN	_	28	OBJ
31	of	of	IN	_	30	NMOD
32	an	an	DT	_	35	NMOD
33	ion	ion	NN	_	35	NMOD
34	channel	channel	NN	_	35	NMOD
35	mutation	mutation	NN	_	31	PMOD
36	in	in	IN	_	30	NMOD
37	the	the	DT	_	38	NMOD
38	etiology	etiology	NN	_	36	PMOD
39	.	.	.	_	16	P

1	Affected	affect	VBN	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	presented	present	VBD	_	0	ROOT
4	at	at	IN	_	3	TMP
5	approximately	approximately	RB	_	7	NMOD
6	postnatal	postnatal	JJ	_	7	NMOD
7	day	day	NN	_	4	PMOD
8	14	0	CD	_	7	NMOD
9	,	,	,	_	3	P
10	and	and	CC	_	3	COORD
11	survival	survival	NN	_	12	NMOD
12	time	time	NN	_	15	SBJ
13	without	without	IN	_	12	NMOD
14	weaning	weaning	NN	_	13	PMOD
15	was	be	VBD	_	10	CONJ
16	on	on	IN	_	15	ADV
17	average	average	JJ	_	16	PMOD
18	4	0	CD	_	19	NMOD
19	wk	wk	NN	_	20	ADV
20	after	after	IN	_	15	TMP
21	onset	onset	NN	_	20	PMOD
22	.	.	.	_	3	P

1	Breeding	breeding	NN	_	2	NMOD
2	experiments	experiment	NNS	_	3	SBJ
3	suggested	suggest	VBD	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	the	the	DT	_	7	NMOD
6	observed	observe	VBN	_	7	NMOD
7	disorder	disorder	NN	_	8	SBJ
8	was	be	VBD	_	4	SUB
9	inherited	inherit	VBN	_	8	VC
10	in	in	IN	_	9	MNR
11	an	an	DT	_	14	NMOD
12	autosomal	autosomal	JJ	_	14	NMOD
13	recessive	recessive	JJ	_	14	NMOD
14	manner	manner	NN	_	10	PMOD
15	.	.	.	_	3	P

1	To	to	TO	_	13	PRP
2	map	map	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	location	location	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	disease	disease	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	causing	cause	VBG	_	10	NMOD
10	lesion	lesion	NN	_	5	PMOD
11	,	,	,	_	13	P
12	we	we	PRP	_	13	SBJ
13	performed	perform	VBD	_	0	ROOT
14	genome	genome	NN	_	16	AMOD
15	-	-	HYPH	_	14	P
16	wide	wide	JJ	_	18	NMOD
17	linkage	linkage	NN	_	18	NMOD
18	analysis	analysis	NN	_	13	OBJ
19	using	use	VBG	_	13	MNR
20	strain	strain	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	specific	specific	JJ	_	27	NMOD
23	single	single	JJ	_	24	NMOD
24	nucleotide	nucleotide	NN	_	25	NMOD
25	polymorphisms	polymorphism	NNS	_	27	NMOD
26	(	(	-LRB-	_	27	P
27	SNPs	snp	NNS	_	19	OBJ
28	)	)	-RRB-	_	19	P
29	at	at	IN	_	19	LOC
30	120	0	CD	_	31	NMOD
31	loci	locus	NNS	_	29	PMOD
32	across	across	IN	_	19	ADV
33	the	the	DT	_	35	NMOD
34	mouse	mouse	NN	_	35	NMOD
35	genome	genome	NN	_	32	PMOD
36	.	.	.	_	13	P

1	Analysis	analysis	NN	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	these	these	DT	_	4	NMOD
4	data	datum	NNS	_	2	PMOD
5	showed	show	VBD	_	0	ROOT
6	a	a	DT	_	9	NMOD
7	single	single	JJ	_	9	NMOD
8	genomic	genomic	JJ	_	9	NMOD
9	region	region	NN	_	5	OBJ
10	with	with	IN	_	9	NMOD
11	significant	significant	JJ	_	12	NMOD
12	linkage	linkage	NN	_	10	PMOD
13	to	to	IN	_	12	NMOD
14	disease	disease	NN	_	13	PMOD
15	,	,	,	_	5	P
16	providing	provide	VBG	_	5	ADV
17	a	a	DT	_	22	NMOD
18	two	two	CD	_	20	NMOD
19	-	-	HYPH	_	18	P
20	point	point	NN	_	22	NMOD
21	LOD	lod	NN	_	22	NMOD
22	score	score	NN	_	16	OBJ
23	of	of	IN	_	22	NMOD
24	5.13	0	CD	_	23	PMOD
25	at	at	IN	_	22	LOC
26	marker	marker	NN	_	27	NMOD
27	20.MMHAP85FLG2	0.mmhap0flg0	NN	_	25	PMOD
28	on	on	IN	_	27	LOC
29	Chromosome	chromosome	NN	_	30	NMOD
30	6qE1	0qe0	NN	_	28	PMOD
31	.	.	.	_	5	P

1	The	the	DT	_	3	NMOD
2	linked	link	VBN	_	3	NMOD
3	haplotype	haplotype	NN	_	4	SBJ
4	suggested	suggest	VBD	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	mutation	mutation	NN	_	7	SBJ
7	had	have	VBD	_	4	OBJ
8	occurred	occur	VBN	_	7	VC
9	on	on	IN	_	8	ADV
10	the	the	DT	_	14	NMOD
11	129x1	0x0	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	SvJ	svj	NN	_	14	NMOD
14	background	background	NN	_	9	PMOD
15	(	(	-LRB-	_	17	P
16	Figure	figure	NN	_	17	NMOD
17	S1	s0	NN	_	4	PRN
18	)	)	-RRB-	_	17	P
19	.	.	.	_	4	P

1	Literature	literature	NN	_	2	NMOD
2	searches	search	NNS	_	3	SBJ
3	revealed	reveal	VBD	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	among	among	IN	_	17	ADV
6	disease	disease	NN	_	7	NMOD
7	lines	line	NNS	_	5	PMOD
8	mapped	map	VBN	_	7	NMOD
9	to	to	IN	_	8	ADV
10	6qE1	0qe0	NN	_	9	PMOD
11	,	,	,	_	17	P
12	the	the	DT	_	14	NMOD
13	spontaneous	spontaneous	JJ	_	14	NMOD
14	mutant	mutant	NN	_	16	NMOD
15	opt	opt	NN	_	16	NMOD
16	mouse	mouse	NN	_	17	SBJ
17	displays	display	VBZ	_	4	SUB
18	a	a	DT	_	21	NMOD
19	strikingly	strikingly	RB	_	20	AMOD
20	similar	similar	JJ	_	21	NMOD
21	presentation	presentation	NN	_	17	OBJ
22	to	to	IN	_	21	NMOD
23	that	that	DT	_	22	PMOD
24	described	describe	VBN	_	23	NMOD
25	here	here	RB	_	24	ADV
26	[	[	-LRB-	_	27	P
27	1	0	CD	_	3	PRN
28	]	]	-RRB-	_	27	P
29	.	.	.	_	3	P

1	The	the	DT	_	4	NMOD
2	underlying	underlie	VBG	_	4	NMOD
3	genetic	genetic	JJ	_	4	NMOD
4	lesion	lesion	NN	_	9	SBJ
5	causing	cause	VBG	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	opt	opt	NN	_	8	NMOD
8	phenotype	phenotype	NN	_	5	OBJ
9	is	be	VBZ	_	0	ROOT
10	a	a	DT	_	15	NMOD
11	homozygous	homozygous	JJ	_	15	NMOD
12	in	in	IN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	frame	frame	NN	_	15	NMOD
15	deletion	deletion	NN	_	9	PRD
16	of	of	IN	_	15	NMOD
17	exons	exon	NNS	_	18	NMOD
18	43	0	CD	_	16	PMOD
19	and	and	CC	_	18	COORD
20	44	0	CD	_	19	CONJ
21	of	of	IN	_	18	NMOD
22	the	the	DT	_	24	NMOD
23	gene	gene	NN	_	24	NMOD
24	Itpr1	itpr0	NN	_	21	PMOD
25	(	(	-LRB-	_	28	P
26	Itpr1opt	itpr0opt	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	opt	opt	NN	_	24	PRN
29	)	)	-RRB-	_	28	P
30	,	,	,	_	18	P
31	encoding	encode	VBG	_	18	NMOD
32	inositol	inositol	NN	_	40	NMOD
33	1	0	CD	_	37	NMOD
34	,	,	,	_	37	P
35	4	0	CD	_	37	NMOD
36	,	,	,	_	37	P
37	5	0	CD	_	39	NMOD
38	-	-	HYPH	_	37	P
39	triphosphate	triphosphate	NN	_	40	NMOD
40	receptor	receptor	NN	_	31	OBJ
41	1	0	CD	_	40	NMOD
42	(	(	-LRB-	_	43	P
43	Itpr1	itpr0	NN	_	40	PRN
44	)	)	-RRB-	_	43	P
45	.	.	.	_	9	P

1	Sequencing	sequencing	NN	_	19	SBJ
2	of	of	IN	_	1	NMOD
3	all	all	DT	_	4	NMOD
4	exons	exon	NNS	_	2	PMOD
5	and	and	CC	_	4	COORD
6	intron	intron	NN	_	8	NMOD
7	–	–	HYPH	_	6	P
8	exon	exon	NN	_	9	NMOD
9	boundaries	boundary	NNS	_	5	CONJ
10	of	of	IN	_	9	NMOD
11	Itpr1	itpr0	NN	_	10	PMOD
12	in	in	IN	_	4	LOC
13	affected	affect	VBN	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	from	from	IN	_	14	NMOD
16	the	the	DT	_	18	NMOD
17	current	current	JJ	_	18	NMOD
18	study	study	NN	_	15	PMOD
19	revealed	reveal	VBD	_	0	ROOT
20	a	a	DT	_	22	NMOD
21	single	single	JJ	_	22	NMOD
22	mutation	mutation	NN	_	31	NMOD
23	within	within	IN	_	22	LOC
24	Itpr1	itpr0	NN	_	23	PMOD
25	:	:	:	_	31	P
26	a	a	DT	_	31	NMOD
27	novel	novel	JJ	_	31	NMOD
28	in	in	IN	_	31	NMOD
29	-	-	HYPH	_	28	P
30	frame	frame	NN	_	28	PMOD
31	deletion	deletion	NN	_	19	OBJ
32	of	of	IN	_	31	NMOD
33	18	0	CD	_	34	NMOD
34	bp	bp	NN	_	32	PMOD
35	within	within	IN	_	31	LOC
36	exon	exon	NN	_	35	PMOD
37	36	0	CD	_	36	NMOD
38	(	(	-LRB-	_	41	P
39	Itpr1Δ18	itpr0δ0	NN	_	41	NMOD
40	/	/	HYPH	_	39	P
41	Δ18	δ0	NN	_	31	PRN
42	)	)	-RRB-	_	41	P
43	.	.	.	_	19	P

1	To	to	TO	_	9	PRP
2	confirm	confirm	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	pathogenicity	pathogenicity	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	this	this	DT	_	7	NMOD
7	mutation	mutation	NN	_	5	PMOD
8	we	we	PRP	_	9	SBJ
9	crossed	cross	VBD	_	0	ROOT
10	heterozygous	heterozygous	JJ	_	11	NMOD
11	mice	mouse	NNS	_	9	OBJ
12	from	from	IN	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	current	current	JJ	_	15	NMOD
15	study	study	NN	_	12	PMOD
16	(	(	-LRB-	_	19	P
17	Itpr1wt	itpr0wt	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	Δ18	δ0	NN	_	12	PRN
20	)	)	-RRB-	_	19	P
21	with	with	IN	_	9	ADV
22	mice	mouse	NNS	_	21	PMOD
23	heterozygous	heterozygous	JJ	_	22	NMOD
24	for	for	IN	_	23	AMOD
25	the	the	DT	_	27	NMOD
26	opt	opt	NN	_	27	NMOD
27	mutation	mutation	NN	_	24	PMOD
28	(	(	-LRB-	_	31	P
29	Itpr1wt	itpr0wt	NN	_	31	NMOD
30	/	/	HYPH	_	29	P
31	opt	opt	NN	_	22	PRN
32	)	)	-RRB-	_	31	P
33	.	.	.	_	9	P

1	This	this	DT	_	2	SBJ
2	resulted	result	VBD	_	0	ROOT
3	in	in	IN	_	2	ADV
4	two	two	CD	_	5	NMOD
5	litters	litter	NNS	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	mice	mouse	NNS	_	6	PMOD
8	with	with	IN	_	5	NMOD
9	a	a	DT	_	10	NMOD
10	total	total	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	four	four	CD	_	17	NMOD
13	affected	affect	VBN	_	17	NMOD
14	Itpr1opt	itpr0opt	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	Δ18	δ0	NN	_	17	NMOD
17	pups	pup	NNS	_	11	PMOD
18	(	(	-LRB-	_	10	P
19	from	from	IN	_	10	NMOD
20	a	a	DT	_	21	NMOD
21	total	total	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	15	0	CD	_	22	PMOD
24	)	)	-RRB-	_	10	P
25	with	with	IN	_	10	NMOD
26	a	a	DT	_	27	NMOD
27	phenotype	phenotype	NN	_	25	PMOD
28	indistinguishable	indistinguishable	JJ	_	27	NMOD
29	from	from	IN	_	28	AMOD
30	that	that	DT	_	29	PMOD
31	of	of	IN	_	30	NMOD
32	the	the	DT	_	40	NMOD
33	Itpr1Δ18	itpr0δ0	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	Δ18	δ0	NN	_	40	NMOD
36	and	and	CC	_	35	COORD
37	Itpr1opt	itpr0opt	NN	_	39	NMOD
38	/	/	HYPH	_	37	P
39	opt	opt	NN	_	36	CONJ
40	mice	mouse	NNS	_	31	PMOD
41	[	[	-LRB-	_	42	P
42	1	0	CD	_	2	PRN
43	]	]	-RRB-	_	42	P
44	.	.	.	_	2	P

1	Furthermore	furthermore	RB	_	5	ADV
2	,	,	,	_	5	P
3	this	this	DT	_	4	NMOD
4	phenotype	phenotype	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	similar	similar	JJ	_	5	PRD
7	,	,	,	_	6	P
8	although	although	IN	_	5	ADV
9	less	less	RBR	_	10	AMOD
10	severe	severe	JJ	_	8	SUB
11	,	,	,	_	6	P
12	to	to	IN	_	6	AMOD
13	that	that	DT	_	12	PMOD
14	described	describe	VBN	_	13	NMOD
15	in	in	IN	_	14	ADV
16	a	a	DT	_	18	NMOD
17	mouse	mouse	NN	_	18	NMOD
18	line	line	NN	_	15	PMOD
19	with	with	IN	_	18	NMOD
20	targeted	target	VBN	_	21	NMOD
21	deletion	deletion	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	Itpr1	itpr0	NN	_	22	PMOD
24	,	,	,	_	23	P
25	where	where	WRB	_	28	LOC
26	ataxia	ataxia	NN	_	27	SBJ
27	was	be	VBD	_	23	NMOD
28	described	describe	VBN	_	27	VC
29	as	as	IN	_	28	MNR
30	a	a	DT	_	32	NMOD
31	prominent	prominent	JJ	_	32	NMOD
32	feature	feature	NN	_	29	PMOD
33	[	[	-LRB-	_	34	P
34	4	0	CD	_	5	PRN
35	]	]	-RRB-	_	34	P
36	.	.	.	_	5	P

1	As	as	IN	_	37	ADV
2	with	with	IN	_	1	PMOD
3	the	the	DT	_	7	NMOD
4	Itpr1opt	itpr0opt	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	opt	opt	NN	_	7	NMOD
7	mice	mouse	NNS	_	2	PMOD
8	,	,	,	_	7	P
9	where	where	WRB	_	19	LOC
10	the	the	DT	_	11	NMOD
11	deletion	deletion	NN	_	17	SBJ
12	of	of	IN	_	11	NMOD
13	exons	exon	NNS	_	14	NMOD
14	43	0	CD	_	12	PMOD
15	and	and	CC	_	14	COORD
16	44	0	CD	_	15	CONJ
17	is	be	VBZ	_	7	NMOD
18	also	also	RB	_	17	ADV
19	predicted	predict	VBN	_	17	VC
20	to	to	TO	_	19	OPRD
21	leave	leave	VB	_	20	IM
22	the	the	DT	_	25	NMOD
23	translational	translational	JJ	_	25	NMOD
24	reading	reading	NN	_	25	NMOD
25	frame	frame	NN	_	21	OBJ
26	unaffected	unaffected	JJ	_	21	OPRD
27	,	,	,	_	37	P
28	the	the	DT	_	36	NMOD
29	in	in	IN	_	36	NMOD
30	-	-	HYPH	_	29	P
31	frame	frame	NN	_	29	PMOD
32	Itpr1Δ18	itpr0δ0	NN	_	34	NMOD
33	/	/	HYPH	_	32	P
34	Δ18	δ0	NN	_	36	NMOD
35	deletion	deletion	NN	_	36	NMOD
36	mutation	mutation	NN	_	37	SBJ
37	results	result	VBZ	_	0	ROOT
38	in	in	IN	_	37	ADV
39	markedly	markedly	RB	_	40	AMOD
40	decreased	decrease	VBN	_	41	NMOD
41	levels	level	NNS	_	38	PMOD
42	of	of	IN	_	41	NMOD
43	Itpr1	itpr0	NN	_	42	PMOD
44	in	in	IN	_	37	LOC
45	cerebellar	cerebellar	JJ	_	47	NMOD
46	Purkinje	purkinje	NNP	_	47	NMOD
47	cells	cell	NNS	_	44	PMOD
48	.	.	.	_	37	P

1	In	in	IN	_	27	LOC
2	these	these	DT	_	5	NMOD
3	two	two	CD	_	5	NMOD
4	spontaneous	spontaneous	JJ	_	5	NMOD
5	mutants	mutant	NNS	_	1	PMOD
6	[	[	-LRB-	_	7	P
7	1	0	CD	_	5	PRN
8	]	]	-RRB-	_	7	P
9	and	and	CC	_	1	COORD
10	in	in	IN	_	9	CONJ
11	the	the	DT	_	15	NMOD
12	Itpr1	itpr0	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	deficient	deficient	JJ	_	15	NMOD
15	mouse	mouse	NN	_	10	PMOD
16	[	[	-LRB-	_	17	P
17	4	0	CD	_	15	PRN
18	]	]	-RRB-	_	17	P
19	generated	generate	VBN	_	15	NMOD
20	by	by	IN	_	19	MNR
21	gene	gene	NN	_	22	NMOD
22	targeting	targeting	NN	_	20	PMOD
23	,	,	,	_	27	P
24	decreased	decrease	VBN	_	26	NMOD
25	Itpr1	itpr0	NN	_	26	NMOD
26	expression	expression	NN	_	27	SBJ
27	is	be	VBZ	_	0	ROOT
28	associated	associate	VBN	_	27	VC
29	with	with	IN	_	28	ADV
30	the	the	DT	_	35	NMOD
31	same	same	JJ	_	35	NMOD
32	autosomal	autosomal	JJ	_	35	NMOD
33	recessive	recessive	JJ	_	35	NMOD
34	movement	movement	NN	_	35	NMOD
35	disorder	disorder	NN	_	29	PMOD
36	(	(	-LRB-	_	37	P
37	Figure	figure	NN	_	28	PRN
38	1	0	CD	_	37	NMOD
39	)	)	-RRB-	_	37	P
40	.	.	.	_	27	P

1	Given	give	VBN	_	9	ADV
2	our	our	PRP$	_	3	NMOD
3	interest	interest	NN	_	1	PMOD
4	in	in	IN	_	3	NMOD
5	human	human	JJ	_	7	NMOD
6	neurological	neurological	JJ	_	7	NMOD
7	disease	disease	NN	_	4	PMOD
8	we	we	PRP	_	9	SBJ
9	sought	seek	VBD	_	0	ROOT
10	to	to	TO	_	9	OPRD
11	identify	identify	VB	_	10	IM
12	any	any	DT	_	15	NMOD
13	cognate	cognate	JJ	_	15	NMOD
14	human	human	JJ	_	15	NMOD
15	disorders	disorder	NNS	_	11	OBJ
16	where	where	WRB	_	20	LOC
17	linkage	linkage	NN	_	18	SBJ
18	had	have	VBD	_	15	NMOD
19	been	be	VBN	_	18	VC
20	established	establish	VBN	_	19	VC
21	to	to	IN	_	17	NMOD
22	the	the	DT	_	24	NMOD
23	syntenic	syntenic	JJ	_	24	NMOD
24	region	region	NN	_	21	PMOD
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	28	NMOD
27	human	human	JJ	_	28	NMOD
28	genome	genome	NN	_	25	PMOD
29	,	,	,	_	18	P
30	but	but	CC	_	18	COORD
31	where	where	WRB	_	37	LOC
32	no	no	DT	_	34	NMOD
33	causal	causal	JJ	_	34	NMOD
34	mutation	mutation	NN	_	35	SBJ
35	had	have	VBD	_	30	CONJ
36	been	be	VBN	_	35	VC
37	identified	identify	VBN	_	36	VC
38	.	.	.	_	9	P

1	SCA15	sca0	NN	_	11	SBJ
2	,	,	,	_	1	P
3	an	an	DT	_	10	NMOD
4	adult	adult	JJ	_	6	NMOD
5	-	-	HYPH	_	4	P
6	onset	onset	NN	_	10	NMOD
7	autosomal	autosomal	JJ	_	8	AMOD
8	dominant	dominant	JJ	_	10	NMOD
9	progressive	progressive	JJ	_	10	NMOD
10	ataxia	ataxia	NN	_	1	APPO
11	is	be	VBZ	_	0	ROOT
12	linked	link	VBN	_	11	VC
13	to	to	IN	_	12	ADV
14	this	this	DT	_	15	NMOD
15	locus	locus	NN	_	13	PMOD
16	[	[	-LRB-	_	17	P
17	5	0	CD	_	12	PRN
18	]	]	-RRB-	_	17	P
19	.	.	.	_	11	P

1	Although	although	IN	_	39	ADV
2	missense	missense	NN	_	3	NMOD
3	mutation	mutation	NN	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	ITPR1	itpr0	NN	_	4	PMOD
6	had	have	VBD	_	1	SUB
7	previously	previously	RB	_	6	TMP
8	been	be	VBN	_	6	VC
9	ruled	rule	VBN	_	8	VC
10	out	out	RP	_	9	PRT
11	[	[	-LRB-	_	12	P
12	2	0	CD	_	9	PRN
13	]	]	-RRB-	_	12	P
14	and	and	CC	_	6	COORD
15	the	the	DT	_	16	NMOD
16	mode	mode	NN	_	19	SBJ
17	of	of	IN	_	16	NMOD
18	inheritance	inheritance	NN	_	17	PMOD
19	was	be	VBD	_	14	CONJ
20	inconsistent	inconsistent	JJ	_	19	PRD
21	with	with	IN	_	20	AMOD
22	that	that	DT	_	21	PMOD
23	seen	see	VBN	_	22	NMOD
24	in	in	IN	_	23	LOC
25	the	the	DT	_	29	NMOD
26	Itpr1Δ18	itpr0δ0	NN	_	29	NMOD
27	and	and	CC	_	26	COORD
28	Itpr1opt	itpr0opt	NN	_	27	CONJ
29	mice	mouse	NNS	_	24	PMOD
30	,	,	,	_	39	P
31	the	the	DT	_	33	NMOD
32	phenotypic	phenotypic	JJ	_	33	NMOD
33	presence	presence	NN	_	39	SBJ
34	of	of	IN	_	33	NMOD
35	ataxia	ataxia	NN	_	34	PMOD
36	in	in	IN	_	33	LOC
37	the	the	DT	_	38	NMOD
38	mice	mouse	NNS	_	36	PMOD
39	led	lead	VBD	_	0	ROOT
40	us	us	PRP	_	39	OBJ
41	to	to	TO	_	39	OPRD
42	reexamine	reexamine	VB	_	41	IM
43	this	this	DT	_	45	NMOD
44	candidate	candidate	NN	_	45	NMOD
45	gene	gene	NN	_	42	OBJ
46	as	as	IN	_	42	ADV
47	a	a	DT	_	49	NMOD
48	possible	possible	JJ	_	49	NMOD
49	cause	cause	NN	_	46	PMOD
50	of	of	IN	_	49	NMOD
51	SCA15	sca0	NN	_	50	PMOD
52	.	.	.	_	39	P

1	We	we	PRP	_	2	SBJ
2	obtained	obtain	VBD	_	0	ROOT
3	genomic	genomic	JJ	_	4	NMOD
4	DNA	dna	NN	_	2	OBJ
5	from	from	IN	_	2	ADV
6	three	three	CD	_	9	NMOD
7	affected	affect	VBN	_	9	NMOD
8	family	family	NN	_	9	NMOD
9	members	member	NNS	_	5	PMOD
10	and	and	CC	_	9	COORD
11	one	one	CD	_	13	NMOD
12	family	family	NN	_	13	NMOD
13	member	member	NN	_	10	CONJ
14	with	with	IN	_	13	NMOD
15	unknown	unknown	JJ	_	17	NMOD
16	disease	disease	NN	_	17	NMOD
17	status	status	NN	_	14	PMOD
18	from	from	IN	_	9	NMOD
19	the	the	DT	_	20	NMOD
20	kindred	kindred	NN	_	18	PMOD
21	originally	originally	RB	_	22	ADV
22	used	use	VBN	_	20	NMOD
23	to	to	TO	_	22	PRP
24	define	define	VB	_	23	IM
25	and	and	CC	_	24	COORD
26	map	map	VB	_	25	CONJ
27	SCA15	sca0	NN	_	24	OBJ
28	(	(	-LRB-	_	30	P
29	family	family	NN	_	30	NMOD
30	AUS1	aus0	NN	_	27	PRN
31	,	,	,	_	30	P
32	of	of	IN	_	30	NMOD
33	Australian	australian	JJ	_	37	NMOD
34	Anglo	anglo	AFX	_	36	AMOD
35	-	-	HYPH	_	34	P
36	Celtic	celtic	JJ	_	37	NMOD
37	origin	origin	NN	_	32	PMOD
38	)	)	-RRB-	_	30	P
39	[	[	-LRB-	_	40	P
40	2	0	CD	_	2	PRN
41	]	]	-RRB-	_	40	P
42	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	performed	perform	VBD	_	0	ROOT
3	two	two	CD	_	4	NMOD
4	experiments	experiment	NNS	_	2	OBJ
5	concurrently	concurrently	RB	_	2	ADV
6	in	in	IN	_	2	LOC
7	three	three	CD	_	9	NMOD
8	affected	affect	VBN	_	9	NMOD
9	members	member	NNS	_	6	PMOD
10	of	of	IN	_	9	NMOD
11	this	this	DT	_	12	NMOD
12	family	family	NN	_	10	PMOD
13	:	:	:	_	4	P
14	sequence	sequence	NN	_	15	NMOD
15	analysis	analysis	NN	_	4	NMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	coding	code	VBG	_	19	NMOD
19	exons	exon	NNS	_	16	PMOD
20	of	of	IN	_	19	NMOD
21	ITPR1	itpr0	NN	_	20	PMOD
22	and	and	CC	_	15	COORD
23	high	high	JJ	_	25	NMOD
24	-	-	HYPH	_	23	P
25	density	density	NN	_	30	NMOD
26	genome	genome	NN	_	30	NMOD
27	-	-	HYPH	_	26	P
28	wide	wide	JJ	_	26	NMOD
29	SNP	snp	NN	_	30	NMOD
30	genotyping	genotyping	NN	_	22	CONJ
31	.	.	.	_	2	P

1	Sequence	sequence	NN	_	2	NMOD
2	analysis	analysis	NN	_	3	SBJ
3	failed	fail	VBD	_	0	ROOT
4	to	to	TO	_	3	OPRD
5	show	show	VB	_	4	IM
6	any	any	DT	_	8	NMOD
7	coding	coding	NN	_	8	NMOD
8	alterations	alteration	NNS	_	5	OBJ
9	segregating	segregate	VBG	_	8	NMOD
10	with	with	IN	_	9	ADV
11	disease	disease	NN	_	10	PMOD
12	or	or	CC	_	11	COORD
13	any	any	DT	_	14	NMOD
14	alterations	alteration	NNS	_	12	CONJ
15	that	that	WDT	_	16	SBJ
16	were	be	VBD	_	14	NMOD
17	inconsistent	inconsistent	JJ	_	16	PRD
18	with	with	IN	_	17	AMOD
19	Mendelian	mendelian	JJ	_	20	NMOD
20	patterns	pattern	NNS	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	inheritance	inheritance	NN	_	21	PMOD
23	within	within	IN	_	20	NMOD
24	the	the	DT	_	25	NMOD
25	family	family	NN	_	23	PMOD
26	.	.	.	_	3	P

1	However	however	RB	_	22	ADV
2	,	,	,	_	22	P
3	visualization	visualization	NN	_	22	SBJ
4	of	of	IN	_	3	NMOD
5	log	log	NN	_	6	NMOD
6	R	r	NN	_	7	NMOD
7	ratio	ratio	NN	_	4	PMOD
8	and	and	CC	_	7	COORD
9	B	b	NN	_	10	NMOD
10	allele	allele	NN	_	12	NMOD
11	frequency	frequency	NN	_	12	NMOD
12	metrics	metric	NNS	_	8	CONJ
13	from	from	IN	_	12	NMOD
14	the	the	DT	_	20	NMOD
15	genome	genome	NN	_	17	AMOD
16	-	-	HYPH	_	15	P
17	wide	wide	JJ	_	20	NMOD
18	SNP	snp	NN	_	20	NMOD
19	genotyping	genotyping	NN	_	20	NMOD
20	experiments	experiment	NNS	_	13	PMOD
21	clearly	clearly	RB	_	22	ADV
22	showed	show	VBD	_	0	ROOT
23	data	datum	NNS	_	22	OBJ
24	consistent	consistent	JJ	_	23	NMOD
25	with	with	IN	_	24	AMOD
26	a	a	DT	_	29	NMOD
27	heterozygous	heterozygous	JJ	_	29	NMOD
28	genomic	genomic	JJ	_	29	NMOD
29	deletion	deletion	NN	_	25	PMOD
30	across	across	IN	_	29	LOC
31	the	the	DT	_	35	NMOD
32	first	$#ORD#$	JJ	_	35	NMOD
33	one	one	CD	_	35	NMOD
34	-	-	HYPH	_	33	P
35	third	$#ORD#$	NN	_	30	PMOD
36	of	of	IN	_	35	NMOD
37	ITPR1	itpr0	NN	_	36	PMOD
38	and	and	CC	_	30	COORD
39	across	across	IN	_	38	CONJ
40	the	the	DT	_	42	NMOD
41	first	$#ORD#$	JJ	_	42	NMOD
42	half	half	NN	_	39	PMOD
43	of	of	IN	_	42	NMOD
44	a	a	DT	_	46	NMOD
45	neighboring	neighboring	JJ	_	46	NMOD
46	gene	gene	NN	_	43	PMOD
47	,	,	,	_	46	P
48	SUMF1	sumf0	NN	_	46	APPO
49	(	(	-LRB-	_	50	P
50	Figure	figure	NN	_	22	PRN
51	2	0	CD	_	50	NMOD
52	)	)	-RRB-	_	50	P
53	.	.	.	_	22	P

1	This	this	DT	_	2	NMOD
2	deletion	deletion	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	apparent	apparent	JJ	_	3	PRD
5	in	in	IN	_	4	LOC
6	all	all	DT	_	10	NMOD
7	three	three	CD	_	10	NMOD
8	affected	affect	VBN	_	10	NMOD
9	family	family	NN	_	10	NMOD
10	members	member	NNS	_	5	PMOD
11	studied	study	VBN	_	10	NMOD
12	and	and	CC	_	4	COORD
13	absent	absent	JJ	_	12	CONJ
14	from	from	IN	_	13	AMOD
15	the	the	DT	_	17	NMOD
16	family	family	NN	_	17	NMOD
17	member	member	NN	_	14	PMOD
18	with	with	IN	_	17	NMOD
19	unknown	unknown	JJ	_	21	NMOD
20	affection	affection	NN	_	21	NMOD
21	status	status	NN	_	18	PMOD
22	(	(	-LRB-	_	23	P
23	Figure	figure	NN	_	3	PRN
24	3	0	CD	_	23	NMOD
25	)	)	-RRB-	_	23	P
26	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	SNP	snp	NN	_	3	NMOD
3	data	datum	NNS	_	4	SBJ
4	showed	show	VBD	_	28	DEP
5	a	a	DT	_	6	NMOD
6	deletion	deletion	NN	_	4	OBJ
7	of	of	IN	_	6	NMOD
8	between	between	IN	_	7	PMOD
9	188	0	CD	_	10	NMOD
10	kb	kb	NN	_	8	PMOD
11	and	and	CC	_	10	COORD
12	210	0	CD	_	13	NMOD
13	kb	kb	NN	_	11	CONJ
14	in	in	IN	_	10	NMOD
15	size	size	NN	_	14	PMOD
16	;	;	:	_	28	P
17	examination	examination	NN	_	28	SBJ
18	of	of	IN	_	17	NMOD
19	SNPs	snp	NNS	_	18	PMOD
20	at	at	IN	_	19	LOC
21	the	the	DT	_	24	NMOD
22	flanking	flank	VBG	_	24	NMOD
23	unknown	unknown	JJ	_	24	NMOD
24	regions	region	NNS	_	20	PMOD
25	of	of	IN	_	24	NMOD
26	this	this	DT	_	27	NMOD
27	deletion	deletion	NN	_	25	PMOD
28	allowed	allow	VBD	_	0	ROOT
29	us	us	PRP	_	30	SBJ
30	to	to	TO	_	28	OPRD
31	delimit	delimit	VB	_	30	IM
32	the	the	DT	_	33	NMOD
33	borders	border	NNS	_	31	OBJ
34	of	of	IN	_	33	NMOD
35	the	the	DT	_	36	NMOD
36	deletion	deletion	NN	_	34	PMOD
37	to	to	IN	_	31	ADV
38	7.5	0	CD	_	39	NMOD
39	kb	kb	NN	_	37	PMOD
40	on	on	IN	_	39	LOC
41	the	the	DT	_	43	NMOD
42	telomeric	telomeric	JJ	_	43	NMOD
43	side	side	NN	_	40	PMOD
44	of	of	IN	_	43	NMOD
45	the	the	DT	_	46	NMOD
46	deletion	deletion	NN	_	44	PMOD
47	(	(	-LRB-	_	43	P
48	between	between	IN	_	43	NMOD
49	rs12634249	rs0	NN	_	48	PMOD
50	and	and	CC	_	49	COORD
51	rs793396	rs0	NN	_	50	CONJ
52	)	)	-RRB-	_	43	P
53	and	and	CC	_	39	COORD
54	~	~	SYM	_	55	P
55	14.4	0	CD	_	56	NMOD
56	kb	kb	NN	_	53	CONJ
57	on	on	IN	_	56	LOC
58	the	the	DT	_	60	NMOD
59	centromeric	centromeric	JJ	_	60	NMOD
60	side	side	NN	_	57	PMOD
61	of	of	IN	_	60	NMOD
62	the	the	DT	_	63	NMOD
63	deletion	deletion	NN	_	61	PMOD
64	(	(	-LRB-	_	60	P
65	between	between	IN	_	60	NMOD
66	rs4073665	rs0	NN	_	65	PMOD
67	and	and	CC	_	66	COORD
68	rs17709863	rs0	NN	_	67	CONJ
69	)	)	-RRB-	_	60	P
70	.	.	.	_	28	P

1	In	in	IN	_	14	ADV
2	an	an	DT	_	3	NMOD
3	attempt	attempt	NN	_	1	PMOD
4	to	to	TO	_	3	NMOD
5	define	define	VB	_	4	IM
6	whether	whether	IN	_	5	OBJ
7	this	this	DT	_	8	NMOD
8	variation	variation	NN	_	9	SBJ
9	was	be	VBD	_	6	SUB
10	a	a	DT	_	12	NMOD
11	benign	benign	JJ	_	12	NMOD
12	polymorphism	polymorphism	NN	_	9	PRD
13	we	we	PRP	_	14	SBJ
14	analyzed	analyze	VBD	_	0	ROOT
15	genome	genome	NN	_	17	AMOD
16	-	-	HYPH	_	15	P
17	wide	wide	JJ	_	19	NMOD
18	SNP	snp	NN	_	19	NMOD
19	data	datum	NNS	_	14	OBJ
20	at	at	IN	_	19	LOC
21	this	this	DT	_	22	NMOD
22	locus	locus	NN	_	20	PMOD
23	,	,	,	_	19	P
24	produced	produce	VBN	_	19	NMOD
25	using	use	VBG	_	24	MNR
26	the	the	DT	_	29	NMOD
27	same	same	JJ	_	29	NMOD
28	genotyping	genotyping	NN	_	29	NMOD
29	chip	chip	NN	_	25	OBJ
30	,	,	,	_	29	P
31	from	from	IN	_	29	NMOD
32	577	0	CD	_	33	NMOD
33	individuals	individual	NNS	_	31	PMOD
34	of	of	IN	_	33	NMOD
35	European	european	JJ	_	36	NMOD
36	descent	descent	NN	_	34	PMOD
37	who	who	WP	_	38	SBJ
38	were	be	VBD	_	33	NMOD
39	either	either	CC	_	40	COORD
40	controls	control	NNS	_	38	PRD
41	or	or	CC	_	40	COORD
42	individuals	individual	NNS	_	41	CONJ
43	with	with	IN	_	42	NMOD
44	an	an	DT	_	47	NMOD
45	unrelated	unrelated	JJ	_	47	NMOD
46	neurological	neurological	JJ	_	47	NMOD
47	disorder	disorder	NN	_	43	PMOD
48	.	.	.	_	14	P

1	We	we	PRP	_	2	SBJ
2	failed	fail	VBD	_	20	DEP
3	to	to	TO	_	2	OPRD
4	find	find	VB	_	3	IM
5	any	any	DT	_	6	NMOD
6	deletions	deletion	NNS	_	4	OBJ
7	affecting	affect	VBG	_	6	NMOD
8	the	the	DT	_	10	NMOD
9	coding	coding	NN	_	10	NMOD
10	sequence	sequence	NN	_	7	OBJ
11	of	of	IN	_	10	NMOD
12	either	either	DT	_	13	NMOD
13	gene	gene	NN	_	11	PMOD
14	,	,	,	_	13	P
15	ITPR1	itpr0	NN	_	13	APPO
16	or	or	CC	_	15	COORD
17	SUMF1	sumf0	NN	_	16	CONJ
18	;	;	:	_	20	P
19	we	we	PRP	_	20	SBJ
20	did	do	VBD	_	0	ROOT
21	,	,	,	_	20	P
22	however	however	RB	_	20	ADV
23	,	,	,	_	20	P
24	identify	identify	VB	_	20	VC
25	a	a	DT	_	27	NMOD
26	single	single	JJ	_	27	NMOD
27	individual	individual	NN	_	24	OBJ
28	with	with	IN	_	27	NMOD
29	a	a	DT	_	32	NMOD
30	possible	possible	JJ	_	32	NMOD
31	heterozygous	heterozygous	JJ	_	32	NMOD
32	deletion	deletion	NN	_	35	NMOD
33	approximately	approximately	RB	_	34	QMOD
34	6	0	CD	_	35	NMOD
35	kb	kb	NN	_	28	PMOD
36	in	in	IN	_	35	NMOD
37	size	size	NN	_	36	PMOD
38	within	within	IN	_	35	LOC
39	intron	intron	NN	_	40	NMOD
40	40	0	CD	_	38	PMOD
41	–	–	SYM	_	42	P
42	41	0	CD	_	40	NMOD
43	of	of	IN	_	40	NMOD
44	ITPR1	itpr0	NN	_	43	PMOD
45	,	,	,	_	40	P
46	at	at	RB	_	47	QMOD
47	least	least	RBS	_	49	NMOD
48	5	0	CD	_	47	QMOD
49	kb	kb	NN	_	50	AMOD
50	away	away	RB	_	40	LOC
51	from	from	IN	_	50	AMOD
52	exon	exon	NN	_	51	PMOD
53	40	0	CD	_	52	NMOD
54	.	.	.	_	20	P

1	Given	give	VBN	_	8	ADV
2	the	the	DT	_	3	NMOD
3	location	location	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	alteration	alteration	NN	_	4	PMOD
7	it	it	PRP	_	8	SBJ
8	is	be	VBZ	_	0	ROOT
9	unlikely	unlikely	JJ	_	8	PRD
10	to	to	TO	_	9	AMOD
11	effect	effect	VB	_	10	IM
12	the	the	DT	_	13	NMOD
13	expression	expression	NN	_	11	OBJ
14	or	or	CC	_	13	COORD
15	splicing	splicing	NN	_	14	CONJ
16	of	of	IN	_	13	NMOD
17	ITPR1	itpr0	NN	_	16	PMOD
18	.	.	.	_	8	P

1	In	in	IN	_	17	ADV
2	an	an	DT	_	3	NMOD
3	attempt	attempt	NN	_	1	PMOD
4	to	to	TO	_	3	NMOD
5	fine	fine	RB	_	7	ADV
6	-	-	HYPH	_	5	P
7	map	map	VB	_	4	IM
8	the	the	DT	_	9	NMOD
9	breakpoints	breakpoints	NNS	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	15	NMOD
12	disease	disease	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	causing	cause	VBG	_	15	NMOD
15	deletion	deletion	NN	_	10	PMOD
16	we	we	PRP	_	17	SBJ
17	performed	perform	VBD	_	0	ROOT
18	a	a	DT	_	19	NMOD
19	series	series	NN	_	17	OBJ
20	of	of	IN	_	19	NMOD
21	experiments	experiment	NNS	_	20	PMOD
22	designed	design	VBN	_	21	NMOD
23	to	to	TO	_	22	PRP
24	refine	refine	VB	_	23	IM
25	the	the	DT	_	27	NMOD
26	unknown	unknown	JJ	_	27	NMOD
27	intervals	interval	NNS	_	24	OBJ
28	at	at	IN	_	24	ADV
29	the	the	DT	_	30	NMOD
30	edges	edge	NNS	_	28	PMOD
31	between	between	IN	_	30	NMOD
32	definite	definite	JJ	_	33	AMOD
33	deleted	delete	VBN	_	37	NMOD
34	and	and	CC	_	33	COORD
35	definite	definite	JJ	_	36	AMOD
36	diploid	diploid	JJ	_	34	CONJ
37	sequences	sequence	NNS	_	31	PMOD
38	.	.	.	_	17	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	narrowed	narrow	VBD	_	0	ROOT
4	the	the	DT	_	6	NMOD
5	unknown	unknown	JJ	_	6	NMOD
6	borders	border	NNS	_	3	OBJ
7	to	to	IN	_	3	ADV
8	~	~	SYM	_	9	P
9	4	0	CD	_	10	NMOD
10	kb	kb	NN	_	7	PMOD
11	on	on	IN	_	10	LOC
12	the	the	DT	_	14	NMOD
13	telomeric	telomeric	JJ	_	14	NMOD
14	side	side	NN	_	11	PMOD
15	and	and	CC	_	10	COORD
16	~	~	SYM	_	17	P
17	7	0	CD	_	18	NMOD
18	kb	kb	NN	_	15	CONJ
19	on	on	IN	_	18	LOC
20	the	the	DT	_	22	NMOD
21	centromeric	centromeric	JJ	_	22	NMOD
22	side	side	NN	_	19	PMOD
23	.	.	.	_	3	P

1	We	we	PRP	_	2	SBJ
2	used	use	VBD	_	0	ROOT
3	all	all	DT	_	5	NMOD
4	possible	possible	JJ	_	5	NMOD
5	combinations	combination	NNS	_	2	OBJ
6	of	of	IN	_	5	NMOD
7	forward	forward	JJ	_	8	NMOD
8	orientation	orientation	NN	_	9	NMOD
9	primers	primer	NNS	_	6	PMOD
10	designed	design	VBN	_	9	NMOD
11	within	within	IN	_	10	LOC
12	the	the	DT	_	16	NMOD
13	newly	newly	RB	_	14	AMOD
14	defined	define	VBN	_	16	NMOD
15	telomeric	telomeric	JJ	_	16	NMOD
16	boundary	boundary	NN	_	11	PMOD
17	and	and	CC	_	6	COORD
18	of	of	IN	_	17	CONJ
19	reverse	reverse	JJ	_	20	NMOD
20	orientation	orientation	NN	_	21	NMOD
21	primers	primer	NNS	_	18	PMOD
22	designed	design	VBN	_	21	NMOD
23	within	within	IN	_	22	LOC
24	the	the	DT	_	28	NMOD
25	newly	newly	RB	_	26	AMOD
26	defined	define	VBN	_	28	NMOD
27	centromeric	centromeric	JJ	_	28	NMOD
28	boundary	boundary	NN	_	23	PMOD
29	in	in	IN	_	2	ADV
30	PCR	pcr	NN	_	31	NMOD
31	assays	assay	NNS	_	29	PMOD
32	in	in	IN	_	2	ADV
33	an	an	DT	_	34	NMOD
34	attempt	attempt	NN	_	32	PMOD
35	to	to	TO	_	34	NMOD
36	amplify	amplify	VB	_	35	IM
37	across	across	IN	_	36	ADV
38	the	the	DT	_	39	NMOD
39	deletion	deletion	NN	_	37	PMOD
40	in	in	IN	_	39	LOC
41	affected	affect	VBN	_	43	NMOD
42	family	family	NN	_	43	NMOD
43	members	member	NNS	_	40	PMOD
44	.	.	.	_	2	P

1	Using	use	VBG	_	18	MNR
2	PCR	pcr	NN	_	3	NMOD
3	primers	primer	NNS	_	4	NMOD
4	T3F	t0f	NN	_	1	OBJ
5	and	and	CC	_	4	COORD
6	C11R	c0r	NN	_	5	CONJ
7	,	,	,	_	4	P
8	which	which	WDT	_	9	SBJ
9	should	should	MD	_	4	NMOD
10	be	be	VB	_	9	VC
11	more	more	JJR	_	14	NMOD
12	than	than	IN	_	11	QMOD
13	200	0	CD	_	11	QMOD
14	kb	kb	NN	_	15	AMOD
15	apart	apart	RB	_	10	LOC
16	,	,	,	_	18	P
17	we	we	PRP	_	18	SBJ
18	were	be	VBD	_	0	ROOT
19	able	able	JJ	_	18	PRD
20	to	to	TO	_	19	AMOD
21	amplify	amplify	VB	_	20	IM
22	a	a	DT	_	23	NMOD
23	fragment	fragment	NN	_	25	NMOD
24	953	0	CD	_	25	NMOD
25	bp	bp	NN	_	21	OBJ
26	in	in	IN	_	25	NMOD
27	size	size	NN	_	26	PMOD
28	using	use	VBG	_	21	MNR
29	DNA	dna	NN	_	28	OBJ
30	from	from	IN	_	29	NMOD
31	each	each	DT	_	30	PMOD
32	of	of	IN	_	31	NMOD
33	the	the	DT	_	37	NMOD
34	three	three	CD	_	37	NMOD
35	affected	affect	VBN	_	37	NMOD
36	family	family	NN	_	37	NMOD
37	members	member	NNS	_	32	PMOD
38	as	as	IN	_	28	MNR
39	template	template	NN	_	38	PMOD
40	.	.	.	_	18	P

1	Sequencing	sequencing	NN	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	this	this	DT	_	4	NMOD
4	fragment	fragment	NN	_	2	PMOD
5	revealed	reveal	VBD	_	0	ROOT
6	a	a	DT	_	7	NMOD
7	deletion	deletion	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	201,509	0	CD	_	10	NMOD
10	bp	bp	NN	_	8	PMOD
11	(	(	-LRB-	_	13	P
12	Figure	figure	NN	_	13	NMOD
13	S3	s0	NN	_	5	PRN
14	)	)	-RRB-	_	13	P
15	,	,	,	_	5	P
16	removing	remove	VBG	_	5	ADV
17	the	the	DT	_	19	NMOD
18	first	$#ORD#$	JJ	_	19	NMOD
19	three	three	CD	_	16	OBJ
20	of	of	IN	_	19	NMOD
21	the	the	DT	_	23	NMOD
22	nine	nine	CD	_	23	NMOD
23	exons	exon	NNS	_	20	PMOD
24	of	of	IN	_	23	NMOD
25	SUMF1	sumf0	NN	_	24	PMOD
26	and	and	CC	_	19	COORD
27	the	the	DT	_	29	NMOD
28	first	$#ORD#$	JJ	_	29	NMOD
29	ten	ten	CD	_	26	CONJ
30	of	of	IN	_	29	NMOD
31	the	the	DT	_	33	NMOD
32	58	0	CD	_	33	NMOD
33	exons	exon	NNS	_	30	PMOD
34	of	of	IN	_	33	NMOD
35	ITPR1	itpr0	NN	_	34	PMOD
36	.	.	.	_	5	P

1	We	we	PRP	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	unable	unable	JJ	_	2	PRD
4	to	to	TO	_	3	AMOD
5	amplify	amplify	VB	_	4	IM
6	the	the	DT	_	10	NMOD
7	deletion	deletion	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	specific	specific	JJ	_	10	NMOD
10	fragment	fragment	NN	_	5	OBJ
11	in	in	IN	_	10	LOC
12	the	the	DT	_	14	NMOD
13	family	family	NN	_	14	NMOD
14	member	member	NN	_	11	PMOD
15	of	of	IN	_	14	NMOD
16	unknown	unknown	JJ	_	18	NMOD
17	affection	affection	NN	_	18	NMOD
18	status	status	NN	_	15	PMOD
19	,	,	,	_	11	P
20	or	or	CC	_	11	COORD
21	in	in	IN	_	20	CONJ
22	275	0	CD	_	25	NMOD
23	neurologically	neurologically	RB	_	24	AMOD
24	normal	normal	JJ	_	25	NMOD
25	controls	control	NNS	_	21	PMOD
26	.	.	.	_	2	P

1	To	to	TO	_	14	PRP
2	further	far	RB	_	1	ADV
3	establish	establish	VB	_	1	IM
4	genetic	genetic	JJ	_	5	NMOD
5	deletion	deletion	NN	_	3	OBJ
6	at	at	IN	_	5	LOC
7	ITPR1	itpr0	NN	_	6	PMOD
8	as	as	IN	_	3	ADV
9	the	the	DT	_	10	NMOD
10	cause	cause	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	SCA15	sca0	NN	_	11	PMOD
13	we	we	PRP	_	14	SBJ
14	analyzed	analyze	VBD	_	0	ROOT
15	two	two	CD	_	17	NMOD
16	additional	additional	JJ	_	17	NMOD
17	families	family	NNS	_	14	OBJ
18	with	with	IN	_	17	NMOD
19	an	an	DT	_	22	NMOD
20	inherited	inherit	VBN	_	22	NMOD
21	cerebellar	cerebellar	JJ	_	22	NMOD
22	ataxia	ataxia	NN	_	18	PMOD
23	similar	similar	JJ	_	22	NMOD
24	to	to	IN	_	23	AMOD
25	that	that	DT	_	24	PMOD
26	described	describe	VBN	_	25	NMOD
27	in	in	IN	_	26	ADV
28	the	the	DT	_	30	NMOD
29	AUS1	aus0	NN	_	30	NMOD
30	family	family	NN	_	27	PMOD
31	,	,	,	_	26	P
32	ascertained	ascertain	VBN	_	26	VC
33	through	through	IN	_	32	MNR
34	neurology	neurology	NN	_	35	NMOD
35	clinics	clinic	NNS	_	33	PMOD
36	in	in	IN	_	35	LOC
37	London	london	NNP	_	36	PMOD
38	,	,	,	_	37	P
39	United	united	NNP	_	40	NMOD
40	Kingdom	kingdom	NNP	_	37	APPO
41	.	.	.	_	14	P

1	DNA	dna	NN	_	16	SBJ
2	extracted	extract	VBN	_	1	NMOD
3	from	from	IN	_	2	ADV
4	probands	probands	NNS	_	3	PMOD
5	from	from	IN	_	4	NMOD
6	these	these	DT	_	8	NMOD
7	two	two	CD	_	8	NMOD
8	families	family	NNS	_	5	PMOD
9	(	(	-LRB-	_	11	P
10	family	family	NN	_	11	NMOD
11	H33	h0	NN	_	8	PRN
12	and	and	CC	_	11	COORD
13	family	family	NN	_	14	NMOD
14	H27	h0	NN	_	12	CONJ
15	)	)	-RRB-	_	11	P
16	were	be	VBD	_	0	ROOT
17	also	also	RB	_	16	ADV
18	analyzed	analyze	VBN	_	16	VC
19	using	use	VBG	_	18	MNR
20	Illumina	illumina	NNP	_	22	NMOD
21	Infinium	infinium	NNP	_	22	NMOD
22	HumanHap550	humanhap0	NNP	_	24	NMOD
23	genotyping	genotyping	NN	_	24	NMOD
24	chips	chip	NNS	_	19	OBJ
25	.	.	.	_	16	P

1	These	these	DT	_	2	NMOD
2	experiments	experiment	NNS	_	3	SBJ
3	showed	show	VBD	_	0	ROOT
4	deletion	deletion	NN	_	3	OBJ
5	at	at	IN	_	3	LOC
6	the	the	DT	_	8	NMOD
7	SCA15	sca0	NN	_	8	NMOD
8	locus	locus	NN	_	5	PMOD
9	in	in	IN	_	3	LOC
10	all	all	DT	_	12	NMOD
11	affected	affect	VBN	_	12	NMOD
12	members	member	NNS	_	9	PMOD
13	assayed	assay	VBN	_	12	NMOD
14	,	,	,	_	12	P
15	from	from	IN	_	12	NMOD
16	SUMF1	sumf0	NN	_	15	PMOD
17	through	through	IN	_	15	PMOD
18	ITPR1	itpr0	NN	_	17	PMOD
19	.	.	.	_	3	P

1	These	these	DT	_	2	NMOD
2	mutations	mutation	NNS	_	3	SBJ
3	segregated	segregate	VBD	_	0	ROOT
4	with	with	IN	_	3	ADV
5	disease	disease	NN	_	4	PMOD
6	in	in	IN	_	5	NMOD
7	these	these	DT	_	9	NMOD
8	two	two	CD	_	9	NMOD
9	families	family	NNS	_	6	PMOD
10	(	(	-LRB-	_	12	P
11	Figure	figure	NN	_	12	NMOD
12	S3	s0	NN	_	3	PRN
13	)	)	-RRB-	_	12	P
14	.	.	.	_	3	P

1	A	a	DT	_	2	NMOD
2	strategy	strategy	NN	_	9	SBJ
3	similar	similar	JJ	_	2	NMOD
4	to	to	IN	_	3	AMOD
5	the	the	DT	_	6	NMOD
6	one	one	CD	_	4	PMOD
7	outlined	outline	VBN	_	6	NMOD
8	above	above	RB	_	7	ADV
9	enabled	enable	VBD	_	0	ROOT
10	us	us	PRP	_	9	OBJ
11	to	to	TO	_	9	OPRD
12	sequence	sequence	VB	_	11	IM
13	over	over	IN	_	12	ADV
14	the	the	DT	_	15	NMOD
15	breakpoint	breakpoint	NN	_	13	PMOD
16	in	in	IN	_	12	ADV
17	family	family	NN	_	18	NMOD
18	H27	h0	NN	_	16	PMOD
19	but	but	CC	_	18	COORD
20	not	not	RB	_	19	ADV
21	family	family	NN	_	22	NMOD
22	H33	h0	NN	_	19	CONJ
23	.	.	.	_	9	P

1	In	in	IN	_	7	ADV
2	the	the	DT	_	3	NMOD
3	former	former	JJ	_	1	PMOD
4	,	,	,	_	7	P
5	the	the	DT	_	6	NMOD
6	deletion	deletion	NN	_	7	SBJ
7	spans	span	VBZ	_	30	DEP
8	344,408	0	CD	_	9	NMOD
9	bp	bp	NN	_	7	OBJ
10	,	,	,	_	7	P
11	removing	remove	VBG	_	7	ADV
12	exons	exon	NNS	_	13	NMOD
13	1	0	CD	_	11	OBJ
14	–	–	SYM	_	15	P
15	3	0	CD	_	13	NMOD
16	of	of	IN	_	13	NMOD
17	SUMF1	sumf0	NN	_	16	PMOD
18	and	and	CC	_	13	COORD
19	1	0	CD	_	18	CONJ
20	–	–	SYM	_	21	P
21	44	0	CD	_	19	NMOD
22	of	of	IN	_	19	NMOD
23	ITPR1	itpr0	NN	_	22	PMOD
24	;	;	:	_	30	P
25	in	in	IN	_	30	LOC
26	the	the	DT	_	27	NMOD
27	latter	latter	JJ	_	25	PMOD
28	,	,	,	_	30	P
29	we	we	PRP	_	30	SBJ
30	estimate	estimate	VBP	_	0	ROOT
31	that	that	IN	_	30	OBJ
32	the	the	DT	_	33	NMOD
33	deletion	deletion	NN	_	34	SBJ
34	is	be	VBZ	_	31	SUB
35	310	0	CD	_	36	NMOD
36	kb	kb	NN	_	34	PRD
37	in	in	IN	_	36	NMOD
38	length	length	NN	_	37	PMOD
39	and	and	CC	_	31	COORD
40	that	that	IN	_	39	CONJ
41	it	it	PRP	_	42	SBJ
42	removes	remove	VBZ	_	40	SUB
43	exons	exon	NNS	_	44	NMOD
44	1	0	CD	_	42	OBJ
45	–	–	SYM	_	46	P
46	3	0	CD	_	44	NMOD
47	of	of	IN	_	44	NMOD
48	SUMF1	sumf0	NN	_	47	PMOD
49	and	and	CC	_	44	COORD
50	exons	exon	NNS	_	51	NMOD
51	1	0	CD	_	49	CONJ
52	–	–	SYM	_	53	P
53	40	0	CD	_	51	NMOD
54	of	of	IN	_	51	NMOD
55	ITPR1	itpr0	NN	_	54	PMOD
56	.	.	.	_	30	P

1	The	the	DT	_	2	NMOD
2	site	site	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	mutation	mutation	NN	_	3	PMOD
5	is	be	VBZ	_	37	DEP
6	of	of	IN	_	5	PRD
7	interest	interest	NN	_	6	PMOD
8	,	,	,	_	5	P
9	particularly	particularly	RB	_	11	NMOD
10	the	the	DT	_	11	NMOD
11	fact	fact	NN	_	5	ADV
12	that	that	IN	_	11	NMOD
13	in	in	IN	_	25	ADV
14	each	each	DT	_	13	PMOD
15	of	of	IN	_	14	NMOD
16	the	the	DT	_	18	NMOD
17	three	three	CD	_	18	NMOD
18	families	family	NNS	_	15	PMOD
19	the	the	DT	_	21	NMOD
20	telomeric	telomeric	JJ	_	21	NMOD
21	end	end	NN	_	25	SBJ
22	of	of	IN	_	21	NMOD
23	the	the	DT	_	24	NMOD
24	deletion	deletion	NN	_	22	PMOD
25	is	be	VBZ	_	12	SUB
26	anchored	anchor	VBN	_	25	VC
27	between	between	IN	_	26	LOC
28	exons	exon	NNS	_	29	NMOD
29	3	0	CD	_	27	PMOD
30	and	and	CC	_	29	COORD
31	4	0	CD	_	30	CONJ
32	of	of	IN	_	29	NMOD
33	SUMF1	sumf0	NN	_	32	PMOD
34	;	;	:	_	37	P
35	sequence	sequence	NN	_	36	NMOD
36	searches	search	NNS	_	37	SBJ
37	failed	fail	VBD	_	0	ROOT
38	to	to	TO	_	37	OPRD
39	identify	identify	VB	_	38	IM
40	any	any	DT	_	42	NMOD
41	repeat	repeat	NN	_	42	NMOD
42	sequences	sequence	NNS	_	39	OBJ
43	that	that	WDT	_	44	SBJ
44	might	might	MD	_	42	NMOD
45	explain	explain	VB	_	44	VC
46	this	this	DT	_	47	NMOD
47	phenomenon	phenomenon	NN	_	45	OBJ
48	.	.	.	_	37	P

1	With	with	IN	_	24	ADV
2	three	three	CD	_	5	NMOD
3	cerebellar	cerebellar	JJ	_	5	NMOD
4	ataxia	ataxia	NN	_	5	NMOD
5	families	family	NNS	_	1	PMOD
6	segregating	segregate	VBG	_	5	NMOD
7	a	a	DT	_	11	NMOD
8	SUMF1	sumf0	NN	_	10	NMOD
9	–	–	HYPH	_	8	P
10	ITPR1	itpr0	NN	_	11	NMOD
11	deletion	deletion	NN	_	6	OBJ
12	,	,	,	_	5	P
13	and	and	CC	_	5	COORD
14	this	this	DT	_	15	NMOD
15	deletion	deletion	NN	_	13	CONJ
16	not	not	RB	_	17	ADV
17	observed	observe	VBN	_	15	NMOD
18	in	in	IN	_	17	ADV
19	a	a	DT	_	21	NMOD
20	control	control	NN	_	21	NMOD
21	population	population	NN	_	18	PMOD
22	,	,	,	_	24	P
23	we	we	PRP	_	24	SBJ
24	may	may	MD	_	0	ROOT
25	reasonably	reasonably	RB	_	24	ADV
26	conclude	conclude	VB	_	24	VC
27	that	that	IN	_	26	OBJ
28	the	the	DT	_	29	NMOD
29	association	association	NN	_	30	SBJ
30	is	be	VBZ	_	27	SUB
31	causal	causal	JJ	_	30	PRD
32	,	,	,	_	27	P
33	and	and	CC	_	27	COORD
34	that	that	IN	_	33	CONJ
35	the	the	DT	_	36	NMOD
36	deletion	deletion	NN	_	37	SBJ
37	is	be	VBZ	_	34	SUB
38	indeed	indeed	RB	_	37	ADV
39	the	the	DT	_	41	NMOD
40	genetic	genetic	JJ	_	41	NMOD
41	basis	base	NN	_	37	PRD
42	of	of	IN	_	41	NMOD
43	the	the	DT	_	44	NMOD
44	disease	disease	NN	_	42	PMOD
45	,	,	,	_	37	P
46	with	with	IN	_	37	ADV
47	SCA15	sca0	NN	_	46	SUB
48	the	the	DT	_	49	NMOD
49	diagnosis	diagnosis	NN	_	47	OPRD
50	in	in	IN	_	49	NMOD
51	the	the	DT	_	54	NMOD
52	two	two	CD	_	54	NMOD
53	British	british	JJ	_	54	NMOD
54	families	family	NNS	_	50	PMOD
55	as	as	RB	_	57	ADV
56	well	well	RB	_	57	ADV
57	as	as	IN	_	54	COORD
58	the	the	DT	_	61	NMOD
59	original	original	JJ	_	61	NMOD
60	Australian	australian	JJ	_	61	NMOD
61	family	family	NN	_	57	CONJ
62	.	.	.	_	24	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	improbable	improbable	JJ	_	2	PRD
4	that	that	IN	_	2	OBJ
5	heterozygosity	heterozygosity	NN	_	20	SBJ
6	for	for	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	deletion	deletion	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	SUMF1	sumf0	NN	_	9	PMOD
11	,	,	,	_	5	P
12	encoding	encode	VBG	_	5	NMOD
13	sulfatase	sulfatase	NN	_	15	NMOD
14	modifying	modify	VBG	_	15	NMOD
15	factor	factor	NN	_	12	OBJ
16	1	0	CD	_	15	NMOD
17	,	,	,	_	5	P
18	of	of	IN	_	5	NMOD
19	itself	itself	PRP	_	18	PMOD
20	causes	cause	VBZ	_	4	SUB
21	or	or	CC	_	20	COORD
22	contributes	contribute	VBZ	_	21	CONJ
23	to	to	IN	_	22	ADV
24	SCA15	sca0	NN	_	23	PMOD
25	.	.	.	_	2	P

1	Homozygous	homozygous	JJ	_	2	NMOD
2	mutation	mutation	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	SUMF1	sumf0	NN	_	3	PMOD
5	results	result	VBZ	_	0	ROOT
6	in	in	IN	_	5	ADV
7	autosomal	autosomal	JJ	_	11	NMOD
8	recessive	recessive	JJ	_	11	NMOD
9	multiple	multiple	JJ	_	11	NMOD
10	sulfatase	sulfatase	NN	_	11	NMOD
11	deficiency	deficiency	NN	_	6	PMOD
12	,	,	,	_	11	P
13	a	a	DT	_	15	NMOD
14	metabolic	metabolic	JJ	_	15	NMOD
15	disorder	disorder	NN	_	11	APPO
16	characterized	characterize	VBN	_	15	NMOD
17	by	by	IN	_	16	LGS
18	hepatosplenomegaly	hepatosplenomegaly	NN	_	17	PMOD
19	,	,	,	_	18	P
20	deafness	deafness	NN	_	18	CONJ
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	developmental	developmental	JJ	_	24	NMOD
24	delay	delay	NN	_	22	CONJ
25	[	[	-LRB-	_	28	P
26	6	0	CD	_	28	NMOD
27	,	,	,	_	28	P
28	7	0	CD	_	5	PRN
29	]	]	-RRB-	_	28	P
30	.	.	.	_	5	P

1	No	no	DT	_	2	NMOD
2	co-occurrence	co-occurrence	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	ataxia	ataxia	NN	_	3	PMOD
5	has	have	VBZ	_	0	ROOT
6	been	be	VBN	_	5	VC
7	described	describe	VBN	_	6	VC
8	in	in	IN	_	2	LOC
9	(	(	-LRB-	_	12	P
10	heterozygous	heterozygous	JJ	_	12	NMOD
11	)	)	-RRB-	_	12	P
12	parents	parent	NNS	_	8	PMOD
13	of	of	IN	_	12	NMOD
14	patients	patient	NNS	_	13	PMOD
15	with	with	IN	_	14	NMOD
16	multiple	multiple	JJ	_	18	NMOD
17	sulfatase	sulfatase	NN	_	18	NMOD
18	deficiency	deficiency	NN	_	15	PMOD
19	.	.	.	_	5	P

1	Conversely	conversely	RB	_	36	ADV
2	,	,	,	_	36	P
3	mutation	mutation	NN	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	ITPR1	itpr0	NN	_	4	PMOD
6	is	be	VBZ	_	36	DEP
7	biologically	biologically	RB	_	8	AMOD
8	plausible	plausible	JJ	_	6	PRD
9	as	as	IN	_	6	ADV
10	a	a	DT	_	11	NMOD
11	cause	cause	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	ataxia	ataxia	NN	_	12	PMOD
14	:	:	:	_	36	P
15	the	the	DT	_	16	NMOD
16	protein	protein	NN	_	17	SBJ
17	is	be	VBZ	_	36	DEP
18	highly	highly	RB	_	17	ADV
19	expressed	express	VBN	_	17	VC
20	in	in	IN	_	19	LOC
21	Purkinje	purkinje	NNP	_	22	NMOD
22	cells	cell	NNS	_	20	PMOD
23	;	;	:	_	36	P
24	as	as	IN	_	36	ADV
25	we	we	PRP	_	26	SBJ
26	have	have	VBP	_	24	SUB
27	shown	show	VBN	_	26	VC
28	here	here	RB	_	27	ADV
29	,	,	,	_	36	P
30	mice	mouse	NNS	_	36	SBJ
31	with	with	IN	_	30	NMOD
32	mutation	mutation	NN	_	31	PMOD
33	at	at	IN	_	32	NMOD
34	this	this	DT	_	35	NMOD
35	locus	locus	NN	_	33	PMOD
36	present	present	VBP	_	0	ROOT
37	with	with	IN	_	36	ADV
38	ataxia	ataxia	NN	_	37	PMOD
39	;	;	:	_	36	P
40	and	and	CC	_	36	COORD
41	perturbed	perturb	VBN	_	43	NMOD
42	Ca2+	ca0+	NN	_	43	NMOD
43	signaling	signaling	NN	_	44	SBJ
44	has	have	VBZ	_	40	CONJ
45	previously	previously	RB	_	44	TMP
46	been	be	VBN	_	44	VC
47	implicated	implicate	VBN	_	46	VC
48	in	in	IN	_	47	ADV
49	the	the	DT	_	50	NMOD
50	etiology	etiology	NN	_	48	PMOD
51	of	of	IN	_	50	NMOD
52	ataxia	ataxia	NN	_	51	PMOD
53	,	,	,	_	47	P
54	notably	notably	RB	_	55	PMOD
55	in	in	IN	_	47	LOC
56	episodic	episodic	JJ	_	58	NMOD
57	ataxia	ataxia	NN	_	58	NMOD
58	type	type	NN	_	55	PMOD
59	2	0	CD	_	58	NMOD
60	and	and	CC	_	58	COORD
61	SCA6	sca0	NN	_	60	CONJ
62	[	[	-LRB-	_	63	P
63	8	0	CD	_	47	PRN
64	]	]	-RRB-	_	63	P
65	.	.	.	_	36	P

1	In	in	IN	_	31	ADV
2	further	further	JJ	_	3	NMOD
3	support	support	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	conclusion	conclusion	NN	_	4	PMOD
7	,	,	,	_	31	P
8	analysis	analysis	NN	_	31	SBJ
9	of	of	IN	_	8	NMOD
10	protein	protein	NN	_	11	NMOD
11	levels	level	NNS	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	ITPR1	itpr0	NN	_	12	PMOD
14	in	in	IN	_	13	LOC
15	Epstein	epstein	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	Barr	barr	NN	_	18	NMOD
18	virus	virus	NN	_	20	NMOD
19	(	(	-LRB-	_	20	P
20	EBV	ebv	NN	_	23	NMOD
21	)	)	-RRB-	_	23	P
22	immortalized	immortalize	VBN	_	23	NMOD
23	lymphocytes	lymphocyte	NNS	_	14	PMOD
24	from	from	IN	_	23	NMOD
25	affected	affect	VBN	_	30	NMOD
26	and	and	CC	_	25	COORD
27	unaffected	unaffected	JJ	_	26	CONJ
28	AUS1	aus0	NN	_	30	NMOD
29	family	family	NN	_	30	NMOD
30	members	member	NNS	_	24	PMOD
31	revealed	reveal	VBD	_	0	ROOT
32	that	that	IN	_	31	OBJ
33	all	all	DT	_	35	NMOD
34	affected	affect	VBN	_	35	NMOD
35	members	member	NNS	_	36	SBJ
36	showed	show	VBD	_	32	SUB
37	a	a	DT	_	39	NMOD
38	dramatic	dramatic	JJ	_	39	NMOD
39	decrease	decrease	NN	_	36	OBJ
40	in	in	IN	_	39	NMOD
41	ITPR1	itpr0	NN	_	42	NMOD
42	levels	level	NNS	_	40	PMOD
43	when	when	WRB	_	44	TMP
44	compared	compare	VBN	_	36	TMP
45	with	with	IN	_	44	ADV
46	the	the	DT	_	48	NMOD
47	family	family	NN	_	48	NMOD
48	member	member	NN	_	45	PMOD
49	without	without	IN	_	48	NMOD
50	the	the	DT	_	51	NMOD
51	deletion	deletion	NN	_	49	PMOD
52	(	(	-LRB-	_	53	P
53	Figure	figure	NN	_	31	PRN
54	4	0	CD	_	53	NMOD
55	)	)	-RRB-	_	53	P
56	.	.	.	_	31	P

1	Itpr1	itpr0	NN	_	2	SBJ
2	contains	contain	VBZ	_	29	DEP
3	three	three	CD	_	4	NMOD
4	domains	domain	NNS	_	2	OBJ
5	,	,	,	_	4	P
6	an	an	DT	_	13	NMOD
7	N	n	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	terminal	terminal	JJ	_	13	NMOD
10	inositol	inositol	NN	_	13	NMOD
11	triphosphate	triphosphate	NN	_	13	NMOD
12	binding	binding	NN	_	13	NMOD
13	domain	domain	NN	_	4	APPO
14	,	,	,	_	13	P
15	a	a	DT	_	17	NMOD
16	coupling	couple	VBG	_	17	NMOD
17	domain	domain	NN	_	13	CONJ
18	,	,	,	_	17	P
19	and	and	CC	_	17	COORD
20	a	a	DT	_	25	NMOD
21	C	c	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	terminal	terminal	JJ	_	25	NMOD
24	transmembrane	transmembrane	NN	_	25	NMOD
25	domain	domain	NN	_	19	CONJ
26	;	;	:	_	29	P
27	it	it	PRP	_	29	SBJ
28	also	also	RB	_	29	ADV
29	contains	contain	VBZ	_	0	ROOT
30	two	two	CD	_	35	NMOD
31	protein	protein	NN	_	33	NMOD
32	kinase	kinase	NN	_	33	NMOD
33	A	a	NN	_	35	NMOD
34	phosphorylation	phosphorylation	NN	_	35	NMOD
35	sites	site	NNS	_	29	OBJ
36	and	and	CC	_	35	COORD
37	an	an	DT	_	41	NMOD
38	ATP	atp	NN	_	40	AMOD
39	-	-	HYPH	_	38	P
40	binding	bind	VBG	_	41	NMOD
41	site	site	NN	_	36	CONJ
42	.	.	.	_	29	P

1	Itpr1	itpr0	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	coupled	couple	VBN	_	2	VC
4	to	to	IN	_	3	ADV
5	Ca2+	ca0+	NN	_	6	NMOD
6	channels	channel	NNS	_	4	PMOD
7	and	and	CC	_	2	COORD
8	facilitates	facilitate	VBZ	_	7	CONJ
9	Ca2+	ca0+	NN	_	10	NMOD
10	release	release	NN	_	8	OBJ
11	from	from	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	endoplasmic	endoplasmic	JJ	_	14	NMOD
14	reticulum	reticulum	NN	_	11	PMOD
15	after	after	IN	_	10	TMP
16	binding	binding	NN	_	15	PMOD
17	by	by	IN	_	16	NMOD
18	the	the	DT	_	21	NMOD
19	intracellular	intracellular	JJ	_	21	NMOD
20	second	$#ORD#$	JJ	_	21	NMOD
21	messenger	messenger	NN	_	29	NMOD
22	inositol	inositol	NN	_	29	NMOD
23	1	0	CD	_	27	NMOD
24	,	,	,	_	27	P
25	4	0	CD	_	27	NMOD
26	,	,	,	_	27	P
27	5	0	CD	_	29	NMOD
28	-	-	HYPH	_	27	P
29	triphosphate	triphosphate	NN	_	17	PMOD
30	[	[	-LRB-	_	31	P
31	9	0	CD	_	2	PRN
32	]	]	-RRB-	_	31	P
33	.	.	.	_	2	P

1	Itpr1	itpr0	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	enriched	enrich	VBN	_	2	VC
4	in	in	IN	_	3	LOC
5	the	the	DT	_	7	NMOD
6	Purkinje	purkinje	NNP	_	7	NMOD
7	cells	cell	NNS	_	4	PMOD
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	cerebellum	cerebellum	NN	_	8	PMOD
11	[	[	-LRB-	_	12	P
12	4	0	CD	_	3	PRN
13	]	]	-RRB-	_	12	P
14	.	.	.	_	2	P

1	ITPR1	itpr0	NN	_	2	NMOD
2	mutations	mutation	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	more	more	JJR	_	9	NMOD
5	than	than	IN	_	4	QMOD
6	one	one	CD	_	4	QMOD
7	potential	potential	JJ	_	9	NMOD
8	pathogenic	pathogenic	JJ	_	9	NMOD
9	mechanism	mechanism	NN	_	3	OBJ
10	.	.	.	_	3	P

1	First	$#ORD#$	RB	_	16	ADV
2	,	,	,	_	16	P
3	the	the	DT	_	4	NMOD
4	disease	disease	NN	_	5	SBJ
5	may	may	MD	_	16	DEP
6	be	be	VB	_	5	VC
7	a	a	DT	_	8	NMOD
8	result	result	NN	_	6	PRD
9	of	of	IN	_	8	NMOD
10	haploinsufficiency	haploinsufficiency	NN	_	9	PMOD
11	at	at	IN	_	10	LOC
12	ITPR1	itpr0	NN	_	11	PMOD
13	;	;	:	_	16	P
14	this	this	DT	_	15	NMOD
15	concept	concept	NN	_	16	SBJ
16	is	be	VBZ	_	0	ROOT
17	consistent	consistent	JJ	_	16	PRD
18	with	with	IN	_	17	AMOD
19	the	the	DT	_	20	NMOD
20	observation	observation	NN	_	18	PMOD
21	that	that	IN	_	20	NMOD
22	heterozygous	heterozygous	JJ	_	23	NMOD
23	deletion	deletion	NN	_	24	SBJ
24	leads	lead	VBZ	_	21	SUB
25	to	to	IN	_	24	ADV
26	a	a	DT	_	29	NMOD
27	later	late	JJ	_	28	NMOD
28	onset	onset	NN	_	29	NMOD
29	disorder	disorder	NN	_	25	PMOD
30	in	in	IN	_	24	LOC
31	humans	human	NNS	_	30	PMOD
32	,	,	,	_	24	P
33	whereas	whereas	IN	_	24	ADV
34	homozygous	homozygous	JJ	_	35	NMOD
35	deletion	deletion	NN	_	38	SBJ
36	in	in	IN	_	35	LOC
37	mice	mouse	NNS	_	36	PMOD
38	leads	lead	VBZ	_	33	SUB
39	to	to	IN	_	38	ADV
40	an	an	DT	_	43	NMOD
41	early	early	JJ	_	42	NMOD
42	onset	onset	NN	_	43	NMOD
43	disorder	disorder	NN	_	39	PMOD
44	,	,	,	_	43	P
45	able	able	JJ	_	43	NMOD
46	to	to	TO	_	45	AMOD
47	be	be	VB	_	46	IM
48	expressed	express	VBN	_	47	VC
49	within	within	IN	_	48	TMP
50	the	the	DT	_	54	NMOD
51	much	much	RB	_	52	AMOD
52	shorter	short	JJR	_	54	NMOD
53	life	life	NN	_	54	NMOD
54	span	span	NN	_	49	PMOD
55	of	of	IN	_	54	NMOD
56	the	the	DT	_	57	NMOD
57	mouse	mouse	NN	_	55	PMOD
58	.	.	.	_	16	P

1	Second	$#ORD#$	RB	_	64	ADV
2	,	,	,	_	64	P
3	we	we	PRP	_	4	SBJ
4	can	can	MD	_	64	DEP
5	not	not	RB	_	4	ADV
6	rule	rule	VB	_	4	VC
7	out	out	RP	_	6	PRT
8	the	the	DT	_	9	NMOD
9	existence	existence	NN	_	6	OBJ
10	of	of	IN	_	9	NMOD
11	an	an	DT	_	14	NMOD
12	alternate	alternate	JJ	_	14	NMOD
13	start	start	NN	_	14	NMOD
14	site	site	NN	_	10	PMOD
15	for	for	IN	_	14	NMOD
16	ITPR1	itpr0	NN	_	15	PMOD
17	that	that	WDT	_	18	SBJ
18	may	may	MD	_	14	NMOD
19	result	result	VB	_	18	VC
20	in	in	IN	_	19	ADV
21	a	a	DT	_	22	NMOD
22	product	product	NN	_	20	PMOD
23	that	that	WDT	_	24	SBJ
24	confers	confer	VBZ	_	22	NMOD
25	a	a	DT	_	27	NMOD
26	pathogenic	pathogenic	JJ	_	27	NMOD
27	gain	gain	NN	_	24	OBJ
28	of	of	IN	_	27	NMOD
29	function	function	NN	_	28	PMOD
30	to	to	IN	_	24	ADV
31	the	the	DT	_	32	NMOD
32	protein	protein	NN	_	30	PMOD
33	;	;	:	_	64	P
34	however	however	RB	_	64	ADV
35	,	,	,	_	64	P
36	Western	western	NNP	_	37	NMOD
37	blot	blot	NN	_	38	NMOD
38	analysis	analysis	NN	_	64	SBJ
39	of	of	IN	_	38	NMOD
40	cells	cell	NNS	_	39	PMOD
41	derived	derive	VBN	_	40	NMOD
42	from	from	IN	_	41	ADV
43	affected	affect	VBN	_	46	NMOD
44	AUS1	aus0	NN	_	45	NMOD
45	family	family	NN	_	46	NMOD
46	members	member	NNS	_	42	PMOD
47	,	,	,	_	38	P
48	which	which	WDT	_	49	SBJ
49	was	be	VBD	_	38	NMOD
50	performed	perform	VBN	_	49	VC
51	using	use	VBG	_	50	MNR
52	an	an	DT	_	53	NMOD
53	antibody	antibody	NN	_	51	OBJ
54	raised	raise	VBN	_	53	NMOD
55	against	against	IN	_	54	ADV
56	the	the	DT	_	60	NMOD
57	C	c	NN	_	59	AMOD
58	-	-	HYPH	_	57	P
59	terminal	terminal	JJ	_	60	NMOD
60	portion	portion	NN	_	55	PMOD
61	of	of	IN	_	60	NMOD
62	ITPR1	itpr0	NN	_	61	PMOD
63	,	,	,	_	64	P
64	failed	fail	VBD	_	0	ROOT
65	to	to	TO	_	64	OPRD
66	identify	identify	VB	_	65	IM
67	any	any	DT	_	73	NMOD
68	disease	disease	NN	_	70	AMOD
69	-	-	HYPH	_	68	P
70	specific	specific	JJ	_	73	NMOD
71	truncated	truncate	VBN	_	72	NMOD
72	protein	protein	NN	_	73	NMOD
73	products	product	NNS	_	66	OBJ
74	.	.	.	_	64	P

1	Clearly	clearly	RB	_	11	ADV
2	,	,	,	_	11	P
3	the	the	DT	_	4	NMOD
4	identification	identification	NN	_	11	SBJ
5	of	of	IN	_	4	NMOD
6	distinct	distinct	JJ	_	8	NMOD
7	ITPR1	itpr0	NN	_	8	NMOD
8	mutations	mutation	NNS	_	5	PMOD
9	underlying	underlie	VBG	_	8	NMOD
10	SCA15	sca0	NN	_	9	OBJ
11	will	will	MD	_	0	ROOT
12	help	help	VB	_	11	VC
13	elucidate	elucidate	VB	_	12	OBJ
14	the	the	DT	_	16	NMOD
15	pathogenic	pathogenic	JJ	_	16	NMOD
16	mechanism	mechanism	NN	_	13	OBJ
17	of	of	IN	_	16	NMOD
18	this	this	DT	_	19	NMOD
19	disorder	disorder	NN	_	17	PMOD
20	.	.	.	_	11	P

1	We	we	PRP	_	2	SBJ
2	show	show	VBP	_	0	ROOT
3	here	here	RB	_	2	ADV
4	the	the	DT	_	5	NMOD
5	utility	utility	NN	_	2	OBJ
6	of	of	IN	_	5	NMOD
7	investigating	investigate	VBG	_	6	PMOD
8	spontaneous	spontaneous	JJ	_	10	NMOD
9	mouse	mouse	NN	_	10	NMOD
10	mutations	mutation	NNS	_	7	OBJ
11	in	in	IN	_	7	ADV
12	understanding	understand	VBG	_	11	PMOD
13	human	human	JJ	_	14	NMOD
14	disease	disease	NN	_	12	OBJ
15	.	.	.	_	2	P

1	Currently	currently	RB	_	12	ADV
2	,	,	,	_	12	P
3	the	the	DT	_	5	NMOD
4	small	small	JJ	_	5	NMOD
5	number	number	NN	_	12	SBJ
6	of	of	IN	_	5	NMOD
7	aged	age	VBN	_	11	NMOD
8	Itpr1wt	itpr0wt	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	Δ18	δ0	NN	_	11	NMOD
11	animals	animal	NNS	_	6	PMOD
12	precludes	preclude	VBZ	_	35	DEP
13	us	us	PRP	_	12	OBJ
14	from	from	IN	_	12	ADV
15	examining	examine	VBG	_	14	PMOD
16	these	these	DT	_	17	NMOD
17	mice	mouse	NNS	_	15	OBJ
18	for	for	IN	_	15	ADV
19	subtle	subtle	JJ	_	20	NMOD
20	signs	sign	NNS	_	18	PMOD
21	and	and	CC	_	20	COORD
22	symptoms	symptom	NNS	_	21	CONJ
23	similar	similar	JJ	_	20	NMOD
24	to	to	IN	_	23	AMOD
25	those	those	DT	_	24	PMOD
26	seen	see	VBN	_	25	NMOD
27	in	in	IN	_	26	LOC
28	SCA15	sca0	NN	_	29	NMOD
29	patients	patient	NNS	_	27	PMOD
30	;	;	:	_	35	P
31	however	however	RB	_	35	ADV
32	,	,	,	_	35	P
33	these	these	DT	_	34	NMOD
34	mice	mouse	NNS	_	35	SBJ
35	are	be	VBP	_	0	ROOT
36	clearly	clearly	RB	_	35	ADV
37	of	of	IN	_	35	PRD
38	interest	interest	NN	_	37	PMOD
39	to	to	IN	_	38	NMOD
40	us	us	PRP	_	39	PMOD
41	as	as	IN	_	35	ADV
42	a	a	DT	_	44	NMOD
43	potential	potential	JJ	_	44	NMOD
44	model	model	NN	_	41	PMOD
45	of	of	IN	_	44	NMOD
46	SCA15	sca0	NN	_	45	PMOD
47	.	.	.	_	35	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	4	SBJ
3	also	also	RB	_	4	ADV
4	demonstrate	demonstrate	VBP	_	0	ROOT
5	that	that	IN	_	4	OBJ
6	genome	genome	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	wide	wide	JJ	_	10	NMOD
9	SNP	snp	NN	_	10	NMOD
10	assay	assay	NN	_	11	SBJ
11	can	can	MD	_	5	SUB
12	facilitate	facilitate	VB	_	11	VC
13	rapid	rapid	JJ	_	14	NMOD
14	detection	detection	NN	_	12	OBJ
15	of	of	IN	_	14	NMOD
16	structural	structural	JJ	_	18	NMOD
17	genomic	genomic	JJ	_	18	NMOD
18	mutations	mutation	NNS	_	15	PMOD
19	that	that	WDT	_	20	SBJ
20	may	may	MD	_	18	NMOD
21	underlie	underlie	VB	_	20	VC
22	disease	disease	NN	_	21	OBJ
23	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	data	datum	NNS	_	7	SBJ
3	provided	provide	VBN	_	2	NMOD
4	by	by	IN	_	3	LGS
5	these	these	DT	_	6	NMOD
6	approaches	approach	NNS	_	4	PMOD
7	provide	provide	VBP	_	0	ROOT
8	compelling	compelling	JJ	_	9	NMOD
9	evidence	evidence	NN	_	7	OBJ
10	that	that	IN	_	9	NMOD
11	heterozygous	heterozygous	JJ	_	12	NMOD
12	deletion	deletion	NN	_	15	SBJ
13	of	of	IN	_	12	NMOD
14	ITPR1	itpr0	NN	_	13	PMOD
15	causes	cause	VBZ	_	10	SUB
16	SCA15	sca0	NN	_	15	OBJ
17	.	.	.	_	7	P

1	Clearly	clearly	RB	_	11	ADV
2	,	,	,	_	11	P
3	sequence	sequence	NN	_	4	NMOD
4	analysis	analysis	NN	_	11	SBJ
5	of	of	IN	_	4	NMOD
6	ITPR1	itpr0	NN	_	5	PMOD
7	in	in	IN	_	6	NMOD
8	potential	potential	JJ	_	10	NMOD
9	SCA15	sca0	NN	_	10	NMOD
10	cases	case	NNS	_	7	PMOD
11	may	may	MD	_	36	DEP
12	provide	provide	VB	_	11	VC
13	additional	additional	JJ	_	14	NMOD
14	insight	insight	NN	_	12	OBJ
15	into	into	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	disease	disease	NN	_	15	PMOD
18	,	,	,	_	12	P
19	particularly	particularly	RB	_	20	ADV
20	if	if	IN	_	12	ADV
21	a	a	DT	_	23	NMOD
22	stop	stop	NN	_	23	NMOD
23	mutation	mutation	NN	_	24	SBJ
24	were	be	VBD	_	20	SUB
25	to	to	TO	_	24	OPRD
26	be	be	VB	_	25	IM
27	identified	identify	VBN	_	26	VC
28	;	;	:	_	36	P
29	however	however	RB	_	36	ADV
30	,	,	,	_	36	P
31	the	the	DT	_	33	NMOD
32	mutational	mutational	JJ	_	33	NMOD
33	mechanism	mechanism	NN	_	36	SBJ
34	noted	note	VBN	_	33	NMOD
35	here	here	RB	_	34	ADV
36	means	mean	VBZ	_	0	ROOT
37	that	that	IN	_	36	OBJ
38	standard	standard	JJ	_	40	NMOD
39	sequencing	sequencing	NN	_	40	NMOD
40	approaches	approach	NNS	_	42	SBJ
41	alone	alone	RB	_	40	NMOD
42	are	be	VBP	_	61	DEP
43	insufficient	insufficient	JJ	_	42	PRD
44	to	to	TO	_	43	AMOD
45	confidently	confidently	RB	_	44	ADV
46	rule	rule	VB	_	44	IM
47	out	out	RP	_	46	PRT
48	ITPR1	itpr0	NN	_	49	NMOD
49	mutation	mutation	NN	_	46	OBJ
50	as	as	IN	_	46	ADV
51	a	a	DT	_	52	NMOD
52	cause	cause	NN	_	50	PMOD
53	of	of	IN	_	52	NMOD
54	disease	disease	NN	_	53	PMOD
55	:	:	:	_	61	P
56	a	a	DT	_	60	NMOD
57	comprehensive	comprehensive	JJ	_	60	NMOD
58	gene	gene	NN	_	59	NMOD
59	dosage	dosage	NN	_	60	NMOD
60	approach	approach	NN	_	61	SBJ
61	is	be	VBZ	_	37	SUB
62	also	also	RB	_	61	ADV
63	required	require	VBN	_	61	VC
64	.	.	.	_	36	P

1	Given	give	VBN	_	29	ADV
2	that	that	IN	_	1	PMOD
3	SCA16	sca0	NN	_	10	SBJ
4	and	and	CC	_	3	COORD
5	autosomal	autosomal	JJ	_	9	NMOD
6	dominant	dominant	JJ	_	9	NMOD
7	congenital	congenital	JJ	_	9	NMOD
8	nonprogressive	nonprogressive	JJ	_	9	NMOD
9	ataxia	ataxia	NN	_	4	CONJ
10	have	have	VBP	_	2	SUB
11	both	both	DT	_	10	DEP
12	recently	recently	RB	_	10	ADV
13	been	be	VBN	_	10	VC
14	mapped	map	VBN	_	13	VC
15	to	to	IN	_	14	ADV
16	regions	region	NNS	_	15	PMOD
17	overlapping	overlap	VBG	_	16	NMOD
18	with	with	IN	_	17	ADV
19	the	the	DT	_	21	NMOD
20	SCA15	sca0	NN	_	21	NMOD
21	locus	locus	NN	_	18	PMOD
22	[	[	-LRB-	_	25	P
23	10	0	CD	_	25	NMOD
24	,	,	,	_	25	P
25	11	0	CD	_	14	PRN
26	]	]	-RRB-	_	25	P
27	,	,	,	_	29	P
28	ITPR1	itpr0	NN	_	29	SBJ
29	is	be	VBZ	_	0	ROOT
30	a	a	DT	_	31	NMOD
31	gene	gene	NN	_	29	PRD
32	of	of	IN	_	31	NMOD
33	importance	importance	NN	_	32	PMOD
34	for	for	IN	_	33	NMOD
35	screening	screening	NN	_	34	PMOD
36	in	in	IN	_	29	ADV
37	these	these	DT	_	38	NMOD
38	families	family	NNS	_	36	PMOD
39	.	.	.	_	29	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	add	add	VBP	_	0	ROOT
4	weight	weight	NN	_	3	OBJ
5	to	to	IN	_	3	ADV
6	a	a	DT	_	7	NMOD
7	role	role	NN	_	5	PMOD
8	for	for	IN	_	7	NMOD
9	aberrant	aberrant	JJ	_	12	NMOD
10	intracellular	intracellular	JJ	_	12	NMOD
11	Ca2+	ca0+	NN	_	12	NMOD
12	signaling	signaling	NN	_	8	PMOD
13	in	in	IN	_	12	LOC
14	Purkinje	purkinje	NNP	_	15	NMOD
15	cells	cell	NNS	_	13	PMOD
16	in	in	IN	_	7	NMOD
17	the	the	DT	_	18	NMOD
18	pathogenesis	pathogenesis	NN	_	16	PMOD
19	of	of	IN	_	18	NMOD
20	spinocerebellar	spinocerebellar	JJ	_	21	NMOD
21	ataxia	ataxia	NN	_	19	PMOD
22	.	.	.	_	3	P

1	Materials	material	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Methods	method	NNS	_	2	CONJ

1	Genome	genome	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	wide	wide	JJ	_	4	NMOD
4	linkage	linkage	NN	_	0	ROOT
5	in	in	IN	_	4	LOC
6	mice	mouse	NNS	_	5	PMOD
7	.	.	.	_	4	P

1	One	one	CD	_	6	NMOD
2	hundred	hundred	CD	_	1	QMOD
3	and	and	CC	_	2	COORD
4	twenty	twenty	CD	_	3	CONJ
5	DNA	dna	NN	_	6	NMOD
6	fragments	fragment	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	amplified	amplify	VBN	_	7	VC
9	across	across	IN	_	8	LOC
10	the	the	DT	_	11	NMOD
11	genome	genome	NN	_	9	PMOD
12	,	,	,	_	8	P
13	each	each	DT	_	8	ADV
14	selected	select	VBN	_	13	NMOD
15	to	to	TO	_	14	PRP
16	contain	contain	VB	_	15	IM
17	one	one	CD	_	23	NMOD
18	or	or	CC	_	17	COORD
19	more	more	JJR	_	18	CONJ
20	strain	strain	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	specific	specific	JJ	_	23	NMOD
23	SNPs	snp	NNS	_	16	OBJ
24	that	that	WDT	_	25	SBJ
25	would	would	MD	_	23	NMOD
26	differentiate	differentiate	VB	_	25	VC
27	between	between	IN	_	26	ADV
28	C57BL	c0bl	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	6J	0j	NN	_	36	NMOD
31	and	and	CC	_	30	COORD
32	129x1	0x0	NN	_	34	NMOD
33	/	/	HYPH	_	32	P
34	SvJ	svj	NN	_	31	CONJ
35	inbred	inbred	JJ	_	36	NMOD
36	strains	strain	NNS	_	27	PMOD
37	[	[	-LRB-	_	38	P
38	12	0	CD	_	8	PRN
39	]	]	-RRB-	_	38	P
40	.	.	.	_	7	P

1	Each	each	DT	_	2	NMOD
2	fragment	fragment	NN	_	3	SBJ
3	was	be	VBD	_	17	DEP
4	initially	initially	RB	_	3	ADV
5	amplified	amplify	VBN	_	3	VC
6	in	in	IN	_	5	LOC
7	11	0	CD	_	9	NMOD
8	affected	affect	VBN	_	9	NMOD
9	mice	mouse	NNS	_	6	PMOD
10	and	and	CC	_	9	COORD
11	nine	nine	CD	_	13	NMOD
12	unaffected	unaffected	JJ	_	13	NMOD
13	mice	mouse	NNS	_	10	CONJ
14	;	;	:	_	17	P
15	genotype	genotype	NN	_	16	NMOD
16	calling	calling	NN	_	17	SBJ
17	was	be	VBD	_	0	ROOT
18	performed	perform	VBN	_	17	VC
19	by	by	IN	_	18	MNR
20	dye	dye	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	terminator	terminator	NN	_	23	NMOD
23	sequencing	sequencing	NN	_	19	PMOD
24	of	of	IN	_	23	NMOD
25	these	these	DT	_	26	NMOD
26	fragments	fragment	NNS	_	24	PMOD
27	.	.	.	_	17	P

1	Linkage	linkage	NN	_	2	NMOD
2	analysis	analysis	NN	_	6	SBJ
3	using	use	VBG	_	2	NMOD
4	these	these	DT	_	5	NMOD
5	data	datum	NNS	_	3	OBJ
6	was	be	VBD	_	0	ROOT
7	performed	perform	VBN	_	6	VC
8	using	use	VBG	_	7	MNR
9	mlink	mlink	NN	_	8	OBJ
10	[	[	-LRB-	_	11	P
11	13	0	CD	_	8	PRN
12	]	]	-RRB-	_	11	P
13	,	,	,	_	7	P
14	which	which	WDT	_	15	SBJ
15	revealed	reveal	VBD	_	7	ADV
16	a	a	DT	_	18	NMOD
17	positive	positive	JJ	_	18	NMOD
18	linkage	linkage	NN	_	15	OBJ
19	at	at	IN	_	15	LOC
20	Chromosome	chromosome	NN	_	21	NMOD
21	6qE1	0qe0	NN	_	19	PMOD
22	,	,	,	_	15	P
23	on	on	IN	_	15	ADV
24	the	the	DT	_	28	NMOD
25	129x1	0x0	NN	_	27	NMOD
26	/	/	HYPH	_	25	P
27	SvJ	svj	NN	_	28	NMOD
28	background	background	NN	_	23	PMOD
29	(	(	-LRB-	_	34	P
30	two	two	CD	_	32	NMOD
31	-	-	HYPH	_	30	P
32	point	point	NN	_	34	NMOD
33	LOD	lod	NN	_	34	NMOD
34	score	score	NN	_	28	PRN
35	5.13	0	CD	_	34	NMOD
36	at	at	IN	_	34	NMOD
37	marker	marker	NN	_	38	NMOD
38	20.MMHAP85FLG2	0.mmhap0flg0	NN	_	36	PMOD
39	)	)	-RRB-	_	34	P
40	.	.	.	_	6	P

1	In	in	IN	_	10	ADV
2	an	an	DT	_	3	NMOD
3	attempt	attempt	NN	_	1	PMOD
4	to	to	TO	_	3	NMOD
5	narrow	narrow	VB	_	4	IM
6	the	the	DT	_	8	NMOD
7	disease	disease	NN	_	8	NMOD
8	interval	interval	NN	_	5	OBJ
9	we	we	PRP	_	10	SBJ
10	performed	perform	VBD	_	0	ROOT
11	backcross	backcross	NN	_	12	NMOD
12	experiments	experiment	NNS	_	10	OBJ
13	that	that	WDT	_	14	SBJ
14	resulted	result	VBD	_	12	NMOD
15	in	in	IN	_	14	ADV
16	the	the	DT	_	17	NMOD
17	generation	generation	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	three	three	CD	_	22	NMOD
20	additional	additional	JJ	_	22	NMOD
21	affected	affect	VBN	_	22	NMOD
22	mice	mouse	NNS	_	18	PMOD
23	.	.	.	_	10	P

1	Genotyping	genotyping	NN	_	12	SBJ
2	of	of	IN	_	1	NMOD
3	all	all	DT	_	5	NMOD
4	affected	affect	VBN	_	5	NMOD
5	mice	mouse	NNS	_	2	PMOD
6	across	across	IN	_	1	NMOD
7	the	the	DT	_	11	NMOD
8	disease	disease	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	segregating	segregate	VBG	_	11	NMOD
11	interval	interval	NN	_	6	PMOD
12	revealed	reveal	VBD	_	0	ROOT
13	flanking	flank	VBG	_	14	NMOD
14	recombinants	recombinant	NNS	_	12	OBJ
15	and	and	CC	_	14	COORD
16	a	a	DT	_	18	NMOD
17	candidate	candidate	NN	_	18	NMOD
18	region	region	NN	_	15	CONJ
19	of	of	IN	_	18	NMOD
20	~	~	SYM	_	21	P
21	5	0	CD	_	22	NMOD
22	Mb	mb	NN	_	19	PMOD
23	,	,	,	_	12	P
24	between	between	IN	_	12	LOC
25	markers	marker	NNS	_	26	NMOD
26	D6Mit37	d0mit0	NN	_	24	PMOD
27	and	and	CC	_	26	COORD
28	44.MMHAP85FLG5	0.mmhap0flg0	NN	_	27	CONJ
29	(	(	-LRB-	_	31	P
30	Figure	figure	NN	_	31	NMOD
31	S1	s0	NN	_	12	PRN
32	)	)	-RRB-	_	31	P
33	.	.	.	_	12	P

1	This	this	DT	_	2	NMOD
2	region	region	NN	_	3	SBJ
3	contains	contain	VBZ	_	0	ROOT
4	16	0	CD	_	5	NMOD
5	genes	gene	NNS	_	3	OBJ
6	and	and	CC	_	5	COORD
7	predicted	predict	VBN	_	8	NMOD
8	transcripts	transcript	NNS	_	6	CONJ
9	.	.	.	_	3	P

1	Identification	identification	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	6	NMOD
4	underlying	underlie	VBG	_	6	NMOD
5	genetic	genetic	JJ	_	6	NMOD
6	lesion	lesion	NN	_	2	PMOD
7	in	in	IN	_	1	LOC
8	mice	mouse	NNS	_	7	PMOD
9	.	.	.	_	1	P

1	Identification	identification	NN	_	12	SBJ
2	of	of	IN	_	1	NMOD
3	similar	similar	JJ	_	4	NMOD
4	phenotypes	phenotype	NNS	_	2	PMOD
5	in	in	IN	_	4	LOC
6	mice	mouse	NNS	_	5	PMOD
7	linked	link	VBN	_	6	NMOD
8	to	to	IN	_	7	ADV
9	the	the	DT	_	11	NMOD
10	6qE1	0qe0	NN	_	11	NMOD
11	interval	interval	NN	_	8	PMOD
12	was	be	VBD	_	0	ROOT
13	performed	perform	VBN	_	12	VC
14	by	by	IN	_	13	MNR
15	literature	literature	NN	_	16	NMOD
16	searches	search	NNS	_	14	PMOD
17	.	.	.	_	12	P

1	This	this	DT	_	2	SBJ
2	revealed	reveal	VBD	_	0	ROOT
3	the	the	DT	_	7	NMOD
4	Itpr1opt	itpr0opt	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	opt	opt	NN	_	7	NMOD
7	mouse	mouse	NN	_	2	OBJ
8	,	,	,	_	7	P
9	in	in	IN	_	13	LOC
10	which	which	WDT	_	9	PMOD
11	disease	disease	NN	_	12	SBJ
12	is	be	VBZ	_	7	NMOD
13	caused	cause	VBN	_	12	VC
14	by	by	IN	_	13	LGS
15	homozygous	homozygous	JJ	_	17	NMOD
16	deletion	deletion	NN	_	17	NMOD
17	mutation	mutation	NN	_	14	PMOD
18	of	of	IN	_	17	NMOD
19	exons	exon	NNS	_	20	NMOD
20	43	0	CD	_	18	PMOD
21	and	and	CC	_	20	COORD
22	44	0	CD	_	21	CONJ
23	of	of	IN	_	20	NMOD
24	Itpr1	itpr0	NN	_	23	PMOD
25	.	.	.	_	2	P

1	Primer	primer	NN	_	2	NMOD
2	pairs	pair	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	designed	design	VBN	_	3	VC
5	to	to	TO	_	4	PRP
6	sequence	sequence	VB	_	5	IM
7	each	each	DT	_	6	OBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	coding	coding	NN	_	11	NMOD
11	exons	exon	NNS	_	8	PMOD
12	and	and	CC	_	7	COORD
13	at	at	RB	_	14	QMOD
14	least	least	RBS	_	16	NMOD
15	50	0	CD	_	14	QMOD
16	bp	bp	NN	_	12	CONJ
17	of	of	IN	_	16	NMOD
18	each	each	DT	_	21	NMOD
19	flanking	flank	VBG	_	21	NMOD
20	intronic	intronic	JJ	_	21	NMOD
21	sequence	sequence	NN	_	17	PMOD
22	of	of	IN	_	7	NMOD
23	Itpr1	itpr0	NN	_	22	PMOD
24	.	.	.	_	3	P

1	PCR	pcr	NN	_	2	NMOD
2	amplification	amplification	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	each	each	DT	_	5	NMOD
5	exon	exon	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	performed	perform	VBN	_	6	VC
8	using	use	VBG	_	7	MNR
9	DNA	dna	NN	_	8	OBJ
10	from	from	IN	_	9	NMOD
11	two	two	CD	_	13	NMOD
12	affected	affect	VBN	_	13	NMOD
13	mice	mouse	NNS	_	10	PMOD
14	as	as	IN	_	8	MNR
15	templates	template	NNS	_	14	PMOD
16	.	.	.	_	6	P

1	The	the	DT	_	5	NMOD
2	Itpr1Δ18	itpr0δ0	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	Δ18	δ0	NN	_	5	NMOD
5	mutation	mutation	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	confirmed	confirm	VBN	_	6	VC
8	by	by	IN	_	7	MNR
9	sequencing	sequencing	NN	_	8	PMOD
10	in	in	IN	_	7	LOC
11	all	all	DT	_	13	NMOD
12	affected	affect	VBN	_	13	NMOD
13	mice	mouse	NNS	_	10	PMOD
14	(	(	-LRB-	_	16	P
15	Figure	figure	NN	_	16	NMOD
16	S2	s0	NN	_	7	PRN
17	)	)	-RRB-	_	16	P
18	.	.	.	_	6	P

1	Breeding	breed	VBG	_	2	NMOD
2	experiments	experiment	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	between	between	IN	_	4	ADV
6	two	two	CD	_	8	NMOD
7	female	female	JJ	_	8	NMOD
8	mice	mouse	NNS	_	5	PMOD
9	heterozygous	heterozygous	JJ	_	8	NMOD
10	for	for	IN	_	9	AMOD
11	the	the	DT	_	13	NMOD
12	current	current	JJ	_	13	NMOD
13	mutation	mutation	NN	_	10	PMOD
14	(	(	-LRB-	_	17	P
15	Itpr1wt	itpr0wt	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	Δ18	δ0	NN	_	13	PRN
18	)	)	-RRB-	_	17	P
19	and	and	CC	_	8	COORD
20	a	a	DT	_	22	NMOD
21	male	male	JJ	_	22	NMOD
22	mouse	mouse	NN	_	19	CONJ
23	heterozygous	heterozygous	JJ	_	22	NMOD
24	for	for	IN	_	23	AMOD
25	the	the	DT	_	27	NMOD
26	Itpr1opt	itpr0opt	NN	_	27	NMOD
27	mutation	mutation	NN	_	24	PMOD
28	(	(	-LRB-	_	31	P
29	Itpr1wt	itpr0wt	NN	_	31	NMOD
30	/	/	HYPH	_	29	P
31	opt	opt	NN	_	27	PRN
32	)	)	-RRB-	_	31	P
33	.	.	.	_	3	P

1	This	this	DT	_	2	SBJ
2	resulted	result	VBD	_	0	ROOT
3	in	in	IN	_	2	ADV
4	two	two	CD	_	5	NMOD
5	litters	litter	NNS	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	mice	mouse	NNS	_	6	PMOD
8	with	with	IN	_	5	NMOD
9	a	a	DT	_	10	NMOD
10	total	total	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	four	four	CD	_	17	NMOD
13	affected	affect	VBN	_	17	NMOD
14	Itpr1opt	itpr0opt	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	Δ18	δ0	NN	_	17	NMOD
17	pups	pup	NNS	_	11	PMOD
18	(	(	-LRB-	_	32	P
19	from	from	IN	_	32	DEP
20	a	a	DT	_	21	NMOD
21	total	total	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	15	0	CD	_	22	PMOD
24	;	;	:	_	32	P
25	two	two	CD	_	32	DEP
26	of	of	IN	_	25	QMOD
27	seven	seven	CD	_	25	QMOD
28	from	from	IN	_	25	NMOD
29	first	$#ORD#$	JJ	_	30	NMOD
30	mating	mating	NN	_	28	PMOD
31	;	;	:	_	32	P
32	two	two	CD	_	17	PRN
33	of	of	IN	_	32	QMOD
34	eight	eight	CD	_	32	QMOD
35	from	from	IN	_	32	NMOD
36	the	the	DT	_	38	NMOD
37	second	$#ORD#$	JJ	_	38	NMOD
38	mating	mating	NN	_	35	PMOD
39	)	)	-RRB-	_	32	P
40	with	with	IN	_	17	NMOD
41	a	a	DT	_	42	NMOD
42	phenotype	phenotype	NN	_	40	PMOD
43	indistinguishable	indistinguishable	JJ	_	42	NMOD
44	from	from	IN	_	43	AMOD
45	that	that	DT	_	44	PMOD
46	of	of	IN	_	45	NMOD
47	the	the	DT	_	55	NMOD
48	Itpr1Δ18	itpr0δ0	NN	_	50	NMOD
49	/	/	HYPH	_	48	P
50	Δ18	δ0	NN	_	55	NMOD
51	and	and	CC	_	50	COORD
52	Itpr1opt	itpr0opt	NN	_	54	NMOD
53	/	/	HYPH	_	52	P
54	opt	opt	NN	_	51	CONJ
55	mice	mouse	NNS	_	46	PMOD
56	.	.	.	_	2	P

1	Analysis	analysis	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Itpr1	itpr0	NN	_	4	NMOD
4	protein	protein	NN	_	2	PMOD
5	in	in	IN	_	4	LOC
6	mice	mouse	NNS	_	5	PMOD
7	.	.	.	_	1	P

1	We	we	PRP	_	2	SBJ
2	performed	perform	VBD	_	0	ROOT
3	Western	western	NNP	_	4	NMOD
4	blot	blot	NN	_	5	NMOD
5	analyses	analysis	NNS	_	2	OBJ
6	using	use	VBG	_	2	MNR
7	standard	standard	JJ	_	8	NMOD
8	techniques	technique	NNS	_	6	OBJ
9	with	with	IN	_	2	MNR
10	ECL	ecl	NN	_	12	NMOD
11	detection	detection	NN	_	12	NMOD
12	kits	kit	NNS	_	9	PMOD
13	(	(	-LRB-	_	14	P
14	Amersham	amersham	NNP	_	12	PRN
15	,	,	,	_	14	P
16	http://www.amersham.com	http://www.amersham.com	NN	_	14	APPO
17	)	)	-RRB-	_	14	P
18	.	.	.	_	2	P

1	Briefly	briefly	RB	_	11	ADV
2	,	,	,	_	11	P
3	dissected	dissect	VBN	_	5	NMOD
4	whole	whole	JJ	_	5	NMOD
5	brains	brain	NNS	_	11	SBJ
6	from	from	IN	_	5	NMOD
7	postnatal	postnatal	JJ	_	8	NMOD
8	day	day	NN	_	10	NMOD
9	21	0	CD	_	8	NMOD
10	littermates	littermates	NNS	_	6	PMOD
11	were	be	VBD	_	0	ROOT
12	homogenized	homogenize	VBN	_	11	VC
13	in	in	IN	_	12	ADV
14	a	a	DT	_	15	NMOD
15	buffer	buffer	NN	_	13	PMOD
16	containing	contain	VBG	_	15	NMOD
17	50	0	CD	_	18	NMOD
18	mM	mm	NN	_	21	NMOD
19	Tris	tris	NN	_	21	NMOD
20	-	-	HYPH	_	19	P
21	HCl	hcl	NN	_	16	OBJ
22	,	,	,	_	21	P
23	150	0	CD	_	24	NMOD
24	mM	mm	NN	_	25	NMOD
25	NaCl	nacl	NN	_	21	CONJ
26	,	,	,	_	25	P
27	1	0	CD	_	28	NMOD
28	mM	mm	NN	_	29	NMOD
29	EDTA	edta	NN	_	25	CONJ
30	,	,	,	_	29	P
31	1	0	CD	_	32	NMOD
32	%	%	NN	_	34	NMOD
33	Triton	triton	NN	_	34	NMOD
34	X	x	NN	_	29	CONJ
35	-	-	HYPH	_	34	P
36	100	0	CD	_	34	NMOD
37	,	,	,	_	34	P
38	1	0	CD	_	39	NMOD
39	%	%	NN	_	41	NMOD
40	sodium	sodium	NN	_	41	NMOD
41	deoxycholate	deoxycholate	NN	_	34	CONJ
42	,	,	,	_	41	P
43	0.1	0	CD	_	44	NMOD
44	%	%	NN	_	45	NMOD
45	SDS	sd	NN	_	41	CONJ
46	,	,	,	_	45	P
47	and	and	CC	_	45	COORD
48	a	a	DT	_	49	NMOD
49	cocktail	cocktail	NN	_	47	CONJ
50	of	of	IN	_	49	NMOD
51	protease	protease	NN	_	52	NMOD
52	inhibitors	inhibitor	NNS	_	50	PMOD
53	(	(	-LRB-	_	54	P
54	Roche	roche	NNP	_	21	PRN
55	,	,	,	_	54	P
56	http://www.roche.com	http://www.roche.com	NN	_	54	APPO
57	)	)	-RRB-	_	54	P
58	.	.	.	_	11	P

1	Homogenates	homogenate	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	diluted	dilute	VBN	_	2	VC
4	appropriately	appropriately	RB	_	3	ADV
5	,	,	,	_	3	P
6	mixed	mix	VBN	_	3	CONJ
7	with	with	IN	_	6	ADV
8	4	0	CD	_	12	NMOD
9	×	×	SYM	_	8	P
10	reducing	reduce	VBG	_	12	NMOD
11	sample	sample	NN	_	12	NMOD
12	buffer	buffer	NN	_	7	PMOD
13	,	,	,	_	6	P
14	and	and	CC	_	6	COORD
15	loaded	load	VBN	_	14	CONJ
16	onto	onto	IN	_	15	ADV
17	4	0	CD	_	18	NMOD
18	%	%	NN	_	24	NMOD
19	–	–	SYM	_	21	P
20	12	0	CD	_	21	NMOD
21	%	%	NN	_	18	NMOD
22	precast	precast	NN	_	24	NMOD
23	gradient	gradient	NN	_	24	NMOD
24	gels	gel	NNS	_	16	PMOD
25	(	(	-LRB-	_	26	P
26	Novex	novex	NNP	_	24	PRN
27	,	,	,	_	26	P
28	http://www.invitrogen.com	http://www.invitrogen.com	NN	_	26	APPO
29	)	)	-RRB-	_	26	P
30	for	for	IN	_	15	PRP
31	SDS	sd	NN	_	33	NMOD
32	-	-	HYPH	_	31	P
33	PAGE	page	NN	_	30	PMOD
34	and	and	CC	_	33	COORD
35	immunoblotting	immunoblotting	NN	_	34	CONJ
36	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	antibodies	antibody	NNS	_	17	SBJ
3	to	to	IN	_	2	NMOD
4	Itpr1	itpr0	NN	_	3	PMOD
5	(	(	-LRB-	_	6	P
6	1	0	CD	_	4	PRN
7	:	:	SYM	_	8	P
8	2,000	0	CD	_	6	NMOD
9	)	)	-RRB-	_	6	P
10	and	and	CC	_	4	COORD
11	Actb	actb	NN	_	10	CONJ
12	(	(	-LRB-	_	13	P
13	1	0	CD	_	11	PRN
14	:	:	SYM	_	15	P
15	5,000	0	CD	_	13	NMOD
16	)	)	-RRB-	_	13	P
17	were	be	VBD	_	0	ROOT
18	used	use	VBN	_	17	VC
19	as	as	IN	_	18	MNR
20	recommended	recommend	VBN	_	19	SUB
21	by	by	IN	_	20	LGS
22	manufacturers	manufacturer	NNS	_	21	PMOD
23	.	.	.	_	17	P

1	Immunohistochemistry	immunohistochemistry	NN	_	0	ROOT
2	.	.	.	_	1	P

1	Brains	brain	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	isolated	isolate	VBN	_	2	VC
4	from	from	IN	_	3	ADV
5	21	0	CD	_	7	NMOD
6	-	-	HYPH	_	5	P
7	d	d	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	old	old	JJ	_	10	NMOD
10	mice	mouse	NNS	_	4	PMOD
11	,	,	,	_	3	P
12	perfused	perfuse	VBN	_	3	CONJ
13	with	with	IN	_	12	ADV
14	4	0	CD	_	15	NMOD
15	%	%	NN	_	16	NMOD
16	paraformaldehyde	paraformaldehyde	NN	_	13	PMOD
17	in	in	IN	_	16	NMOD
18	PBS	pb	NN	_	17	PMOD
19	,	,	,	_	12	P
20	and	and	CC	_	12	COORD
21	post-fixed	post-fixed	VBN	_	20	CONJ
22	overnight	overnight	RB	_	21	TMP
23	in	in	IN	_	21	MNR
24	the	the	DT	_	26	NMOD
25	same	same	JJ	_	26	NMOD
26	fixative	fixative	NN	_	23	PMOD
27	.	.	.	_	2	P

1	Brains	brain	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	embedded	embed	VBN	_	2	VC
4	in	in	IN	_	3	LOC
5	gelatin	gelatin	NN	_	4	PMOD
6	,	,	,	_	2	P
7	and	and	CC	_	2	COORD
8	35	0	CD	_	10	NMOD
9	-	-	HYPH	_	8	P
10	μm	μm	NN	_	12	NMOD
11	sagittal	sagittal	JJ	_	12	NMOD
12	sections	section	NNS	_	13	SBJ
13	were	be	VBD	_	7	CONJ
14	cut	cut	VBN	_	13	VC
15	using	use	VBG	_	14	MNR
16	a	a	DT	_	18	NMOD
17	sliding	slide	VBG	_	18	NMOD
18	microtome	microtome	NN	_	15	OBJ
19	(	(	-LRB-	_	21	P
20	NeuroScience	neuroscience	NNP	_	21	NMOD
21	Associates	associate	NNP	_	18	PRN
22	,	,	,	_	21	P
23	http://www.neuroscienceassociates.com	http://www.neuroscienceassociates.com	NN	_	21	APPO
24	)	)	-RRB-	_	21	P
25	.	.	.	_	2	P

1	Sections	section	NNS	_	12	SBJ
2	from	from	IN	_	1	NMOD
3	wild	wild	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	type	type	NN	_	11	NMOD
6	,	,	,	_	5	P
7	heterozygote	heterozygote	NN	_	5	CONJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	homozygous	homozygous	JJ	_	9	CONJ
11	brains	brain	NNS	_	2	PMOD
12	were	be	VBD	_	0	ROOT
13	placed	place	VBN	_	12	VC
14	in	in	IN	_	13	LOC
15	the	the	DT	_	17	NMOD
16	MultiBrain	multibrain	NN	_	17	NMOD
17	template	template	NN	_	14	PMOD
18	.	.	.	_	12	P

1	Sections	section	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	washed	wash	VBN	_	2	VC
4	in	in	IN	_	3	MNR
5	1	0	CD	_	7	NMOD
6	×	×	SYM	_	5	P
7	PBS	pb	NN	_	4	PMOD
8	prior	prior	RB	_	9	PMOD
9	to	to	IN	_	3	TMP
10	1	0	CD	_	11	NMOD
11	h	h	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	incubation	incubation	NN	_	12	PMOD
14	in	in	IN	_	13	NMOD
15	block	block	NN	_	16	NMOD
16	solution	solution	NN	_	14	PMOD
17	containing	contain	VBG	_	16	NMOD
18	1	0	CD	_	20	NMOD
19	×	×	SYM	_	18	P
20	PBS	pb	NN	_	17	OBJ
21	with	with	IN	_	20	NMOD
22	20	0	CD	_	23	NMOD
23	%	%	NN	_	26	NMOD
24	normal	normal	JJ	_	26	NMOD
25	goat	goat	NN	_	26	NMOD
26	serum	serum	NN	_	21	PMOD
27	and	and	CC	_	26	COORD
28	0.3	0	CD	_	29	NMOD
29	%	%	NN	_	31	NMOD
30	Triton	triton	NN	_	31	NMOD
31	X	x	NN	_	27	CONJ
32	-	-	HYPH	_	31	P
33	100	0	CD	_	31	NMOD
34	(	(	-LRB-	_	35	P
35	pH	ph	NN	_	31	PRN
36	7.4	0	CD	_	35	NMOD
37	)	)	-RRB-	_	35	P
38	.	.	.	_	2	P

1	Sections	section	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	incubated	incubate	VBN	_	2	VC
4	overnight	overnight	RB	_	3	TMP
5	at	at	IN	_	3	MNR
6	4	0	CD	_	7	NMOD
7	°C	°c	NN	_	5	PMOD
8	in	in	IN	_	3	MNR
9	primary	primary	JJ	_	10	NMOD
10	antibodies	antibody	NNS	_	16	NMOD
11	:	:	:	_	16	P
12	affinity	affinity	NN	_	16	NMOD
13	purified	purify	VBN	_	16	NMOD
14	polyclonal	polyclonal	JJ	_	16	NMOD
15	Itpr1	itpr0	NN	_	16	NMOD
16	antibody	antibody	NN	_	8	PMOD
17	(	(	-LRB-	_	23	P
18	1	0	CD	_	23	DEP
19	:	:	SYM	_	20	P
20	2,000	0	CD	_	18	NMOD
21	,	,	,	_	23	P
22	Chemicon	chemicon	NNP	_	23	NMOD
23	International	international	NNP	_	16	PRN
24	,	,	,	_	23	P
25	http://www.chemicon.com	http://www.chemicon.com	NN	_	23	APPO
26	)	)	-RRB-	_	23	P
27	and	and	CC	_	16	COORD
28	monoclonal	monoclonal	JJ	_	30	NMOD
29	anti-Calb1	anti-calb0	JJ	_	30	NMOD
30	antibody	antibody	NN	_	27	CONJ
31	(	(	-LRB-	_	38	P
32	1	0	CD	_	38	DEP
33	:	:	SYM	_	34	P
34	6,000	0	CD	_	32	NMOD
35	,	,	,	_	38	P
36	Sigma	sigma	NNP	_	38	NMOD
37	-	-	HYPH	_	36	P
38	Aldrich	aldrich	NNP	_	30	PRN
39	,	,	,	_	38	P
40	http://www.sigmaaldrich.com	http://www.sigmaaldrich.com	NN	_	38	APPO
41	)	)	-RRB-	_	38	P
42	diluted	dilute	VBN	_	16	NMOD
43	in	in	IN	_	42	MNR
44	carrier	carrier	NN	_	45	NMOD
45	solution	solution	NN	_	43	PMOD
46	.	.	.	_	2	P

1	Following	follow	VBG	_	16	TMP
2	extensive	extensive	JJ	_	3	NMOD
3	washes	wash	NNS	_	1	PMOD
4	(	(	-LRB-	_	3	P
5	in	in	IN	_	3	NMOD
6	6.0	0	CD	_	7	NMOD
7	ml	ml	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	PBS	pb	NN	_	8	PMOD
10	,	,	,	_	12	P
11	three	three	CD	_	12	NMOD
12	times	time	NNS	_	3	PRN
13	)	)	-RRB-	_	12	P
14	,	,	,	_	16	P
15	sections	section	NNS	_	16	SBJ
16	were	be	VBD	_	0	ROOT
17	incubated	incubate	VBN	_	16	VC
18	with	with	IN	_	17	MNR
19	appropriate	appropriate	JJ	_	21	NMOD
20	secondary	secondary	JJ	_	21	NMOD
21	antibodies	antibody	NNS	_	18	PMOD
22	(	(	-LRB-	_	28	P
23	Alexa	alexa	NNP	_	24	NMOD
24	Fluor	fluor	NNP	_	28	NMOD
25	555	0	CD	_	24	NMOD
26	goat	goat	NN	_	28	NMOD
27	anti-rabbit	anti-rabbit	JJ	_	28	NMOD
28	IgG	igg	NN	_	21	PRN
29	and	and	CC	_	28	COORD
30	Alexa	alexa	NNP	_	31	NMOD
31	Fluor	fluor	NNP	_	35	NMOD
32	488	0	CD	_	31	NMOD
33	goat	goat	NN	_	35	NMOD
34	anti-mouse	anti-mouse	JJ	_	35	NMOD
35	IgG	igg	NN	_	29	CONJ
36	[	[	-LRB-	_	37	P
37	Invitrogen	invitrogen	NNP	_	35	PRN
38	,	,	,	_	37	P
39	http://www.invitrogen.com	http://www.invitrogen.com	NN	_	37	APPO
40	]	]	-RRB-	_	37	P
41	)	)	-RRB-	_	28	P
42	for	for	IN	_	17	TMP
43	1	0	CD	_	44	NMOD
44	h	h	NN	_	42	PMOD
45	at	at	IN	_	17	MNR
46	room	room	NN	_	47	NMOD
47	temperature	temperature	NN	_	45	PMOD
48	.	.	.	_	16	P

1	Sections	section	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	washed	wash	VBN	_	2	VC
4	and	and	CC	_	3	COORD
5	mounted	mount	VBN	_	4	CONJ
6	on	on	IN	_	5	MNR
7	glass	glass	NN	_	8	NMOD
8	slides	slide	NNS	_	6	PMOD
9	in	in	IN	_	5	MNR
10	a	a	DT	_	12	NMOD
11	buffered	buffer	VBN	_	12	NMOD
12	medium	medium	NN	_	9	PMOD
13	containing	contain	VBG	_	12	NMOD
14	Mowiol	mowiol	NN	_	13	OBJ
15	(	(	-LRB-	_	16	P
16	Calbiochem	calbiochem	NNP	_	14	PRN
17	,	,	,	_	16	P
18	http://www.emdbiosciences.com	http://www.emdbiosciences.com	NN	_	16	APPO
19	)	)	-RRB-	_	16	P
20	as	as	IN	_	5	ADV
21	described	describe	VBN	_	20	SUB
22	earlier	earlier	RBR	_	21	TMP
23	[	[	-LRB-	_	24	P
24	14	0	CD	_	5	PRN
25	]	]	-RRB-	_	24	P
26	.	.	.	_	2	P

1	Sections	section	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	imaged	image	VBN	_	2	VC
4	using	use	VBG	_	3	MNR
5	a	a	DT	_	9	NMOD
6	laser	laser	NN	_	9	NMOD
7	scanning	scan	VBG	_	9	NMOD
8	confocal	confocal	JJ	_	9	NMOD
9	microscope	microscope	NN	_	4	OBJ
10	(	(	-LRB-	_	14	P
11	LSM	lsm	NN	_	14	DEP
12	510	0	CD	_	11	NMOD
13	;	;	:	_	14	P
14	Zeiss	zeiss	NNP	_	9	PRN
15	,	,	,	_	14	P
16	http://www.zeiss.com	http://www.zeiss.com	NN	_	14	APPO
17	)	)	-RRB-	_	14	P
18	.	.	.	_	2	P

1	Imaging	imaging	NN	_	2	NMOD
2	parameters	parameter	NNS	_	12	SBJ
3	(	(	-LRB-	_	4	P
4	pinhole	pinhole	NN	_	2	PRN
5	,	,	,	_	4	P
6	detector	detector	NN	_	7	NMOD
7	gain	gain	NN	_	4	APPO
8	,	,	,	_	7	P
9	laser	laser	NN	_	10	NMOD
10	power	power	NN	_	7	APPO
11	)	)	-RRB-	_	4	P
12	were	be	VBD	_	0	ROOT
13	optimized	optimize	VBN	_	12	VC
14	,	,	,	_	12	P
15	and	and	CC	_	12	COORD
16	were	be	VBD	_	15	CONJ
17	kept	keep	VBN	_	16	VC
18	constant	constant	JJ	_	17	OPRD
19	for	for	IN	_	17	ADV
20	the	the	DT	_	30	NMOD
21	wild	wild	JJ	_	23	NMOD
22	-	-	HYPH	_	21	P
23	type	type	NN	_	30	NMOD
24	,	,	,	_	23	P
25	heterozygous	heterozygous	JJ	_	23	CONJ
26	,	,	,	_	25	P
27	and	and	CC	_	25	COORD
28	homozygous	homozygous	JJ	_	27	CONJ
29	mutant	mutant	NN	_	30	NMOD
30	brains	brain	NNS	_	19	PMOD
31	.	.	.	_	12	P

1	Specificity	specificity	NN	_	6	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	Itpr1	itpr0	NN	_	5	NMOD
5	antibodies	antibody	NNS	_	2	PMOD
6	was	be	VBD	_	0	ROOT
7	verified	verify	VBN	_	6	VC
8	by	by	IN	_	7	MNR
9	preabsorption	preabsorption	NN	_	11	NMOD
10	control	control	NN	_	11	NMOD
11	experiments	experiment	NNS	_	8	PMOD
12	.	.	.	_	6	P

1	Antibody	antibody	NN	_	2	NMOD
2	dilutions	dilution	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	incubated	incubate	VBN	_	3	VC
5	for	for	IN	_	4	TMP
6	24	0	CD	_	7	NMOD
7	h	h	NN	_	5	PMOD
8	at	at	IN	_	4	MNR
9	4	0	CD	_	10	NMOD
10	°C	°c	NN	_	8	PMOD
11	with	with	IN	_	4	MNR
12	the	the	DT	_	14	NMOD
13	immunizing	immunize	VBG	_	14	NMOD
14	peptide	peptide	NN	_	11	PMOD
15	.	.	.	_	3	P

1	Tissue	tissue	NN	_	2	NMOD
2	sections	section	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	incubated	incubate	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	the	the	DT	_	8	NMOD
7	preabsorbed	preabsorbed	VBN	_	8	NMOD
8	antibodies	antibody	NNS	_	5	PMOD
9	and	and	CC	_	4	COORD
10	processed	process	VBN	_	9	CONJ
11	as	as	IN	_	10	ADV
12	described	describe	VBN	_	11	SUB
13	above	above	RB	_	12	ADV
14	.	.	.	_	3	P

1	Under	under	IN	_	9	ADV
2	these	these	DT	_	3	NMOD
3	conditions	condition	NNS	_	1	PMOD
4	,	,	,	_	9	P
5	no	no	DT	_	6	NMOD
6	staining	staining	NN	_	9	SBJ
7	above	above	IN	_	6	NMOD
8	autofluorescence	autofluorescence	NN	_	7	PMOD
9	was	be	VBD	_	0	ROOT
10	detected	detect	VBN	_	9	VC
11	.	.	.	_	9	P

1	Analysis	analysis	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	ITPR1	itpr0	NN	_	2	PMOD
4	in	in	IN	_	3	LOC
5	SCA15	sca0	NN	_	6	NMOD
6	patients	patient	NNS	_	4	PMOD
7	.	.	.	_	1	P

1	DNA	dna	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	extracted	extract	VBN	_	2	VC
4	from	from	IN	_	3	ADV
5	EBV	ebv	NN	_	7	NMOD
6	immortalized	immortalize	VBN	_	7	NMOD
7	lymphocytes	lymphocyte	NNS	_	4	PMOD
8	,	,	,	_	7	P
9	derived	derive	VBN	_	7	NMOD
10	from	from	IN	_	9	ADV
11	family	family	NN	_	12	NMOD
12	members	member	NNS	_	10	PMOD
13	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	coding	code	VBG	_	3	NMOD
3	exons	exon	NNS	_	14	SBJ
4	and	and	CC	_	3	COORD
5	at	at	RB	_	6	QMOD
6	least	least	RBS	_	8	NMOD
7	50	0	CD	_	6	QMOD
8	bp	bp	NN	_	4	CONJ
9	of	of	IN	_	8	NMOD
10	flanking	flank	VBG	_	11	NMOD
11	introns	intron	NNS	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	ITPR1	itpr0	NN	_	12	PMOD
14	were	be	VBD	_	0	ROOT
15	PCR	pcr	NN	_	16	DEP
16	amplified	amplify	VBN	_	14	VC
17	and	and	CC	_	16	COORD
18	sequenced	sequence	VBN	_	17	CONJ
19	using	use	VBG	_	18	MNR
20	dye	dye	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	terminator	terminator	NN	_	23	NMOD
23	sequencing	sequencing	NN	_	19	OBJ
24	(	(	-LRB-	_	30	P
25	BigDye	bigdye	NNP	_	26	NMOD
26	version	version	NN	_	30	DEP
27	3.1	0	CD	_	26	NMOD
28	;	;	:	_	30	P
29	Applied	applied	NNP	_	30	NMOD
30	Biosystems	biosystems	NNP	_	23	PRN
31	,	,	,	_	30	P
32	http://www.appliedbiosystems.com	http://www.appliedbiosystems.com	NN	_	30	APPO
33	)	)	-RRB-	_	30	P
34	.	.	.	_	14	P

1	Sequence	sequence	NN	_	2	NMOD
2	reactions	reaction	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	run	run	VBN	_	3	VC
5	on	on	IN	_	4	MNR
6	an	an	DT	_	9	NMOD
7	ABI3730XP	abi0xp	NN	_	9	NMOD
8	automated	automate	VBN	_	9	NMOD
9	sequencer	sequencer	NN	_	5	PMOD
10	as	as	IN	_	4	MNR
11	per	per	IN	_	10	PMOD
12	the	the	DT	_	13	NMOD
13	manufacturer	manufacturer	NN	_	15	NMOD
14	's	's	POS	_	13	NMOD
15	instructions	instruction	NNS	_	11	PMOD
16	(	(	-LRB-	_	18	P
17	Applied	applied	NNP	_	18	NMOD
18	Biosystems	biosystems	NNP	_	15	PRN
19	)	)	-RRB-	_	18	P
20	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	analysis	analysis	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	all	all	DT	_	10	NMOD
7	three	three	CD	_	10	NMOD
8	affected	affect	VBN	_	10	NMOD
9	family	family	NN	_	10	NMOD
10	members	member	NNS	_	5	PMOD
11	for	for	IN	_	15	ADV
12	whom	whom	WP	_	11	PMOD
13	genomic	genomic	JJ	_	14	NMOD
14	DNA	dna	NN	_	15	SBJ
15	was	be	VBD	_	10	NMOD
16	available	available	JJ	_	15	PRD
17	(	(	-LRB-	_	19	P
18	members	member	NNS	_	19	NMOD
19	6	0	CD	_	10	PRN
20	,	,	,	_	19	P
21	7	0	CD	_	19	CONJ
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	19	0	CD	_	23	CONJ
25	)	)	-RRB-	_	19	P
26	.	.	.	_	3	P

1	Primer	primer	NN	_	2	NMOD
2	sequences	sequence	NNS	_	5	SBJ
3	and	and	CC	_	2	COORD
4	conditions	condition	NNS	_	3	CONJ
5	are	be	VBP	_	0	ROOT
6	available	available	JJ	_	5	PRD
7	upon	upon	IN	_	5	ADV
8	request	request	NN	_	7	PMOD
9	.	.	.	_	5	P

1	Sequence	sequence	NN	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	analyzed	analyze	VBN	_	3	VC
5	using	use	VBG	_	4	MNR
6	Sequencher	sequencher	NNP	_	5	OBJ
7	(	(	-LRB-	_	10	P
8	Gene	gene	NNP	_	9	NMOD
9	Codes	code	NNP	_	10	NMOD
10	Corporation	corporation	NNP	_	6	PRN
11	,	,	,	_	10	P
12	http://www.genecodes.com	http://www.genecodes.com	NN	_	10	APPO
13	)	)	-RRB-	_	10	P
14	.	.	.	_	3	P

1	Genome	genome	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	wide	wide	JJ	_	5	NMOD
4	SNP	snp	NN	_	5	NMOD
5	genotyping	genotyping	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	performed	perform	VBN	_	6	VC
8	using	use	VBG	_	7	MNR
9	Infinium	infinium	NNP	_	11	NMOD
10	HumanHap550	humanhap0	NN	_	11	NMOD
11	SNP	snp	NN	_	13	NMOD
12	genotyping	genotyping	NN	_	13	NMOD
13	chips	chip	NNS	_	8	OBJ
14	as	as	IN	_	8	MNR
15	per	per	IN	_	14	PMOD
16	the	the	DT	_	17	NMOD
17	manufacturer	manufacturer	NN	_	19	NMOD
18	's	's	POS	_	17	NMOD
19	protocol	protocol	NN	_	15	PMOD
20	(	(	-LRB-	_	21	P
21	Illumina	illumina	NNP	_	19	PRN
22	,	,	,	_	21	P
23	http://www.illumina.com	http://www.illumina.com	NN	_	21	APPO
24	)	)	-RRB-	_	21	P
25	.	.	.	_	6	P

1	This	this	DT	_	2	NMOD
2	product	product	NN	_	3	SBJ
3	assays	assay	VBZ	_	0	ROOT
4	555,352	0	CD	_	6	NMOD
5	unique	unique	JJ	_	6	NMOD
6	SNPs	snp	NNS	_	3	OBJ
7	.	.	.	_	3	P

1	Data	datum	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	collected	collect	VBN	_	2	VC
4	using	use	VBG	_	3	MNR
5	the	the	DT	_	8	NMOD
6	Illumina	illumina	NNP	_	7	NMOD
7	BeadStation	beadstation	NNP	_	8	NMOD
8	scanner	scanner	NN	_	4	OBJ
9	and	and	CC	_	8	COORD
10	data	datum	NNS	_	11	NMOD
11	collection	collection	NN	_	12	NMOD
12	software	software	NN	_	9	CONJ
13	.	.	.	_	2	P

1	Genotypes	genotype	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	produced	produce	VBN	_	2	VC
4	using	use	VBG	_	3	MNR
5	the	the	DT	_	7	NMOD
6	genotyping	genotyping	NN	_	7	NMOD
7	module	module	NN	_	4	OBJ
8	of	of	IN	_	7	NMOD
9	BeadStudio	beadstudio	NNP	_	8	PMOD
10	(	(	-LRB-	_	14	P
11	version	version	NN	_	14	NMOD
12	2.3.25	0	CD	_	11	NMOD
13	;	;	:	_	14	P
14	Illumina	illumina	NNP	_	9	PRN
15	)	)	-RRB-	_	14	P
16	,	,	,	_	2	P
17	and	and	CC	_	2	COORD
18	log	log	NN	_	19	NMOD
19	R	r	NN	_	20	NMOD
20	ratio	ratio	NN	_	25	SBJ
21	and	and	CC	_	20	COORD
22	B	b	NN	_	23	NMOD
23	allele	allele	NN	_	24	NMOD
24	frequency	frequency	NN	_	21	CONJ
25	were	be	VBD	_	17	CONJ
26	visualized	visualize	VBN	_	25	VC
27	using	use	VBG	_	26	MNR
28	the	the	DT	_	31	NMOD
29	genome	genome	NN	_	31	NMOD
30	viewer	viewer	JJR	_	29	NMOD
31	tool	tool	NN	_	27	OBJ
32	within	within	IN	_	31	NMOD
33	this	this	DT	_	34	NMOD
34	package	package	NN	_	32	PMOD
35	.	.	.	_	2	P

1	In	in	IN	_	21	PRP
2	order	order	NN	_	1	PMOD
3	to	to	TO	_	2	NMOD
4	rule	rule	VB	_	3	IM
5	out	out	RP	_	4	PRT
6	the	the	DT	_	7	NMOD
7	possibility	possibility	NN	_	4	OBJ
8	that	that	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	observed	observe	VBN	_	11	NMOD
11	deletion	deletion	NN	_	14	SBJ
12	within	within	IN	_	11	LOC
13	ITPR1	itpr0	NN	_	12	PMOD
14	was	be	VBD	_	8	SUB
15	a	a	DT	_	19	NMOD
16	benign	benign	JJ	_	19	NMOD
17	copy	copy	NN	_	19	NMOD
18	number	number	NN	_	19	NMOD
19	variant	variant	NN	_	14	PRD
20	we	we	PRP	_	21	SBJ
21	examined	examine	VBD	_	0	ROOT
22	log	log	NN	_	23	NMOD
23	R	r	NN	_	24	NMOD
24	ratio	ratio	NN	_	29	NMOD
25	and	and	CC	_	24	COORD
26	B	b	NN	_	27	NMOD
27	allele	allele	NN	_	28	NMOD
28	frequency	frequency	NN	_	25	CONJ
29	metrics	metric	NNS	_	21	OBJ
30	of	of	IN	_	29	NMOD
31	HumanHap550	humanhap0	NN	_	33	NMOD
32	genotyping	genotyping	NN	_	33	NMOD
33	data	datum	NNS	_	30	PMOD
34	at	at	IN	_	33	LOC
35	this	this	DT	_	36	NMOD
36	locus	locus	NN	_	34	PMOD
37	from	from	IN	_	33	NMOD
38	577	0	CD	_	39	NMOD
39	individuals	individual	NNS	_	37	PMOD
40	of	of	IN	_	39	NMOD
41	Northern	northern	JJ	_	42	AMOD
42	European	european	JJ	_	43	NMOD
43	descent	descent	NN	_	40	PMOD
44	from	from	IN	_	39	NMOD
45	North	north	NNP	_	46	NMOD
46	America	america	NNP	_	44	PMOD
47	and	and	CC	_	46	COORD
48	Europe	europe	NNP	_	47	CONJ
49	,	,	,	_	33	P
50	produced	produce	VBN	_	33	NMOD
51	by	by	IN	_	50	LGS
52	us	us	PRP	_	51	PMOD
53	as	as	IN	_	50	ADV
54	a	a	DT	_	55	NMOD
55	part	part	NN	_	53	PMOD
56	of	of	IN	_	55	NMOD
57	an	an	DT	_	59	NMOD
58	ongoing	ongoing	JJ	_	59	NMOD
59	study	study	NN	_	56	PMOD
60	.	.	.	_	21	P

1	In	in	IN	_	18	ADV
2	an	an	DT	_	3	NMOD
3	attempt	attempt	NN	_	1	PMOD
4	to	to	TO	_	3	NMOD
5	narrow	narrow	VB	_	4	IM
6	the	the	DT	_	8	NMOD
7	unknown	unknown	JJ	_	8	NMOD
8	intervals	interval	NNS	_	5	OBJ
9	flanking	flank	VBG	_	8	NMOD
10	the	the	DT	_	11	NMOD
11	deletion	deletion	NN	_	9	OBJ
12	observed	observe	VBN	_	11	NMOD
13	in	in	IN	_	12	ADV
14	family	family	NN	_	15	NMOD
15	AUS1	aus0	NN	_	13	PMOD
16	,	,	,	_	18	P
17	we	we	PRP	_	18	SBJ
18	designed	design	VBD	_	0	ROOT
19	primers	primer	NNS	_	18	OBJ
20	for	for	IN	_	19	NMOD
21	30	0	CD	_	23	NMOD
22	PCR	pcr	NN	_	23	NMOD
23	amplifications	amplification	NNS	_	20	PMOD
24	that	that	WDT	_	25	SBJ
25	would	would	MD	_	23	NMOD
26	generate	generate	VB	_	25	VC
27	overlapping	overlap	VBG	_	28	NMOD
28	fragments	fragment	NNS	_	26	OBJ
29	across	across	IN	_	26	ADV
30	the	the	DT	_	33	NMOD
31	two	two	CD	_	33	NMOD
32	bordering	bordering	NN	_	33	NMOD
33	regions	region	NNS	_	29	PMOD
34	(	(	-LRB-	_	36	P
35	primer	primer	NN	_	36	NMOD
36	sequence	sequence	NN	_	33	PRN
37	and	and	CC	_	36	COORD
38	conditions	condition	NNS	_	37	CONJ
39	available	available	JJ	_	36	NMOD
40	upon	upon	IN	_	39	AMOD
41	request	request	NN	_	40	PMOD
42	)	)	-RRB-	_	36	P
43	.	.	.	_	18	P

1	There	there	EX	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	ten	ten	CD	_	5	NMOD
4	primer	primer	NN	_	5	NMOD
5	pairs	pair	NNS	_	2	PRD
6	in	in	IN	_	5	LOC
7	the	the	DT	_	10	NMOD
8	telomeric	telomeric	JJ	_	10	NMOD
9	flanking	flanking	NN	_	10	NMOD
10	region	region	NN	_	6	PMOD
11	and	and	CC	_	5	COORD
12	20	0	CD	_	13	NMOD
13	pairs	pair	NNS	_	11	CONJ
14	in	in	IN	_	13	LOC
15	the	the	DT	_	18	NMOD
16	centromeric	centromeric	JJ	_	18	NMOD
17	flanking	flanking	NN	_	18	NMOD
18	region	region	NN	_	14	PMOD
19	(	(	-LRB-	_	21	P
20	Figure	figure	NN	_	21	NMOD
21	S3	s0	NN	_	2	PRN
22	)	)	-RRB-	_	21	P
23	.	.	.	_	2	P

1	On	on	IN	_	5	ADV
2	average	average	JJ	_	1	PMOD
3	each	each	DT	_	4	NMOD
4	product	product	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	~	~	SYM	_	7	P
7	750	0	CD	_	8	NMOD
8	bp	bp	NN	_	5	PRD
9	in	in	IN	_	8	NMOD
10	size	size	NN	_	9	PMOD
11	,	,	,	_	5	P
12	and	and	CC	_	5	COORD
13	amplifications	amplification	NNS	_	14	SBJ
14	were	be	VBD	_	12	CONJ
15	performed	perform	VBN	_	14	VC
16	using	use	VBG	_	15	MNR
17	genomic	genomic	JJ	_	18	NMOD
18	DNA	dna	NN	_	16	OBJ
19	from	from	IN	_	16	ADV
20	each	each	DT	_	19	PMOD
21	of	of	IN	_	20	NMOD
22	the	the	DT	_	25	NMOD
23	three	three	CD	_	25	NMOD
24	affected	affect	VBN	_	25	NMOD
25	individuals	individual	NNS	_	21	PMOD
26	(	(	-LRB-	_	29	P
27	family	family	NN	_	29	NMOD
28	members	member	NNS	_	29	NMOD
29	6	0	CD	_	25	PRN
30	,	,	,	_	29	P
31	7	0	CD	_	29	CONJ
32	,	,	,	_	31	P
33	and	and	CC	_	31	COORD
34	19	0	CD	_	33	CONJ
35	)	)	-RRB-	_	29	P
36	.	.	.	_	5	P

1	Dye	dye	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	terminator	terminator	NN	_	4	NMOD
4	sequencing	sequencing	NN	_	8	SBJ
5	of	of	IN	_	4	NMOD
6	each	each	DT	_	7	NMOD
7	product	product	NN	_	5	PMOD
8	was	be	VBD	_	26	DEP
9	performed	perform	VBN	_	8	VC
10	using	use	VBG	_	9	MNR
11	the	the	DT	_	15	NMOD
12	forward	forward	JJ	_	15	NMOD
13	and	and	CC	_	12	COORD
14	reverse	reverse	JJ	_	13	CONJ
15	primers	primer	NNS	_	10	OBJ
16	designed	design	VBN	_	15	NMOD
17	for	for	IN	_	16	PRP
18	amplification	amplification	NN	_	17	PMOD
19	;	;	:	_	26	P
20	running	run	VBG	_	26	SBJ
21	and	and	CC	_	20	COORD
22	analysis	analysis	NN	_	21	CONJ
23	of	of	IN	_	20	NMOD
24	each	each	DT	_	25	NMOD
25	fragment	fragment	NN	_	23	PMOD
26	was	be	VBD	_	0	ROOT
27	performed	perform	VBN	_	26	VC
28	as	as	IN	_	27	ADV
29	described	describe	VBN	_	28	SUB
30	above	above	RB	_	29	ADV
31	.	.	.	_	26	P

1	Amplification	amplification	NN	_	10	SBJ
2	of	of	IN	_	1	NMOD
3	a	a	DT	_	4	NMOD
4	fragment	fragment	NN	_	2	PMOD
5	from	from	IN	_	4	NMOD
6	a	a	DT	_	9	NMOD
7	normal	normal	JJ	_	9	NMOD
8	diploid	diploid	JJ	_	9	NMOD
9	genome	genome	NN	_	5	PMOD
10	was	be	VBD	_	35	DEP
11	denoted	denote	VBN	_	10	VC
12	by	by	IN	_	11	LGS
13	the	the	DT	_	14	NMOD
14	presence	presence	NN	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	a	a	DT	_	18	NMOD
17	heterozygous	heterozygous	JJ	_	18	NMOD
18	polymorphism	polymorphism	NN	_	15	PMOD
19	;	;	:	_	35	P
20	amplification	amplification	NN	_	35	SBJ
21	of	of	IN	_	20	NMOD
22	a	a	DT	_	23	NMOD
23	fragment	fragment	NN	_	21	PMOD
24	from	from	IN	_	23	NMOD
25	a	a	DT	_	26	NMOD
26	region	region	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	the	the	DT	_	29	NMOD
29	genome	genome	NN	_	27	PMOD
30	harboring	harbor	VBG	_	29	NMOD
31	a	a	DT	_	34	NMOD
32	heterozygous	heterozygous	JJ	_	34	NMOD
33	genomic	genomic	JJ	_	34	NMOD
34	deletion	deletion	NN	_	30	OBJ
35	was	be	VBD	_	0	ROOT
36	inferred	infer	VBN	_	35	VC
37	when	when	WRB	_	48	TMP
38	homozygosity	homozygosity	NN	_	47	SBJ
39	for	for	IN	_	38	NMOD
40	the	the	DT	_	42	NMOD
41	major	major	JJ	_	42	NMOD
42	allele	allele	NN	_	39	PMOD
43	and	and	CC	_	42	COORD
44	the	the	DT	_	46	NMOD
45	minor	minor	JJ	_	46	NMOD
46	allele	allele	NN	_	43	CONJ
47	were	be	VBD	_	36	TMP
48	noted	note	VBN	_	47	VC
49	among	among	IN	_	48	ADV
50	the	the	DT	_	54	NMOD
51	three	three	CD	_	54	NMOD
52	affected	affect	VBN	_	54	NMOD
53	family	family	NN	_	54	NMOD
54	members	member	NNS	_	49	PMOD
55	(	(	-LRB-	_	59	P
56	i.e.	i.e.	FW	_	59	ADV
57	,	,	,	_	59	P
58	this	this	DT	_	59	SBJ
59	is	be	VBZ	_	48	PRN
60	inconsistent	inconsistent	JJ	_	59	PRD
61	with	with	IN	_	60	AMOD
62	Mendelian	mendelian	JJ	_	63	NMOD
63	inheritance	inheritance	NN	_	61	PMOD
64	in	in	IN	_	63	NMOD
65	related	related	JJ	_	66	NMOD
66	individuals	individual	NNS	_	64	PMOD
67	known	know	VBN	_	66	NMOD
68	to	to	TO	_	67	OPRD
69	share	share	VB	_	68	IM
70	a	a	DT	_	72	NMOD
71	common	common	JJ	_	72	NMOD
72	haplotype	haplotype	NN	_	69	OBJ
73	)	)	-RRB-	_	59	P
74	.	.	.	_	35	P

1	Using	use	VBG	_	10	MNR
2	the	the	DT	_	3	NMOD
3	data	datum	NNS	_	1	OBJ
4	from	from	IN	_	1	ADV
5	the	the	DT	_	6	NMOD
6	experiments	experiment	NNS	_	4	PMOD
7	described	describe	VBN	_	6	NMOD
8	above	above	RB	_	7	ADV
9	we	we	PRP	_	10	SBJ
10	were	be	VBD	_	0	ROOT
11	able	able	JJ	_	10	PRD
12	to	to	TO	_	11	AMOD
13	limit	limit	VB	_	12	IM
14	the	the	DT	_	15	NMOD
15	size	size	NN	_	13	OBJ
16	of	of	IN	_	15	NMOD
17	unknown	unknown	JJ	_	18	NMOD
18	regions	region	NNS	_	16	PMOD
19	flanking	flank	VBG	_	18	NMOD
20	the	the	DT	_	21	NMOD
21	deletion	deletion	NN	_	19	OBJ
22	to	to	IN	_	13	ADV
23	~	~	SYM	_	24	P
24	4	0	CD	_	25	NMOD
25	kb	kb	NN	_	22	PMOD
26	on	on	IN	_	25	NMOD
27	the	the	DT	_	29	NMOD
28	telomeric	telomeric	JJ	_	29	NMOD
29	side	side	NN	_	26	PMOD
30	and	and	CC	_	25	COORD
31	7	0	CD	_	32	NMOD
32	kb	kb	NN	_	30	CONJ
33	on	on	IN	_	32	NMOD
34	the	the	DT	_	36	NMOD
35	centromeric	centromeric	JJ	_	36	NMOD
36	side	side	NN	_	33	PMOD
37	.	.	.	_	10	P

1	All	all	DT	_	2	NMOD
2	combinations	combination	NNS	_	33	SBJ
3	of	of	IN	_	2	NMOD
4	forward	forward	JJ	_	5	NMOD
5	primers	primer	NNS	_	3	PMOD
6	from	from	IN	_	5	NMOD
7	the	the	DT	_	10	NMOD
8	newly	newly	RB	_	9	AMOD
9	defined	define	VBN	_	10	NMOD
10	region	region	NN	_	6	PMOD
11	flanking	flank	VBG	_	2	NMOD
12	the	the	DT	_	13	NMOD
13	deletion	deletion	NN	_	11	OBJ
14	on	on	IN	_	11	LOC
15	the	the	DT	_	17	NMOD
16	telomeric	telomeric	JJ	_	17	NMOD
17	side	side	NN	_	14	PMOD
18	with	with	IN	_	11	ADV
19	reverse	reverse	JJ	_	20	NMOD
20	primers	primer	NNS	_	18	PMOD
21	from	from	IN	_	20	NMOD
22	the	the	DT	_	25	NMOD
23	newly	newly	RB	_	24	AMOD
24	defined	define	VBN	_	25	NMOD
25	region	region	NN	_	21	PMOD
26	flanking	flank	VBG	_	20	NMOD
27	the	the	DT	_	28	NMOD
28	deletion	deletion	NN	_	26	OBJ
29	on	on	IN	_	26	LOC
30	the	the	DT	_	32	NMOD
31	centromeric	centromeric	JJ	_	32	NMOD
32	side	side	NN	_	29	PMOD
33	were	be	VBD	_	0	ROOT
34	used	use	VBN	_	33	VC
35	in	in	IN	_	34	ADV
36	PCR	pcr	NN	_	37	NMOD
37	amplification	amplification	NN	_	38	NMOD
38	reactions	reaction	NNS	_	35	PMOD
39	performed	perform	VBN	_	38	NMOD
40	with	with	IN	_	39	MNR
41	DNA	dna	NN	_	40	PMOD
42	from	from	IN	_	41	NMOD
43	the	the	DT	_	47	NMOD
44	three	three	CD	_	47	NMOD
45	affected	affect	VBN	_	47	NMOD
46	family	family	NN	_	47	NMOD
47	members	member	NNS	_	42	PMOD
48	and	and	CC	_	47	COORD
49	single	single	JJ	_	52	NMOD
50	unaffected	unaffected	JJ	_	52	NMOD
51	family	family	NN	_	52	NMOD
52	members	member	NNS	_	48	CONJ
53	.	.	.	_	33	P

1	This	this	DT	_	2	NMOD
2	experiment	experiment	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	an	an	DT	_	7	NMOD
7	attempt	attempt	NN	_	5	PMOD
8	to	to	TO	_	7	NMOD
9	amplify	amplify	VB	_	8	IM
10	across	across	IN	_	9	ADV
11	the	the	DT	_	13	NMOD
12	deleted	delete	VBN	_	13	NMOD
13	fragment	fragment	NN	_	10	PMOD
14	and	and	CC	_	9	COORD
15	define	define	VB	_	14	CONJ
16	the	the	DT	_	18	NMOD
17	exact	exact	JJ	_	18	NMOD
18	breakpoint	breakpoint	NN	_	15	OBJ
19	.	.	.	_	3	P

1	A	a	DT	_	3	NMOD
2	single	single	JJ	_	3	NMOD
3	fragment	fragment	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	obtained	obtain	VBN	_	4	VC
6	from	from	IN	_	5	ADV
7	the	the	DT	_	10	NMOD
8	third	$#ORD#$	JJ	_	10	NMOD
9	forward	forward	JJ	_	10	NMOD
10	primer	primer	NN	_	6	PMOD
11	from	from	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	telomeric	telomeric	JJ	_	14	NMOD
14	side	side	NN	_	11	PMOD
15	(	(	-LRB-	_	20	P
16	T3f	t0f	NN	_	20	NMOD
17	5	0	CD	_	20	NMOD
18	′	′	SYM	_	17	P
19	-	-	HYPH	_	17	P
20	TGAATGCTCAATTTTCCAGC	tgaatgctcaattttccagc	NN	_	10	PRN
21	-	-	HYPH	_	20	P
22	3	0	CD	_	20	NMOD
23	′	′	SYM	_	20	P
24	)	)	-RRB-	_	20	P
25	with	with	IN	_	5	ADV
26	the	the	DT	_	29	NMOD
27	11th	$#ORD#$	JJ	_	29	NMOD
28	reverse	reverse	JJ	_	29	NMOD
29	primer	primer	NN	_	25	PMOD
30	from	from	IN	_	29	NMOD
31	the	the	DT	_	33	NMOD
32	centromeric	centromeric	JJ	_	33	NMOD
33	side	side	NN	_	30	PMOD
34	(	(	-LRB-	_	39	P
35	C11r	c0r	NN	_	39	NMOD
36	5	0	CD	_	39	NMOD
37	′	′	SYM	_	36	P
38	-	-	HYPH	_	36	P
39	GGGAAAATGGATAGAGGGTG	gggaaaatggatagagggtg	NN	_	29	PRN
40	-	-	HYPH	_	39	P
41	3	0	CD	_	39	NMOD
42	′	′	SYM	_	39	P
43	)	)	-RRB-	_	39	P
44	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	fragment	fragment	NN	_	11	SBJ
3	,	,	,	_	2	P
4	which	which	WDT	_	5	SBJ
5	is	be	VBZ	_	2	NMOD
6	953	0	CD	_	7	NMOD
7	bp	bp	NN	_	5	PRD
8	in	in	IN	_	7	NMOD
9	size	size	NN	_	8	PMOD
10	,	,	,	_	11	P
11	was	be	VBD	_	0	ROOT
12	sequenced	sequence	VBN	_	11	VC
13	as	as	IN	_	12	ADV
14	described	describe	VBN	_	13	SUB
15	above	above	RB	_	14	ADV
16	and	and	CC	_	14	COORD
17	compared	compare	VBN	_	16	CONJ
18	to	to	IN	_	17	ADV
19	the	the	DT	_	21	NMOD
20	current	current	JJ	_	21	NMOD
21	build	build	NN	_	18	PMOD
22	of	of	IN	_	21	NMOD
23	the	the	DT	_	25	NMOD
24	human	human	JJ	_	25	NMOD
25	genome	genome	NN	_	22	PMOD
26	.	.	.	_	11	P

1	A	a	DT	_	3	NMOD
2	similar	similar	JJ	_	3	NMOD
3	series	series	NN	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	experiments	experiment	NNS	_	4	PMOD
6	was	be	VBD	_	20	DEP
7	performed	perform	VBN	_	6	VC
8	to	to	TO	_	7	PRP
9	identify	identify	VB	_	8	IM
10	the	the	DT	_	12	NMOD
11	deletion	deletion	NN	_	12	NMOD
12	breakpoints	breakpoints	NNS	_	9	OBJ
13	in	in	IN	_	12	NMOD
14	families	family	NNS	_	15	NMOD
15	H27	h0	NN	_	13	PMOD
16	and	and	CC	_	15	COORD
17	H33	h0	NN	_	16	CONJ
18	;	;	:	_	20	P
19	we	we	PRP	_	20	SBJ
20	were	be	VBD	_	0	ROOT
21	able	able	JJ	_	20	PRD
22	to	to	TO	_	21	AMOD
23	amplify	amplify	VB	_	22	IM
24	a	a	DT	_	29	NMOD
25	369	0	CD	_	27	NMOD
26	-	-	HYPH	_	25	P
27	bp	bp	NN	_	29	NMOD
28	PCR	pcr	NN	_	29	NMOD
29	product	product	NN	_	23	OBJ
30	across	across	IN	_	23	ADV
31	the	the	DT	_	32	NMOD
32	breakpoint	breakpoint	NN	_	30	PMOD
33	found	find	VBN	_	32	NMOD
34	in	in	IN	_	33	LOC
35	affected	affect	VBN	_	36	NMOD
36	members	member	NNS	_	34	PMOD
37	of	of	IN	_	36	NMOD
38	family	family	NN	_	39	NMOD
39	H27	h0	NN	_	37	PMOD
40	using	use	VBG	_	23	MNR
41	primer	primer	NN	_	42	NMOD
42	pair	pair	NN	_	49	NMOD
43	H27	h0	NN	_	45	NMOD
44	-	-	HYPH	_	43	P
45	11F	0f	NN	_	49	NMOD
46	5	0	CD	_	49	NMOD
47	′	′	SYM	_	46	P
48	-	-	HYPH	_	46	P
49	GACCTCAAGAAGGCATGAATAC	gacctcaagaaggcatgaatac	NN	_	40	OBJ
50	-	-	HYPH	_	49	P
51	3	0	CD	_	49	NMOD
52	′	′	SYM	_	49	P
53	and	and	CC	_	49	COORD
54	H27	h0	NN	_	56	NMOD
55	-	-	HYPH	_	54	P
56	3R	0r	NN	_	60	NMOD
57	5	0	CD	_	60	NMOD
58	′	′	SYM	_	57	P
59	-	-	HYPH	_	57	P
60	ATGGTGGCCAGGTACACAAG	atggtggccaggtacacaag	NN	_	53	CONJ
61	-	-	HYPH	_	60	P
62	3	0	CD	_	60	NMOD
63	′	′	SYM	_	60	P
64	(	(	-LRB-	_	66	P
65	Figure	figure	NN	_	66	NMOD
66	S4	s0	NN	_	40	PRN
67	)	)	-RRB-	_	66	P
68	,	,	,	_	20	P
69	but	but	CC	_	20	COORD
70	to	to	IN	_	73	TMP
71	date	date	NN	_	70	PMOD
72	we	we	PRP	_	73	SBJ
73	have	have	VBP	_	69	CONJ
74	been	be	VBN	_	73	VC
75	unable	unable	JJ	_	74	PRD
76	to	to	TO	_	75	AMOD
77	identify	identify	VB	_	76	IM
78	the	the	DT	_	79	NMOD
79	breakpoint	breakpoint	NN	_	77	OBJ
80	in	in	IN	_	79	NMOD
81	family	family	NN	_	82	NMOD
82	H33	h0	NN	_	80	PMOD
83	.	.	.	_	20	P

1	Western	western	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	0	ROOT
4	in	in	IN	_	3	LOC
5	SCA15	sca0	NN	_	6	NMOD
6	patients	patient	NNS	_	4	PMOD
7	.	.	.	_	3	P

1	EBV	ebv	NN	_	3	NMOD
2	immortalized	immortalize	VBN	_	3	NMOD
3	lymphoblasts	lymphoblast	NNS	_	20	SBJ
4	from	from	IN	_	3	NMOD
5	three	three	CD	_	8	NMOD
6	affected	affect	VBN	_	8	NMOD
7	family	family	NN	_	8	NMOD
8	members	member	NNS	_	4	PMOD
9	who	who	WP	_	10	SBJ
10	carry	carry	VBP	_	8	NMOD
11	the	the	DT	_	12	NMOD
12	deletion	deletion	NN	_	10	OBJ
13	and	and	CC	_	8	COORD
14	one	one	CD	_	16	NMOD
15	family	family	NN	_	16	NMOD
16	member	member	NN	_	13	CONJ
17	without	without	IN	_	16	NMOD
18	the	the	DT	_	19	NMOD
19	mutation	mutation	NN	_	17	PMOD
20	were	be	VBD	_	32	DEP
21	used	use	VBN	_	20	VC
22	as	as	IN	_	21	MNR
23	a	a	DT	_	26	NMOD
24	readily	readily	RB	_	25	AMOD
25	accessible	accessible	JJ	_	26	NMOD
26	source	source	NN	_	22	PMOD
27	of	of	IN	_	26	NMOD
28	protein	protein	NN	_	27	PMOD
29	;	;	:	_	32	P
30	all	all	DT	_	31	NMOD
31	samples	sample	NNS	_	32	SBJ
32	came	come	VBD	_	0	ROOT
33	from	from	IN	_	32	ADV
34	members	member	NNS	_	33	PMOD
35	of	of	IN	_	34	NMOD
36	family	family	NN	_	37	NMOD
37	AUS1	aus0	NN	_	35	PMOD
38	.	.	.	_	32	P

1	Protein	protein	NN	_	2	NMOD
2	extraction	extraction	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	using	use	VBG	_	4	MNR
6	lysis	lysis	NN	_	7	NMOD
7	buffer	buffer	NN	_	5	OBJ
8	containing	contain	VBG	_	7	NMOD
9	1	0	CD	_	11	NMOD
10	×	×	SYM	_	9	P
11	TBS	tb	NN	_	8	OBJ
12	,	,	,	_	11	P
13	1	0	CD	_	14	NMOD
14	%	%	NN	_	16	NMOD
15	Triton	triton	NN	_	16	NMOD
16	X	x	NN	_	11	CONJ
17	-	-	HYPH	_	16	P
18	100	0	CD	_	16	NMOD
19	,	,	,	_	16	P
20	and	and	CC	_	16	COORD
21	a	a	DT	_	22	NMOD
22	cocktail	cocktail	NN	_	20	CONJ
23	of	of	IN	_	22	NMOD
24	protease	protease	NN	_	25	NMOD
25	inhibitors	inhibitor	NNS	_	23	PMOD
26	(	(	-LRB-	_	27	P
27	Roche	roche	NNP	_	25	PRN
28	)	)	-RRB-	_	27	P
29	with	with	IN	_	4	MNR
30	overnight	overnight	JJ	_	31	NMOD
31	lysis	lysis	NN	_	29	PMOD
32	at	at	IN	_	4	MNR
33	−	−	SYM	_	34	P
34	80	0	CD	_	35	NMOD
35	°C	°c	NN	_	32	PMOD
36	.	.	.	_	3	P

1	Homogenates	homogenate	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	diluted	dilute	VBN	_	2	VC
4	appropriately	appropriately	RB	_	3	ADV
5	,	,	,	_	3	P
6	mixed	mix	VBN	_	3	CONJ
7	with	with	IN	_	6	ADV
8	4	0	CD	_	12	NMOD
9	×	×	SYM	_	8	P
10	reducing	reduce	VBG	_	12	NMOD
11	sample	sample	NN	_	12	NMOD
12	buffer	buffer	NN	_	7	PMOD
13	,	,	,	_	6	P
14	and	and	CC	_	6	COORD
15	loaded	load	VBN	_	14	CONJ
16	onto	onto	IN	_	15	ADV
17	4	0	CD	_	18	NMOD
18	%	%	NN	_	24	NMOD
19	–	–	SYM	_	21	P
20	12	0	CD	_	21	NMOD
21	%	%	NN	_	18	NMOD
22	precast	precast	JJ	_	24	NMOD
23	gradient	gradient	NN	_	24	NMOD
24	gels	gel	NNS	_	16	PMOD
25	(	(	-LRB-	_	26	P
26	NuPAGE	nupage	NN	_	24	PRN
27	,	,	,	_	26	P
28	Invitrogen	invitrogen	NNP	_	26	APPO
29	)	)	-RRB-	_	26	P
30	for	for	IN	_	15	PRP
31	SDS	sd	NN	_	33	NMOD
32	-	-	HYPH	_	31	P
33	PAGE	page	NN	_	30	PMOD
34	and	and	CC	_	33	COORD
35	immunoblotting	immunoblotting	NN	_	34	CONJ
36	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	antibodies	antibody	NNS	_	17	SBJ
3	to	to	IN	_	2	NMOD
4	ITPR1	itpr0	NN	_	3	PMOD
5	(	(	-LRB-	_	6	P
6	1	0	CD	_	4	PRN
7	:	:	SYM	_	8	P
8	1,000	0	CD	_	6	NMOD
9	)	)	-RRB-	_	6	P
10	and	and	CC	_	4	COORD
11	ACTB	actb	NN	_	10	CONJ
12	(	(	-LRB-	_	13	P
13	1	0	CD	_	11	PRN
14	:	:	SYM	_	15	P
15	5,000	0	CD	_	13	NMOD
16	)	)	-RRB-	_	13	P
17	were	be	VBD	_	0	ROOT
18	used	use	VBN	_	17	VC
19	as	as	IN	_	18	ADV
20	recommended	recommend	VBN	_	19	SUB
21	by	by	IN	_	20	LGS
22	manufacturers	manufacturer	NNS	_	21	PMOD
23	.	.	.	_	17	P

1	Supporting	supporting	JJ	_	2	NMOD
2	Information	information	NN	_	0	ROOT

1	Figure	figure	NN	_	2	NMOD
2	S1	s0	NN	_	0	ROOT

1	Schematic	schematic	JJ	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Genotyping	genotyping	NN	_	4	NMOD
4	Results	result	NNS	_	2	PMOD
5	across	across	IN	_	4	NMOD
6	Mouse	mouse	NN	_	7	NMOD
7	Chromosome	chromosome	NN	_	5	PMOD
8	6	0	CD	_	7	NMOD
9	in	in	IN	_	4	LOC
10	Affected	affect	VBN	_	11	NMOD
11	Mice	mouse	NNS	_	9	PMOD

1	Black	black	JJ	_	2	NMOD
2	squares	square	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	indicative	indicative	JJ	_	3	PRD
5	of	of	IN	_	4	AMOD
6	a	a	DT	_	11	NMOD
7	C57BL	c0bl	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	6J	0j	NN	_	11	NMOD
10	homozygous	homozygous	JJ	_	11	NMOD
11	genotype	genotype	NN	_	5	PMOD
12	;	;	:	_	5	P
13	light	light	JJ	_	14	AMOD
14	grey	grey	JJ	_	15	NMOD
15	squares	square	NNS	_	5	GAP-SBJ
16	,	,	,	_	15	P
17	a	a	DT	_	22	NMOD
18	129x1	0x0	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	SvJ	svj	NN	_	22	NMOD
21	homozygous	homozygous	JJ	_	22	NMOD
22	genotype	genotype	NN	_	15	DEP
23	;	;	:	_	15	P
24	grey	grey	JJ	_	25	NMOD
25	squares	square	NNS	_	15	GAP-SBJ
26	,	,	,	_	25	P
27	a	a	DT	_	35	NMOD
28	C57BL	c0bl	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	6J	0j	NN	_	35	NMOD
31	129x1	0x0	NN	_	33	NMOD
32	/	/	HYPH	_	31	P
33	SvJ	svj	NN	_	35	NMOD
34	heterozygous	heterozygous	JJ	_	35	NMOD
35	genotype	genotype	NN	_	25	DEP
36	;	;	:	_	25	P
37	white	white	JJ	_	38	NMOD
38	squares	square	NNS	_	25	GAP-SBJ
39	,	,	,	_	38	P
40	undetermined	undetermined	JJ	_	41	NMOD
41	genotype	genotype	NN	_	38	DEP
42	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	black	black	JJ	_	3	NMOD
3	box	box	NN	_	4	SBJ
4	bounds	bound	VBZ	_	23	DEP
5	a	a	DT	_	6	NMOD
6	region	region	NN	_	4	OBJ
7	of	of	IN	_	6	NMOD
8	homozygous	homozygous	JJ	_	12	NMOD
9	129x1	0x0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	SvJ	svj	NN	_	12	NMOD
12	genotypes	genotype	NNS	_	7	PMOD
13	that	that	WDT	_	14	SBJ
14	segregate	segregate	VBP	_	6	NMOD
15	with	with	IN	_	14	ADV
16	disease	disease	NN	_	15	PMOD
17	;	;	:	_	23	P
18	thus	thus	RB	_	23	ADV
19	,	,	,	_	23	P
20	the	the	DT	_	22	NMOD
21	critical	critical	JJ	_	22	NMOD
22	region	region	NN	_	23	SBJ
23	was	be	VBD	_	0	ROOT
24	determined	determine	VBN	_	23	VC
25	to	to	TO	_	24	OPRD
26	be	be	VB	_	25	IM
27	between	between	IN	_	26	LOC
28	markers	marker	NNS	_	29	NMOD
29	D6Mit37	d0mit0	NN	_	27	PMOD
30	and	and	CC	_	29	COORD
31	44.MMHAP85FLG5	0.mmhap0flg0	NN	_	30	CONJ
32	.	.	.	_	23	P

1	(	(	-LRB-	_	4	P
2	10	0	CD	_	3	NMOD
3	MB	mb	NN	_	4	NMOD
4	TIF	tif	NN	_	0	ROOT
5	)	)	-RRB-	_	4	P

1	Click	click	VB	_	0	ROOT
2	here	here	RB	_	1	ADV
3	for	for	IN	_	1	PRP
4	additional	additional	JJ	_	6	NMOD
5	data	datum	NNS	_	6	NMOD
6	file	file	NN	_	3	PMOD
7	.	.	.	_	1	P

1	Figure	figure	NN	_	2	NMOD
2	S2	s0	NN	_	0	ROOT

1	Sequence	sequence	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Exon	exon	NN	_	2	PMOD
4	36	0	CD	_	3	NMOD
5	of	of	IN	_	3	NMOD
6	Itpr1	itpr0	NN	_	5	PMOD
7	from	from	IN	_	6	NMOD
8	Four	four	CD	_	9	NMOD
9	Mice	mouse	NNS	_	7	PMOD

1	A	a	DT	_	9	NMOD
2	wild	wild	JJ	_	4	NMOD
3	-	-	HYPH	_	2	P
4	type	type	NN	_	9	NMOD
5	homozygous	homozygous	JJ	_	9	NMOD
6	C57BL	c0bl	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	6J	0j	NN	_	9	NMOD
9	mouse	mouse	NN	_	0	ROOT
10	(	(	-LRB-	_	11	P
11	A	a	NN	_	9	PRN
12	)	)	-RRB-	_	11	P
13	,	,	,	_	9	P
14	a	a	DT	_	22	NMOD
15	wild	wild	JJ	_	17	NMOD
16	-	-	HYPH	_	15	P
17	type	type	NN	_	22	NMOD
18	homozygous	homozygous	JJ	_	22	NMOD
19	129x1	0x0	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	SvJ	svj	NN	_	22	NMOD
22	mouse	mouse	NN	_	9	CONJ
23	(	(	-LRB-	_	24	P
24	B	b	NN	_	22	PRN
25	)	)	-RRB-	_	24	P
26	,	,	,	_	22	P
27	an	an	DT	_	30	NMOD
28	affected	affect	VBN	_	30	NMOD
29	129x1B6	0x0b0	NN	_	30	NMOD
30	mice	mouse	NNS	_	22	CONJ
31	homozygous	homozygous	JJ	_	30	NMOD
32	for	for	IN	_	31	AMOD
33	the	the	DT	_	38	NMOD
34	18	0	CD	_	36	NMOD
35	-	-	HYPH	_	34	P
36	bp	bp	NN	_	38	NMOD
37	deletion	deletion	NN	_	38	NMOD
38	mutation	mutation	NN	_	32	PMOD
39	(	(	-LRB-	_	40	P
40	C	c	NN	_	30	PRN
41	)	)	-RRB-	_	40	P
42	,	,	,	_	30	P
43	and	and	CC	_	30	COORD
44	an	an	DT	_	46	NMOD
45	unaffected	unaffected	JJ	_	46	NMOD
46	mouse	mouse	NN	_	43	CONJ
47	heterozygous	heterozygous	JJ	_	46	NMOD
48	for	for	IN	_	47	AMOD
49	the	the	DT	_	54	NMOD
50	18	0	CD	_	52	NMOD
51	-	-	HYPH	_	50	P
52	bp	bp	NN	_	54	NMOD
53	deletion	deletion	NN	_	54	NMOD
54	mutation	mutation	NN	_	48	PMOD
55	(	(	-LRB-	_	56	P
56	D	d	NN	_	46	PRN
57	)	)	-RRB-	_	56	P
58	.	.	.	_	9	P

1	The	the	DT	_	3	NMOD
2	deleted	delete	VBN	_	3	NMOD
3	nucleotides	nucleotide	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	bounded	bound	VBN	_	4	VC
6	by	by	IN	_	5	LGS
7	a	a	DT	_	9	NMOD
8	green	green	JJ	_	9	NMOD
9	box	box	NN	_	6	PMOD
10	.	.	.	_	4	P

1	(	(	-LRB-	_	4	P
2	5.1	0	CD	_	3	NMOD
3	MB	mb	NN	_	4	NMOD
4	TIF	tif	NN	_	0	ROOT
5	)	)	-RRB-	_	4	P

1	Click	click	VB	_	0	ROOT
2	here	here	RB	_	1	ADV
3	for	for	IN	_	1	PRP
4	additional	additional	JJ	_	6	NMOD
5	data	datum	NNS	_	6	NMOD
6	file	file	NN	_	3	PMOD
7	.	.	.	_	1	P

1	Figure	figure	NN	_	2	NMOD
2	S3	s0	NN	_	0	ROOT

1	Additional	additional	JJ	_	2	NMOD
2	Families	family	NNS	_	0	ROOT
3	Harboring	harbor	VBG	_	2	NMOD
4	Deletion	deletion	NN	_	3	OBJ
5	at	at	IN	_	3	LOC
6	the	the	DT	_	8	NMOD
7	SCA15	sca0	NN	_	8	NMOD
8	Locus	locus	NN	_	5	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Family	family	NN	_	5	NMOD
5	H33	h0	NN	_	11	NMOD
6	;	;	:	_	11	P
7	(	(	-LRB-	_	8	P
8	B	b	LS	_	11	NMOD
9	)	)	-RRB-	_	8	P
10	family	family	NN	_	11	NMOD
11	H27	h0	NN	_	0	ROOT
12	.	.	.	_	11	P

1	Upper	upper	JJ	_	2	NMOD
2	panel	panel	NN	_	3	SBJ
3	shows	show	VBZ	_	0	ROOT
4	log	log	NN	_	5	NMOD
5	R	r	NN	_	6	NMOD
6	ratio	ratio	NN	_	11	NMOD
7	and	and	CC	_	6	COORD
8	B	b	NN	_	9	NMOD
9	allele	allele	NN	_	10	NMOD
10	frequency	frequency	NN	_	7	CONJ
11	metrics	metric	NNS	_	3	OBJ
12	generated	generate	VBN	_	11	NMOD
13	from	from	IN	_	12	MNR
14	Infinium	infinium	NNP	_	15	NMOD
15	HumanHap550	humanhap0	NN	_	16	NMOD
16	arrays	array	NNS	_	13	PMOD
17	for	for	IN	_	16	NMOD
18	an	an	DT	_	21	NMOD
19	affected	affect	VBN	_	21	NMOD
20	family	family	NN	_	21	NMOD
21	member	member	NN	_	17	PMOD
22	from	from	IN	_	21	NMOD
23	each	each	DT	_	24	NMOD
24	family	family	NN	_	22	PMOD
25	.	.	.	_	3	P

1	Log	log	NN	_	2	NMOD
2	R	r	NN	_	3	NMOD
3	ratio	ratio	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	ratio	ratio	NN	_	4	PRD
7	of	of	IN	_	6	NMOD
8	normalized	normalize	VBN	_	11	NMOD
9	,	,	,	_	11	P
10	observed	observe	VBN	_	11	NMOD
11	R	r	NN	_	7	PMOD
12	to	to	IN	_	6	NMOD
13	expected	expected	JJ	_	14	NMOD
14	R	r	NN	_	12	PMOD
15	for	for	IN	_	6	NMOD
16	each	each	DT	_	17	NMOD
17	SNP	snp	NN	_	15	PMOD
18	(	(	-LRB-	_	21	P
19	each	each	DT	_	20	NMOD
20	SNP	snp	NN	_	21	SBJ
21	is	be	VBZ	_	4	PRN
22	a	a	DT	_	24	NMOD
23	blue	blue	JJ	_	24	NMOD
24	dot	dot	NN	_	21	PRD
25	)	)	-RRB-	_	21	P
26	and	and	CC	_	4	COORD
27	thus	thus	RB	_	28	ADV
28	serves	serve	VBZ	_	26	CONJ
29	as	as	IN	_	28	ADV
30	a	a	DT	_	31	NMOD
31	surrogate	surrogate	NN	_	29	PMOD
32	of	of	IN	_	31	NMOD
33	copy	copy	NN	_	34	NMOD
34	number	number	NN	_	32	PMOD
35	at	at	IN	_	28	LOC
36	each	each	DT	_	37	NMOD
37	locus	locus	NN	_	35	PMOD
38	.	.	.	_	4	P

1	B	b	NN	_	2	NMOD
2	allele	allele	NN	_	3	NMOD
3	frequency	frequency	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	a	a	DT	_	6	NMOD
6	measure	measure	NN	_	4	PRD
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	9	NMOD
9	number	number	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	times	time	NNS	_	10	PMOD
12	the	the	DT	_	16	NMOD
13	A	a	NN	_	16	NMOD
14	or	or	CC	_	13	COORD
15	B	b	NN	_	14	CONJ
16	alleles	allele	NNS	_	17	SBJ
17	are	be	VBP	_	9	NMOD
18	detected	detect	VBN	_	17	VC
19	at	at	IN	_	18	LOC
20	each	each	DT	_	21	NMOD
21	locus	locus	NN	_	19	PMOD
22	(	(	-LRB-	_	25	P
23	each	each	DT	_	24	NMOD
24	SNP	snp	NN	_	25	SBJ
25	is	be	VBZ	_	4	PRN
26	denoted	denote	VBN	_	25	VC
27	by	by	IN	_	26	LGS
28	a	a	DT	_	30	NMOD
29	blue	blue	JJ	_	30	NMOD
30	dot	dot	NN	_	27	PMOD
31	)	)	-RRB-	_	25	P
32	.	.	.	_	4	P

1	Thus	thus	RB	_	11	ADV
2	,	,	,	_	11	P
3	SNPs	snp	NNS	_	11	SBJ
4	with	with	IN	_	3	NMOD
5	a	a	DT	_	8	NMOD
6	B	b	NN	_	7	NMOD
7	allele	allele	NN	_	8	NMOD
8	frequency	frequency	NN	_	4	PMOD
9	of	of	IN	_	8	NMOD
10	one	one	CD	_	9	PMOD
11	are	be	VBP	_	0	ROOT
12	apparent	apparent	JJ	_	16	NMOD
13	B	b	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	B	b	NN	_	16	NMOD
16	homozygotes	homozygote	NNS	_	11	PRD
17	,	,	,	_	11	P
18	SNPs	snp	NNS	_	26	SBJ
19	with	with	IN	_	18	NMOD
20	a	a	DT	_	23	NMOD
21	B	b	NN	_	22	NMOD
22	allele	allele	NN	_	23	NMOD
23	frequency	frequency	NN	_	19	PMOD
24	of	of	IN	_	23	NMOD
25	0.5	0	CD	_	24	PMOD
26	are	be	VBP	_	11	CONJ
27	apparent	apparent	JJ	_	31	NMOD
28	A	a	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	B	b	NN	_	31	NMOD
31	heterozygotes	heterozygote	NNS	_	26	PRD
32	,	,	,	_	26	P
33	and	and	CC	_	26	COORD
34	those	those	DT	_	42	SBJ
35	with	with	IN	_	34	NMOD
36	a	a	DT	_	39	NMOD
37	B	b	NN	_	38	NMOD
38	allele	allele	NN	_	39	NMOD
39	frequency	frequency	NN	_	35	PMOD
40	of	of	IN	_	39	NMOD
41	zero	zero	CD	_	40	PMOD
42	are	be	VBP	_	33	CONJ
43	apparent	apparent	JJ	_	47	NMOD
44	A	a	NN	_	46	NMOD
45	/	/	HYPH	_	44	P
46	A	a	NN	_	47	NMOD
47	homozygotes	homozygote	NNS	_	42	PRD
48	.	.	.	_	11	P

1	These	these	DT	_	2	NMOD
2	plots	plot	NNS	_	3	SBJ
3	show	show	VBP	_	0	ROOT
4	a	a	DT	_	6	NMOD
5	contiguous	contiguous	JJ	_	6	NMOD
6	region	region	NN	_	3	OBJ
7	~	~	SYM	_	8	P
8	310	0	CD	_	9	NMOD
9	kb	kb	NN	_	10	AMOD
10	long	long	JJ	_	6	NMOD
11	(	(	-LRB-	_	13	P
12	family	family	NN	_	13	NMOD
13	H33	h0	NN	_	10	PRN
14	)	)	-RRB-	_	13	P
15	and	and	CC	_	10	COORD
16	~	~	SYM	_	17	P
17	350	0	CD	_	18	NMOD
18	kb	kb	NN	_	19	AMOD
19	long	long	JJ	_	15	CONJ
20	(	(	-LRB-	_	22	P
21	family	family	NN	_	22	NMOD
22	H27	h0	NN	_	19	PRN
23	)	)	-RRB-	_	22	P
24	with	with	IN	_	6	NMOD
25	decreased	decrease	VBN	_	27	NMOD
26	copy	copy	NN	_	27	NMOD
27	number	number	NN	_	24	PMOD
28	and	and	CC	_	27	COORD
29	apparent	apparent	JJ	_	30	NMOD
30	homozygosity	homozygosity	NN	_	28	CONJ
31	indicative	indicative	JJ	_	27	NMOD
32	of	of	IN	_	31	AMOD
33	a	a	DT	_	35	NMOD
34	genomic	genomic	JJ	_	35	NMOD
35	deletion	deletion	NN	_	32	PMOD
36	(	(	-LRB-	_	38	P
37	shaded	shade	VBN	_	38	NMOD
38	grey	grey	NN	_	27	PRN
39	)	)	-RRB-	_	38	P
40	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	pedigrees	pedigree	NNS	_	4	SBJ
3	below	below	RB	_	2	NMOD
4	show	show	VBP	_	0	ROOT
5	the	the	DT	_	8	NMOD
6	available	available	JJ	_	8	NMOD
7	family	family	NN	_	8	NMOD
8	members	member	NNS	_	4	OBJ
9	assayed	assay	VBN	_	8	NMOD
10	for	for	IN	_	9	ADV
11	these	these	DT	_	12	NMOD
12	deletions	deletion	NNS	_	10	PMOD
13	,	,	,	_	8	P
14	all	all	DT	_	17	SBJ
15	of	of	IN	_	14	NMOD
16	whom	whom	WP	_	15	PMOD
17	were	be	VBD	_	8	NMOD
18	affected	affect	VBN	_	17	VC
19	and	and	CC	_	17	COORD
20	all	all	DT	_	23	SBJ
21	of	of	IN	_	20	NMOD
22	whom	whom	WP	_	21	PMOD
23	carried	carry	VBD	_	19	CONJ
24	a	a	DT	_	25	NMOD
25	deletion	deletion	NN	_	23	OBJ
26	at	at	IN	_	23	LOC
27	this	this	DT	_	28	NMOD
28	locus	locus	NN	_	26	PMOD
29	.	.	.	_	4	P

1	(	(	-LRB-	_	4	P
2	6.8	0	CD	_	3	NMOD
3	MB	mb	NN	_	4	NMOD
4	TIF	tif	NN	_	0	ROOT
5	)	)	-RRB-	_	4	P

1	Click	click	VB	_	0	ROOT
2	here	here	RB	_	1	ADV
3	for	for	IN	_	1	PRP
4	additional	additional	JJ	_	6	NMOD
5	data	datum	NNS	_	6	NMOD
6	file	file	NN	_	3	PMOD
7	.	.	.	_	1	P

1	Figure	figure	NN	_	2	NMOD
2	S4	s0	NN	_	0	ROOT

1	Deleted	delete	VBN	_	2	NMOD
2	Regions	region	NNS	_	0	ROOT
3	Identified	identify	VBN	_	2	NMOD
4	in	in	IN	_	3	ADV
5	Families	family	NNS	_	6	NMOD
6	AUS1	aus0	NN	_	4	PMOD
7	and	and	CC	_	6	COORD
8	H27	h0	NN	_	7	CONJ

1	(	(	-LRB-	_	2	P
2	Top	top	NN	_	7	PRN
3	)	)	-RRB-	_	2	P
4	Family	family	NN	_	5	NMOD
5	AUS1	aus0	NN	_	7	NMOD
6	;	;	:	_	7	P
7	sequence	sequence	NN	_	0	ROOT
8	from	from	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	PCR	pcr	NN	_	11	NMOD
11	product	product	NN	_	8	PMOD
12	generated	generate	VBN	_	11	NMOD
13	using	use	VBG	_	12	MNR
14	primers	primer	NNS	_	15	NMOD
15	T3f	t0f	NN	_	13	OBJ
16	and	and	CC	_	15	COORD
17	C11r	c0r	NN	_	16	CONJ
18	from	from	IN	_	15	NMOD
19	genomic	genomic	JJ	_	20	NMOD
20	DNA	dna	NN	_	18	PMOD
21	from	from	IN	_	20	NMOD
22	an	an	DT	_	25	NMOD
23	affected	affect	VBN	_	25	NMOD
24	family	family	NN	_	25	NMOD
25	member	member	NN	_	21	PMOD
26	.	.	.	_	7	P

1	Red	red	JJ	_	2	NMOD
2	arrowhead	arrowhead	NN	_	3	SBJ
3	denotes	denote	VBZ	_	10	DEP
4	the	the	DT	_	6	NMOD
5	deletion	deletion	NN	_	6	NMOD
6	breakpoint	breakpoint	NN	_	3	OBJ
7	;	;	:	_	10	P
8	the	the	DT	_	9	NMOD
9	deletion	deletion	NN	_	10	SBJ
10	is	be	VBZ	_	0	ROOT
11	201,510	0	CD	_	12	NMOD
12	bp	bp	NN	_	10	PRD
13	in	in	IN	_	12	NMOD
14	length	length	NN	_	13	PMOD
15	.	.	.	_	10	P

1	(	(	-LRB-	_	2	P
2	Bottom	bottom	NN	_	7	PRN
3	)	)	-RRB-	_	2	P
4	Family	family	NN	_	5	NMOD
5	H27	h0	NN	_	7	NMOD
6	;	;	:	_	7	P
7	sequence	sequence	NN	_	0	ROOT
8	flanking	flank	VBG	_	7	NMOD
9	deleted	delete	VBN	_	10	NMOD
10	region	region	NN	_	8	OBJ
11	.	.	.	_	7	P

1	Green	green	JJ	_	2	NMOD
2	font	font	NN	_	3	SBJ
3	indicates	indicate	VBZ	_	12	DEP
4	nucleotides	nucleotide	NNS	_	3	OBJ
5	telomeric	telomeric	JJ	_	4	NMOD
6	to	to	IN	_	5	AMOD
7	the	the	DT	_	8	NMOD
8	deletion	deletion	NN	_	6	PMOD
9	;	;	:	_	12	P
10	blue	blue	JJ	_	11	NMOD
11	font	font	NN	_	12	SBJ
12	indicates	indicate	VBZ	_	0	ROOT
13	nucleotides	nucleotide	NNS	_	12	OBJ
14	centromeric	centromeric	JJ	_	13	NMOD
15	to	to	IN	_	14	AMOD
16	the	the	DT	_	17	NMOD
17	deletion	deletion	NN	_	15	PMOD
18	.	.	.	_	12	P

1	The	the	DT	_	2	NMOD
2	deletion	deletion	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	344,408	0	CD	_	5	NMOD
5	bp	bp	NN	_	3	PRD
6	in	in	IN	_	5	NMOD
7	length	length	NN	_	6	PMOD
8	.	.	.	_	3	P

1	Basepair	basepair	NN	_	2	NMOD
2	positions	position	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	based	base	VBN	_	3	VC
5	on	on	IN	_	4	ADV
6	NCBI	ncbi	NN	_	11	NMOD
7	genome	genome	NN	_	11	NMOD
8	build	build	VB	_	7	NMOD
9	36	0	CD	_	7	NMOD
10	reference	reference	NN	_	11	NMOD
11	assembly	assembly	NN	_	5	PMOD
12	.	.	.	_	3	P

1	(	(	-LRB-	_	5	P
2	876	0	CD	_	3	NMOD
3	KB	kb	NN	_	5	NMOD
4	MB	mb	NN	_	5	NMOD
5	TIF	tif	NN	_	0	ROOT
6	)	)	-RRB-	_	5	P
7	.	.	.	_	5	P

1	Click	click	VB	_	0	ROOT
2	here	here	RB	_	1	ADV
3	for	for	IN	_	1	PRP
4	additional	additional	JJ	_	6	NMOD
5	data	datum	NNS	_	6	NMOD
6	file	file	NN	_	3	PMOD
7	.	.	.	_	1	P

1	Accession	accession	NN	_	2	NMOD
2	Numbers	number	NNS	_	0	ROOT

1	The	the	DT	_	7	NMOD
2	OMIM	omim	NN	_	7	NMOD
3	(	(	-LRB-	_	4	P
4	http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM	http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim	NN	_	2	PRN
5	)	)	-RRB-	_	4	P
6	accession	accession	NN	_	7	NMOD
7	number	number	NN	_	10	SBJ
8	for	for	IN	_	7	NMOD
9	SUMF1	sumf0	NN	_	8	PMOD
10	is	be	VBZ	_	0	ROOT
11	607939	0	CD	_	10	PRD
12	.	.	.	_	10	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	thank	thank	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	SCA15	sca0	NN	_	6	NMOD
5	family	family	NN	_	6	NMOD
6	members	member	NNS	_	2	OBJ
7	for	for	IN	_	2	PRP
8	participating	participate	VBG	_	7	PMOD
9	in	in	IN	_	8	ADV
10	this	this	DT	_	11	NMOD
11	study	study	NN	_	9	PMOD
12	.	.	.	_	2	P

1	Abbreviations	abbreviation	NNS	_	0	ROOT

1	EBV	ebv	NN	_	6	NMOD
2	-	-	:	_	6	P
3	Epstein	epstein	NNP	_	5	NMOD
4	-	-	HYPH	_	3	P
5	Barr	barr	NNP	_	6	NMOD
6	virus	virus	NN	_	0	ROOT

1	SCA	sca	NN	_	3	NMOD
2	[	[	-LRB-	_	3	P
3	number	number	NN	_	9	NMOD
4	]	]	-RRB-	_	3	P
5	-	-	:	_	9	P
6	spinocerebellar	spinocerebellar	JJ	_	9	NMOD
7	ataxia	ataxia	NN	_	9	NMOD
8	[	[	-LRB-	_	9	P
9	number	number	NN	_	0	ROOT
10	]	]	-RRB-	_	9	P

1	SNP	snp	NN	_	5	NMOD
2	-	-	:	_	5	P
3	single	single	JJ	_	4	NMOD
4	nucleotide	nucleotide	NN	_	5	NMOD
5	polymorphism	polymorphism	NN	_	0	ROOT

1	Figures	figure	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Tables	table	NNS	_	2	CONJ

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Immunohistochemistry	immunohistochemistry	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Western	western	NNP	_	4	NMOD
4	Blot	blot	NN	_	5	NMOD
5	Analysis	analysis	NN	_	2	CONJ
6	of	of	IN	_	1	NMOD
7	ITPR1	itpr0	NN	_	9	NMOD
8	Protein	protein	NN	_	9	NMOD
9	Levels	level	NNS	_	6	PMOD
10	in	in	IN	_	9	LOC
11	Mouse	mouse	NN	_	12	NMOD
12	Cerebellum	cerebellum	NN	_	10	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	6	NMOD
3	–	–	SYM	_	2	P
4	F	f	LS	_	2	DEP
5	)	)	-RRB-	_	2	P
6	Immunohistochemistry	immunohistochemistry	NN	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	cerebellum	cerebellum	NN	_	7	PMOD
9	from	from	IN	_	8	NMOD
10	a	a	DT	_	14	NMOD
11	wild	wild	JJ	_	13	NMOD
12	-	-	HYPH	_	11	P
13	type	type	NN	_	14	NMOD
14	mouse	mouse	NN	_	9	PMOD
15	(	(	-LRB-	_	16	P
16	A	a	NN	_	14	PRN
17	and	and	CC	_	16	COORD
18	D	d	NN	_	17	CONJ
19	)	)	-RRB-	_	16	P
20	,	,	,	_	14	P
21	a	a	DT	_	22	NMOD
22	mouse	mouse	NN	_	14	CONJ
23	heterozygous	heterozygous	JJ	_	22	NMOD
24	for	for	IN	_	23	AMOD
25	the	the	DT	_	30	NMOD
26	Itpr1	itpr0	NN	_	30	NMOD
27	18	0	CD	_	29	NMOD
28	-	-	HYPH	_	27	P
29	bp	bp	NN	_	30	NMOD
30	deletion	deletion	NN	_	24	PMOD
31	(	(	-LRB-	_	32	P
32	B	b	NN	_	22	PRN
33	and	and	CC	_	32	COORD
34	E	e	NN	_	33	CONJ
35	)	)	-RRB-	_	32	P
36	,	,	,	_	22	P
37	and	and	CC	_	22	COORD
38	a	a	DT	_	39	NMOD
39	mouse	mouse	NN	_	37	CONJ
40	homozygous	homozygous	JJ	_	39	NMOD
41	for	for	IN	_	40	AMOD
42	the	the	DT	_	47	NMOD
43	18	0	CD	_	45	NMOD
44	-	-	HYPH	_	43	P
45	bp	bp	NN	_	47	NMOD
46	Itpr1	itpr0	NN	_	47	NMOD
47	deletion	deletion	NN	_	41	PMOD
48	(	(	-LRB-	_	49	P
49	C	c	NN	_	39	PRN
50	and	and	CC	_	49	COORD
51	F	f	NN	_	50	CONJ
52	)	)	-RRB-	_	49	P
53	.	.	.	_	6	P

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	6	NMOD
3	–	–	SYM	_	2	P
4	C	c	LS	_	2	DEP
5	)	)	-RRB-	_	2	P
6	Immunohistochemistry	immunohistochemistry	NN	_	27	NMOD
7	using	use	VBG	_	6	NMOD
8	polyclonal	polyclonal	JJ	_	11	NMOD
9	Itpr1	itpr0	NN	_	11	NMOD
10	anti-rabbit	anti-rabbit	JJ	_	11	NMOD
11	antibody	antibody	NN	_	7	OBJ
12	(	(	-LRB-	_	18	P
13	1	0	CD	_	18	DEP
14	:	:	SYM	_	15	P
15	2,000	0	CD	_	13	NMOD
16	;	;	:	_	18	P
17	Alexa	alexa	NNP	_	18	NMOD
18	Fluor	fluor	NNP	_	11	PRN
19	555	0	CD	_	18	NMOD
20	)	)	-RRB-	_	18	P
21	;	;	:	_	27	P
22	(	(	-LRB-	_	23	P
23	D	d	LS	_	27	NMOD
24	–	–	SYM	_	23	P
25	F	f	LS	_	23	DEP
26	)	)	-RRB-	_	23	P
27	immunohistochemistry	immunohistochemistry	NN	_	0	ROOT
28	using	use	VBG	_	27	NMOD
29	monoclonal	monoclonal	JJ	_	32	NMOD
30	Calb1	calb0	NN	_	32	NMOD
31	anti-mouse	anti-mouse	JJ	_	32	NMOD
32	antibody	antibody	NN	_	28	OBJ
33	(	(	-LRB-	_	39	P
34	1	0	CD	_	39	DEP
35	:	:	SYM	_	36	P
36	6,000	0	CD	_	34	NMOD
37	;	;	:	_	39	P
38	Alexa	alexa	NNP	_	39	NMOD
39	Fluor	fluor	NNP	_	32	PRN
40	488	0	CD	_	39	NMOD
41	)	)	-RRB-	_	39	P
42	.	.	.	_	27	P

1	Scale	scale	NN	_	2	NMOD
2	bars	bar	NNS	_	3	SBJ
3	denote	denote	VBP	_	0	ROOT
4	100	0	CD	_	5	NMOD
5	μm	μm	NN	_	3	OBJ
6	.	.	.	_	3	P

1	As	as	IN	_	6	ADV
2	previously	previously	RB	_	3	TMP
3	described	describe	VBN	_	1	SUB
4	,	,	,	_	6	P
5	Iptr1	iptr0	NN	_	6	SBJ
6	is	be	VBZ	_	0	ROOT
7	highly	highly	RB	_	6	ADV
8	expressed	express	VBN	_	6	VC
9	in	in	IN	_	8	LOC
10	the	the	DT	_	12	NMOD
11	Purkinje	purkinje	NNP	_	12	NMOD
12	cells	cell	NNS	_	9	PMOD
13	.	.	.	_	6	P

1	Notably	notably	RB	_	4	ADV
2	,	,	,	_	4	P
3	there	there	EX	_	4	SBJ
4	appears	appear	VBZ	_	0	ROOT
5	to	to	TO	_	4	OPRD
6	be	be	VB	_	5	IM
7	decreased	decrease	VBN	_	8	NMOD
8	immunoreactivity	immunoreactivity	NN	_	6	PRD
9	to	to	IN	_	8	NMOD
10	Itpr1	itpr0	NN	_	9	PMOD
11	in	in	IN	_	6	LOC
12	the	the	DT	_	17	NMOD
13	heterozygous	heterozygous	JJ	_	17	NMOD
14	and	and	CC	_	13	COORD
15	homozygous	homozygous	JJ	_	14	CONJ
16	mutant	mutant	NN	_	17	NMOD
17	mice	mouse	NNS	_	11	PMOD
18	.	.	.	_	4	P

1	(	(	-LRB-	_	2	P
2	G	g	LS	_	5	DEP
3	)	)	-RRB-	_	2	P
4	Western	western	NNP	_	5	NMOD
5	blot	blot	NN	_	0	ROOT
6	performed	perform	VBN	_	5	NMOD
7	to	to	TO	_	6	PRP
8	examine	examine	VB	_	7	IM
9	Itpr1	itpr0	NN	_	10	NMOD
10	levels	level	NNS	_	8	OBJ
11	in	in	IN	_	8	LOC
12	whole	whole	JJ	_	13	NMOD
13	brain	brain	NN	_	11	PMOD
14	from	from	IN	_	13	NMOD
15	wild	wild	JJ	_	17	NMOD
16	-	-	HYPH	_	15	P
17	type	type	NN	_	27	NMOD
18	,	,	,	_	17	P
19	Itpr1wt	itpr0wt	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	Δ18	δ0	NN	_	17	CONJ
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	Itpr1Δ18	itpr0δ0	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	Δ18	δ0	NN	_	23	CONJ
27	mice	mouse	NNS	_	14	PMOD
28	;	;	:	_	5	P
29	this	this	DT	_	31	SBJ
30	clearly	clearly	RB	_	31	ADV
31	shows	show	VBZ	_	5	DEP
32	a	a	DT	_	33	NMOD
33	reduction	reduction	NN	_	31	OBJ
34	of	of	IN	_	33	NMOD
35	Itpr1	itpr0	NN	_	34	PMOD
36	in	in	IN	_	33	LOC
37	brain	brain	NN	_	38	NMOD
38	tissue	tissue	NN	_	36	PMOD
39	from	from	IN	_	38	NMOD
40	Itpr1wt	itpr0wt	NN	_	42	NMOD
41	/	/	HYPH	_	40	P
42	Δ18	δ0	NN	_	43	NMOD
43	mice	mouse	NNS	_	39	PMOD
44	and	and	CC	_	33	COORD
45	a	a	DT	_	47	NMOD
46	greater	great	JJR	_	47	NMOD
47	reduction	reduction	NN	_	44	CONJ
48	of	of	IN	_	47	NMOD
49	Itpr1	itpr0	NN	_	48	PMOD
50	in	in	IN	_	47	LOC
51	Itpr1Δ18	itpr0δ0	NN	_	53	NMOD
52	/	/	HYPH	_	51	P
53	Δ18	δ0	NN	_	54	NMOD
54	mice	mouse	NNS	_	50	PMOD
55	.	.	.	_	5	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Metrics	metric	NNS	_	0	ROOT
2	Derived	derive	VBN	_	1	NMOD
3	from	from	IN	_	2	ADV
4	Analysis	analysis	NN	_	3	PMOD
5	of	of	IN	_	4	NMOD
6	DNA	dna	NN	_	5	PMOD
7	from	from	IN	_	6	NMOD
8	Affected	affect	VBN	_	10	NMOD
9	Family	family	NN	_	10	NMOD
10	Member	member	NN	_	7	PMOD
11	7	0	CD	_	10	NMOD
12	Using	use	VBG	_	2	MNR
13	Illumina	illumina	NNP	_	15	NMOD
14	Infinium	infinium	NNP	_	15	NMOD
15	HumanHap550	humanhap0	NNP	_	17	NMOD
16	Genotyping	genotyping	NN	_	17	NMOD
17	Chips	chip	NNS	_	12	OBJ

1	The	the	DT	_	5	NMOD
2	upper	upper	JJ	_	5	NMOD
3	and	and	CC	_	2	COORD
4	lower	low	JJ	_	3	CONJ
5	plots	plot	NNS	_	6	SBJ
6	are	be	VBP	_	0	ROOT
7	log	log	NN	_	8	NMOD
8	R	r	NN	_	9	NMOD
9	ratio	ratio	NN	_	6	PRD
10	and	and	CC	_	9	COORD
11	B	b	NN	_	12	NMOD
12	allele	allele	NN	_	13	NMOD
13	frequency	frequency	NN	_	10	CONJ
14	,	,	,	_	6	P
15	respectively	respectively	RB	_	6	ADV
16	,	,	,	_	6	P
17	at	at	IN	_	6	LOC
18	an	an	DT	_	23	NMOD
19	~	~	SYM	_	20	P
20	800	0	CD	_	22	NMOD
21	-	-	HYPH	_	20	P
22	kb	kb	NN	_	23	NMOD
23	segment	segment	NN	_	17	PMOD
24	on	on	IN	_	23	NMOD
25	the	the	DT	_	27	NMOD
26	p	p	NN	_	27	NMOD
27	arm	arm	NN	_	24	PMOD
28	of	of	IN	_	27	NMOD
29	Chromosome	chromosome	NN	_	28	PMOD
30	3	0	CD	_	29	NMOD
31	.	.	.	_	6	P

1	Log	log	NN	_	2	NMOD
2	R	r	NN	_	3	NMOD
3	ratio	ratio	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	ratio	ratio	NN	_	4	PRD
7	of	of	IN	_	6	NMOD
8	normalized	normalize	VBN	_	11	NMOD
9	,	,	,	_	11	P
10	observed	observe	VBN	_	11	NMOD
11	R	r	NN	_	7	PMOD
12	to	to	IN	_	6	NMOD
13	expected	expect	VBN	_	14	NMOD
14	R	r	NN	_	12	PMOD
15	for	for	IN	_	6	NMOD
16	each	each	DT	_	17	NMOD
17	SNP	snp	NN	_	15	PMOD
18	(	(	-LRB-	_	21	P
19	each	each	DT	_	20	NMOD
20	SNP	snp	NN	_	21	SBJ
21	is	be	VBZ	_	6	PRN
22	a	a	DT	_	24	NMOD
23	blue	blue	JJ	_	24	NMOD
24	dot	dot	NN	_	21	PRD
25	)	)	-RRB-	_	21	P
26	and	and	CC	_	4	COORD
27	thus	thus	RB	_	28	ADV
28	serves	serve	VBZ	_	26	CONJ
29	as	as	IN	_	28	ADV
30	a	a	DT	_	31	NMOD
31	surrogate	surrogate	NN	_	29	PMOD
32	of	of	IN	_	31	NMOD
33	copy	copy	NN	_	34	NMOD
34	number	number	NN	_	32	PMOD
35	at	at	IN	_	28	LOC
36	each	each	DT	_	37	NMOD
37	locus	locus	NN	_	35	PMOD
38	.	.	.	_	4	P

1	B	b	NN	_	2	NMOD
2	allele	allele	NN	_	3	NMOD
3	frequency	frequency	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	a	a	DT	_	6	NMOD
6	measure	measure	NN	_	4	PRD
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	9	NMOD
9	number	number	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	times	time	NNS	_	10	PMOD
12	the	the	DT	_	16	NMOD
13	A	a	NN	_	16	NMOD
14	or	or	CC	_	13	COORD
15	B	b	NN	_	14	CONJ
16	alleles	allele	NNS	_	17	SBJ
17	are	be	VBP	_	11	NMOD
18	detected	detect	VBN	_	17	VC
19	at	at	IN	_	18	LOC
20	each	each	DT	_	21	NMOD
21	locus	locus	NN	_	19	PMOD
22	(	(	-LRB-	_	25	P
23	each	each	DT	_	24	NMOD
24	SNP	snp	NN	_	25	SBJ
25	is	be	VBZ	_	4	PRN
26	denoted	denote	VBN	_	25	VC
27	by	by	IN	_	26	LGS
28	a	a	DT	_	30	NMOD
29	blue	blue	JJ	_	30	NMOD
30	dot	dot	NN	_	27	PMOD
31	)	)	-RRB-	_	25	P
32	.	.	.	_	4	P

1	Thus	thus	RB	_	26	ADV
2	,	,	,	_	26	P
3	SNPs	snp	NNS	_	11	SBJ
4	with	with	IN	_	3	NMOD
5	a	a	DT	_	8	NMOD
6	B	b	NN	_	7	NMOD
7	allele	allele	NN	_	8	NMOD
8	frequency	frequency	NN	_	4	PMOD
9	of	of	IN	_	8	NMOD
10	one	one	CD	_	9	PMOD
11	are	be	VBP	_	26	DEP
12	apparent	apparent	JJ	_	16	NMOD
13	B	b	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	B	b	NN	_	16	NMOD
16	homozygotes	homozygote	NNS	_	11	PRD
17	,	,	,	_	26	P
18	SNPs	snp	NNS	_	26	SBJ
19	with	with	IN	_	18	NMOD
20	a	a	DT	_	23	NMOD
21	B	b	NN	_	22	NMOD
22	allele	allele	NN	_	23	NMOD
23	frequency	frequency	NN	_	19	PMOD
24	of	of	IN	_	23	NMOD
25	0.5	0	CD	_	24	PMOD
26	are	be	VBP	_	0	ROOT
27	apparent	apparent	JJ	_	31	NMOD
28	A	a	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	B	b	NN	_	31	NMOD
31	heterozygotes	heterozygote	NNS	_	26	PRD
32	,	,	,	_	26	P
33	and	and	CC	_	26	COORD
34	those	those	DT	_	42	SBJ
35	with	with	IN	_	34	NMOD
36	a	a	DT	_	39	NMOD
37	B	b	NN	_	38	NMOD
38	allele	allele	NN	_	39	NMOD
39	frequency	frequency	NN	_	35	PMOD
40	of	of	IN	_	39	NMOD
41	zero	zero	CD	_	40	PMOD
42	are	be	VBP	_	33	CONJ
43	apparent	apparent	JJ	_	47	NMOD
44	A	a	NN	_	46	NMOD
45	/	/	HYPH	_	44	P
46	A	a	NN	_	47	NMOD
47	homozygotes	homozygote	NNS	_	42	PRD
48	.	.	.	_	26	P

1	Clearly	clearly	RB	_	5	ADV
2	,	,	,	_	5	P
3	these	these	DT	_	4	NMOD
4	plots	plot	NNS	_	5	SBJ
5	show	show	VBP	_	0	ROOT
6	a	a	DT	_	8	NMOD
7	contiguous	contiguous	JJ	_	8	NMOD
8	region	region	NN	_	5	OBJ
9	~	~	SYM	_	10	P
10	200	0	CD	_	11	NMOD
11	kb	kb	NN	_	12	AMOD
12	long	long	JJ	_	8	NMOD
13	with	with	IN	_	8	NMOD
14	decreased	decrease	VBN	_	16	NMOD
15	copy	copy	NN	_	16	NMOD
16	number	number	NN	_	13	PMOD
17	and	and	CC	_	16	COORD
18	apparent	apparent	JJ	_	19	NMOD
19	homozygosity	homozygosity	NN	_	17	CONJ
20	(	(	-LRB-	_	8	P
21	bounded	bound	VBN	_	8	NMOD
22	by	by	IN	_	21	LGS
23	a	a	DT	_	25	NMOD
24	red	red	JJ	_	25	NMOD
25	box	box	NN	_	22	PMOD
26	)	)	-RRB-	_	5	P
27	.	.	.	_	5	P

1	As	as	IN	_	8	ADV
2	we	we	PRP	_	3	SBJ
3	have	have	VBP	_	1	SUB
4	demonstrated	demonstrate	VBN	_	3	VC
5	previously	previously	RB	_	4	TMP
6	,	,	,	_	8	P
7	this	this	DT	_	8	SBJ
8	is	be	VBZ	_	0	ROOT
9	indicative	indicative	JJ	_	8	PRD
10	of	of	IN	_	9	AMOD
11	a	a	DT	_	14	NMOD
12	heterozygous	heterozygous	JJ	_	14	NMOD
13	genomic	genomic	JJ	_	14	NMOD
14	deletion	deletion	NN	_	10	PMOD
15	[	[	-LRB-	_	16	P
16	15	0	CD	_	8	PRN
17	]	]	-RRB-	_	16	P
18	.	.	.	_	8	P

1	Below	below	IN	_	4	PRD
2	these	these	DT	_	3	NMOD
3	plots	plot	NNS	_	1	PMOD
4	is	be	VBZ	_	0	ROOT
5	a	a	DT	_	6	NMOD
6	schematic	schematic	NN	_	4	SBJ
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	11	NMOD
9	two	two	CD	_	11	NMOD
10	known	know	VBN	_	11	NMOD
11	genes	gene	NNS	_	7	PMOD
12	affected	affect	VBN	_	11	NMOD
13	by	by	IN	_	12	LGS
14	this	this	DT	_	15	NMOD
15	deletion	deletion	NN	_	13	PMOD
16	,	,	,	_	11	P
17	ITPR1	itpr0	NN	_	11	APPO
18	and	and	CC	_	17	COORD
19	SUMF1	sumf0	NN	_	18	CONJ
20	.	.	.	_	4	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Mutation	mutation	NN	_	2	NMOD
2	Analysis	analysis	NN	_	0	ROOT
3	in	in	IN	_	2	NMOD
4	the	the	DT	_	7	NMOD
5	Australian	australian	JJ	_	7	NMOD
6	SCA15	sca0	NN	_	7	NMOD
7	Family	family	NN	_	3	PMOD

1	(	(	-LRB-	_	2	P
2	Top	top	NN	_	4	PRN
3	)	)	-RRB-	_	2	P
4	Pedigree	pedigree	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	kindred	kindred	NN	_	5	PMOD
7	.	.	.	_	4	P

1	Filled	fill	VBN	_	2	NMOD
2	symbols	symbol	NNS	_	3	SBJ
3	denote	denote	VBP	_	24	DEP
4	affected	affect	VBN	_	5	NMOD
5	individuals	individual	NNS	_	3	OBJ
6	;	;	:	_	3	P
7	open	open	JJ	_	8	NMOD
8	symbols	symbol	NNS	_	3	GAP-SBJ
9	,	,	,	_	8	P
10	unaffected	unaffected	JJ	_	11	NMOD
11	individuals	individual	NNS	_	8	DEP
12	;	;	:	_	24	P
13	grey	grey	JJ	_	14	NMOD
14	symbol	symbol	NN	_	15	SBJ
15	denotes	denote	VBZ	_	24	DEP
16	unknown	unknown	JJ	_	18	NMOD
17	disease	disease	NN	_	18	NMOD
18	status	status	NN	_	15	OBJ
19	;	;	:	_	24	P
20	bulls	bull	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	eye	eye	NN	_	23	NMOD
23	symbol	symbol	NN	_	24	SBJ
24	denotes	denote	VBZ	_	0	ROOT
25	obligate	obligate	JJ	_	26	NMOD
26	carrier	carrier	NN	_	24	OBJ
27	.	.	.	_	24	P

1	w	w	NN	_	3	NMOD
2	/	/	HYPH	_	1	P
3	w	w	NN	_	13	NMOD
4	,	,	,	_	3	P
5	wild	wild	JJ	_	7	NMOD
6	-	-	HYPH	_	5	P
7	type	type	NN	_	3	APPO
8	at	at	IN	_	7	NMOD
9	ITPR1	itpr0	NN	_	8	PMOD
10	;	;	:	_	13	P
11	w	w	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	m	m	NN	_	0	ROOT
14	,	,	,	_	13	P
15	heterozygous	heterozygous	JJ	_	16	NMOD
16	carrier	carrier	NN	_	13	APPO
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	ITPR1	itpr0	NN	_	20	NMOD
20	deletion	deletion	NN	_	17	PMOD
21	.	.	.	_	13	P

1	(	(	-LRB-	_	2	P
2	Middle	middle	NN	_	4	PRN
3	)	)	-RRB-	_	2	P
4	Schematic	schematic	JJ	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	primer	primer	NN	_	7	NMOD
7	pairs	pair	NNS	_	5	PMOD
8	used	use	VBN	_	7	NMOD
9	to	to	TO	_	8	PRP
10	narrow	narrow	VB	_	9	IM
11	the	the	DT	_	13	NMOD
12	unknown	unknown	JJ	_	13	NMOD
13	regions	region	NNS	_	10	OBJ
14	between	between	IN	_	13	LOC
15	known	know	VBN	_	17	NMOD
16	deleted	delete	VBN	_	17	NMOD
17	sequence	sequence	NN	_	14	PMOD
18	and	and	CC	_	17	COORD
19	known	know	VBN	_	21	NMOD
20	diploid	diploid	JJ	_	21	NMOD
21	sequence	sequence	NN	_	18	CONJ
22	at	at	IN	_	10	LOC
23	the	the	DT	_	25	NMOD
24	SCA15	sca0	NN	_	25	NMOD
25	locus	locus	NN	_	22	PMOD
26	.	.	.	_	4	P

1	Nine	nine	CD	_	3	NMOD
2	primer	primer	NN	_	3	NMOD
3	pairs	pair	NNS	_	9	SBJ
4	(	(	-LRB-	_	5	P
5	T1	t0	NN	_	3	PRN
6	–	–	SYM	_	7	P
7	T9	t0	NN	_	5	NMOD
8	)	)	-RRB-	_	5	P
9	were	be	VBD	_	32	DEP
10	used	use	VBN	_	9	VC
11	to	to	TO	_	10	PRP
12	amplify	amplify	VB	_	11	IM
13	across	across	IN	_	12	ADV
14	the	the	DT	_	16	NMOD
15	unknown	unknown	JJ	_	16	NMOD
16	region	region	NN	_	13	PMOD
17	telomeric	telomeric	JJ	_	16	NMOD
18	to	to	IN	_	17	AMOD
19	the	the	DT	_	22	NMOD
20	known	know	VBN	_	22	NMOD
21	deleted	delete	VBN	_	22	NMOD
22	region	region	NN	_	18	PMOD
23	;	;	:	_	32	P
24	19	0	CD	_	26	NMOD
25	primer	primer	NN	_	26	NMOD
26	pairs	pair	NNS	_	32	SBJ
27	(	(	-LRB-	_	28	P
28	C1	c0	NN	_	26	PRN
29	–	–	SYM	_	30	P
30	C19	c0	NN	_	28	NMOD
31	)	)	-RRB-	_	28	P
32	were	be	VBD	_	0	ROOT
33	used	use	VBN	_	32	VC
34	to	to	TO	_	33	PRP
35	amplify	amplify	VB	_	34	IM
36	across	across	IN	_	35	ADV
37	the	the	DT	_	39	NMOD
38	unknown	unknown	JJ	_	39	NMOD
39	region	region	NN	_	36	PMOD
40	centromeric	centromeric	JJ	_	39	NMOD
41	to	to	IN	_	35	ADV
42	the	the	DT	_	45	NMOD
43	known	know	VBN	_	45	NMOD
44	deleted	delete	VBN	_	45	NMOD
45	region	region	NN	_	41	PMOD
46	.	.	.	_	32	P

1	All	all	DT	_	2	NMOD
2	PCRs	pcrs	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	carried	carry	VBN	_	3	VC
5	out	out	RP	_	4	PRT
6	in	in	IN	_	4	LOC
7	the	the	DT	_	11	NMOD
8	three	three	CD	_	11	NMOD
9	affected	affect	VBN	_	11	NMOD
10	family	family	NN	_	11	NMOD
11	members	member	NNS	_	6	PMOD
12	.	.	.	_	3	P

1	Analysis	analysis	NN	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	these	these	DT	_	4	NMOD
4	data	datum	NNS	_	2	PMOD
5	narrowed	narrow	VBD	_	0	ROOT
6	the	the	DT	_	8	NMOD
7	unknown	unknown	JJ	_	8	NMOD
8	region	region	NN	_	5	OBJ
9	,	,	,	_	5	P
10	and	and	CC	_	5	COORD
11	ultimately	ultimately	RB	_	13	ADV
12	we	we	PRP	_	13	SBJ
13	were	be	VBD	_	10	CONJ
14	able	able	JJ	_	13	PRD
15	to	to	TO	_	14	AMOD
16	use	use	VB	_	15	IM
17	primer	primer	NN	_	18	NMOD
18	T3f	t0f	NN	_	16	OBJ
19	and	and	CC	_	18	COORD
20	C11r	c0r	NN	_	19	CONJ
21	to	to	TO	_	16	PRP
22	amplify	amplify	VB	_	21	IM
23	across	across	IN	_	22	LOC
24	the	the	DT	_	26	NMOD
25	deletion	deletion	NN	_	26	NMOD
26	breakpoint	breakpoint	NN	_	23	PMOD
27	in	in	IN	_	22	LOC
28	the	the	DT	_	32	NMOD
29	three	three	CD	_	32	NMOD
30	affected	affect	VBN	_	32	NMOD
31	family	family	NN	_	32	NMOD
32	members	member	NNS	_	27	PMOD
33	,	,	,	_	22	P
34	producing	produce	VBG	_	22	ADV
35	a	a	DT	_	36	NMOD
36	fragment	fragment	NN	_	34	OBJ
37	of	of	IN	_	36	NMOD
38	953	0	CD	_	39	NMOD
39	bp	bp	NN	_	37	PMOD
40	in	in	IN	_	34	LOC
41	affected	affect	VBN	_	42	NMOD
42	individuals	individual	NNS	_	40	PMOD
43	.	.	.	_	5	P

1	(	(	-LRB-	_	2	P
2	Bottom	bottom	NN	_	4	PRN
3	)	)	-RRB-	_	2	P
4	Gel	gel	NN	_	0	ROOT
5	showing	show	VBG	_	4	NMOD
6	amplification	amplification	NN	_	7	NMOD
7	product	product	NN	_	5	OBJ
8	using	use	VBG	_	7	NMOD
9	primer	primer	NN	_	10	NMOD
10	pair	pair	NN	_	11	NMOD
11	T3f	t0f	NN	_	8	OBJ
12	and	and	CC	_	11	COORD
13	C11r	c0r	NN	_	12	CONJ
14	from	from	IN	_	11	NMOD
15	affected	affect	VBN	_	18	NMOD
16	pedigree	pedigree	NN	_	18	NMOD
17	members	member	NNS	_	18	NMOD
18	6	0	CD	_	14	PMOD
19	,	,	,	_	18	P
20	7	0	CD	_	18	CONJ
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	19	0	CD	_	22	CONJ
24	;	;	:	_	14	P
25	in	in	IN	_	14	CONJ
26	pedigree	pedigree	NN	_	27	NMOD
27	member	member	NN	_	25	PMOD
28	23	0	CD	_	27	NMOD
29	,	,	,	_	27	P
30	with	with	IN	_	27	NMOD
31	unknown	unknown	JJ	_	34	NMOD
32	disease	disease	NN	_	33	NMOD
33	affection	affection	NN	_	34	NMOD
34	status	status	NN	_	30	PMOD
35	;	;	:	_	25	P
36	in	in	IN	_	25	CONJ
37	a	a	DT	_	40	NMOD
38	neurologically	neurologically	RB	_	39	AMOD
39	normal	normal	JJ	_	40	NMOD
40	control	control	NN	_	36	PMOD
41	(	(	-LRB-	_	42	P
42	C	c	NN	_	40	PRN
43	)	)	-RRB-	_	42	P
44	;	;	:	_	36	P
45	and	and	CC	_	36	COORD
46	in	in	IN	_	45	CONJ
47	a	a	DT	_	50	NMOD
48	no	no	DT	_	49	NMOD
49	template	template	NN	_	50	NMOD
50	control	control	NN	_	46	PMOD
51	(	(	-LRB-	_	52	P
52	NC	nc	NN	_	50	PRN
53	)	)	-RRB-	_	52	P
54	.	.	.	_	4	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Western	western	NNP	_	2	NMOD
2	Blot	blot	NN	_	3	NMOD
3	Analysis	analysis	NN	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	ITPR1	itpr0	NN	_	7	NMOD
6	Protein	protein	NN	_	7	NMOD
7	Levels	level	NNS	_	4	PMOD
8	in	in	IN	_	3	LOC
9	EBV	ebv	NN	_	11	NMOD
10	Immortalized	immortalize	VBN	_	11	NMOD
11	Lymphoblasts	lymphoblast	NNS	_	8	PMOD
12	from	from	IN	_	11	NMOD
13	AUS1	aus0	NN	_	15	NMOD
14	Family	family	NN	_	15	NMOD
15	Members	member	NNS	_	12	PMOD

1	Western	western	NNP	_	2	NMOD
2	blot	blot	NN	_	0	ROOT
3	performed	perform	VBN	_	2	NMOD
4	to	to	TO	_	3	PRP
5	examine	examine	VB	_	4	IM
6	ITPR1	itpr0	NN	_	7	NMOD
7	levels	level	NNS	_	5	OBJ
8	in	in	IN	_	7	LOC
9	EBV	ebv	NN	_	11	NMOD
10	immortalized	immortalize	VBN	_	11	NMOD
11	lymphocytes	lymphocyte	NNS	_	8	PMOD
12	from	from	IN	_	11	NMOD
13	AUS1	aus0	NN	_	14	AMOD
14	affected	affect	VBN	_	16	NMOD
15	family	family	NN	_	16	NMOD
16	members	member	NNS	_	12	PMOD
17	carrying	carry	VBG	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	ITPR1	itpr0	NN	_	20	NMOD
20	deletion	deletion	NN	_	17	OBJ
21	and	and	CC	_	12	COORD
22	from	from	IN	_	21	CONJ
23	an	an	DT	_	26	NMOD
24	AUS1	aus0	NN	_	26	NMOD
25	family	family	NN	_	26	NMOD
26	member	member	NN	_	22	PMOD
27	of	of	IN	_	26	NMOD
28	unknown	unknown	JJ	_	30	NMOD
29	disease	disease	NN	_	30	NMOD
30	status	status	NN	_	27	PMOD
31	who	who	WP	_	32	SBJ
32	does	do	VBZ	_	26	NMOD
33	not	not	RB	_	32	ADV
34	carry	carry	VB	_	32	VC
35	the	the	DT	_	36	NMOD
36	deletion	deletion	NN	_	34	OBJ
37	.	.	.	_	2	P

1	Notably	notably	RB	_	9	ADV
2	the	the	DT	_	3	NMOD
3	samples	sample	NNS	_	9	SBJ
4	from	from	IN	_	3	NMOD
5	patients	patient	NNS	_	4	PMOD
6	with	with	IN	_	5	NMOD
7	ITPR1	itpr0	NN	_	8	NMOD
8	deletion	deletion	NN	_	6	PMOD
9	show	show	VBP	_	0	ROOT
10	a	a	DT	_	12	NMOD
11	dramatic	dramatic	JJ	_	12	NMOD
12	decrease	decrease	NN	_	9	OBJ
13	in	in	IN	_	12	NMOD
14	ITPR1	itpr0	NN	_	15	NMOD
15	levels	level	NNS	_	13	PMOD
16	.	.	.	_	9	P

1	To	to	TO	_	8	PRP
2	demonstrate	demonstrate	VB	_	1	IM
3	equal	equal	JJ	_	4	NMOD
4	loading	loading	NN	_	2	OBJ
5	,	,	,	_	8	P
6	these	these	DT	_	7	NMOD
7	samples	sample	NNS	_	8	SBJ
8	were	be	VBD	_	0	ROOT
9	diluted	dilute	VBN	_	8	VC
10	one	one	CD	_	9	EXT
11	in	in	IN	_	10	NMOD
12	five	five	CD	_	11	PMOD
13	,	,	,	_	8	P
14	and	and	CC	_	8	COORD
15	the	the	DT	_	17	NMOD
16	Western	western	NNP	_	17	NMOD
17	blot	blot	NN	_	18	SBJ
18	was	be	VBD	_	14	CONJ
19	repeated	repeat	VBN	_	18	VC
20	using	use	VBG	_	19	MNR
21	an	an	DT	_	22	NMOD
22	antibody	antibody	NN	_	20	OBJ
23	against	against	IN	_	22	NMOD
24	ACTB	actb	NN	_	23	PMOD
25	.	.	.	_	8	P

1	Footnotes	footnote	NNS	_	0	ROOT

1	A	a	DT	_	3	NMOD
2	previous	previous	JJ	_	3	NMOD
3	version	version	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	article	article	NN	_	4	PMOD
7	appeared	appear	VBD	_	0	ROOT
8	as	as	IN	_	7	MNR
9	an	an	DT	_	12	NMOD
10	Early	early	JJ	_	12	NMOD
11	Online	online	JJ	_	12	NMOD
12	Release	release	NN	_	8	PMOD
13	on	on	IN	_	7	TMP
14	May	may	NNP	_	13	PMOD
15	16	0	CD	_	14	NMOD
16	,	,	,	_	14	P
17	2007	0	CD	_	14	APPO
18	(	(	-LRB-	_	19	P
19	doi:10.1371/journal.pgen.0030108.eor	doi0/journal.pgen0.eor	NN	_	7	PRN
20	)	)	-RRB-	_	19	P
21	.	.	.	_	7	P

1	Author	author	NN	_	2	NMOD
2	contributions	contribution	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	EMCF	emcf	NNP	_	7	SBJ
2	,	,	,	_	1	P
3	JTR	jtr	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	and	and	CC	_	3	COORD
6	ABS	ab	NNP	_	5	CONJ
7	conceived	conceive	VBD	_	0	ROOT
8	and	and	CC	_	7	COORD
9	designed	design	VBD	_	8	CONJ
10	the	the	DT	_	11	NMOD
11	experiments	experiment	NNS	_	7	OBJ
12	.	.	.	_	7	P

1	JvdL	jvdl	NNP	_	25	SBJ
2	,	,	,	_	1	P
3	JC	jc	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	MAK	mak	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	LAH	lah	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	SS	s	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	MRC	mrc	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	HCF	hcf	NNP	_	11	CONJ
14	,	,	,	_	13	P
15	XL	xl	NNP	_	13	CONJ
16	,	,	,	_	15	P
17	DH	dh	NNP	_	15	CONJ
18	,	,	,	_	17	P
19	JSS	jss	NNP	_	17	CONJ
20	,	,	,	_	19	P
21	IR	ir	NNP	_	19	CONJ
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	HC	hc	NNP	_	23	CONJ
25	performed	perform	VBD	_	0	ROOT
26	the	the	DT	_	27	NMOD
27	experiments	experiment	NNS	_	25	OBJ
28	.	.	.	_	25	P

1	JvdL	jvdl	NNP	_	21	SBJ
2	,	,	,	_	1	P
3	JC	jc	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	MAK	mak	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	SS	s	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	MRC	mrc	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	KGH	kgh	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	HCF	hcf	NNP	_	11	CONJ
14	,	,	,	_	13	P
15	JSS	jss	NNP	_	13	CONJ
16	,	,	,	_	15	P
17	JTR	jtr	NNP	_	15	CONJ
18	,	,	,	_	17	P
19	and	and	CC	_	17	COORD
20	ABS	ab	NNP	_	19	CONJ
21	analyzed	analyze	VBD	_	0	ROOT
22	the	the	DT	_	23	NMOD
23	data	datum	NNS	_	21	OBJ
24	.	.	.	_	21	P

1	HH	hh	NNP	_	19	SBJ
2	,	,	,	_	1	P
3	NWW	nww	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	PG	pg	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	JH	jh	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	ES	e	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	RJMG	rjmg	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	SMF	smf	NNP	_	11	CONJ
14	,	,	,	_	13	P
15	HC	hc	NNP	_	13	CONJ
16	,	,	,	_	15	P
17	and	and	CC	_	15	COORD
18	ABS	ab	NNP	_	17	CONJ
19	contributed	contribute	VBD	_	0	ROOT
20	reagents	reagent	NNS	_	25	NMOD
21	/	/	HYPH	_	20	P
22	materials	material	NNS	_	25	NMOD
23	/	/	HYPH	_	22	P
24	analysis	analysis	NN	_	25	NMOD
25	tools	tool	NNS	_	19	OBJ
26	.	.	.	_	19	P

1	RJMG	rjmg	NNP	_	7	SBJ
2	,	,	,	_	1	P
3	EMCF	emcf	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	and	and	CC	_	3	COORD
6	ABS	ab	NNP	_	5	CONJ
7	wrote	write	VBD	_	0	ROOT
8	the	the	DT	_	9	NMOD
9	paper	paper	NN	_	7	OBJ
10	.	.	.	_	7	P

1	Funding	funding	NN	_	0	ROOT
2	.	.	.	_	1	P

1	This	this	DT	_	2	NMOD
2	research	research	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	funded	fund	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	part	part	JJ	_	5	PMOD
7	by	by	IN	_	4	LGS
8	the	the	DT	_	10	NMOD
9	intramural	intramural	JJ	_	10	NMOD
10	programs	program	NNS	_	7	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	National	national	NNP	_	14	NMOD
14	Institute	institute	NNP	_	30	NMOD
15	on	on	IN	_	14	NMOD
16	Aging	aging	NNP	_	15	PMOD
17	and	and	CC	_	14	COORD
18	the	the	DT	_	20	NMOD
19	National	national	NNP	_	20	NMOD
20	Institute	institute	NNP	_	27	NMOD
21	on	on	IN	_	20	NMOD
22	Neurological	neurological	NNP	_	23	NMOD
23	Disorders	disorder	NNP	_	21	PMOD
24	and	and	CC	_	23	COORD
25	Stroke	stroke	NNP	_	24	CONJ
26	(	(	-LRB-	_	27	P
27	NINDS	ninds	NN	_	17	CONJ
28	)	)	-RRB-	_	30	P
29	,	,	,	_	30	P
30	both	both	DT	_	11	PMOD
31	of	of	IN	_	30	NMOD
32	the	the	DT	_	34	NMOD
33	National	national	NNP	_	34	NMOD
34	Institutes	institute	NNPS	_	31	PMOD
35	of	of	IN	_	34	NMOD
36	Health	health	NNP	_	35	PMOD
37	,	,	,	_	34	P
38	Department	department	NNP	_	34	APPO
39	of	of	IN	_	38	NMOD
40	Health	health	NNP	_	39	PMOD
41	and	and	CC	_	40	COORD
42	Human	human	NNP	_	43	NMOD
43	Services	service	NNPS	_	41	CONJ
44	,	,	,	_	38	P
45	United	united	NNP	_	46	NMOD
46	States	state	NNP	_	38	APPO
47	of	of	IN	_	46	NMOD
48	America	america	NNP	_	47	PMOD
49	.	.	.	_	3	P

1	MAK	mak	NNP	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	supported	support	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	a	a	DT	_	9	NMOD
6	NINDS	ninds	NN	_	9	NMOD
7	Competitive	competitive	JJ	_	9	NMOD
8	Postdoctoral	postdoctoral	JJ	_	9	NMOD
9	Fellowship	fellowship	NN	_	4	PMOD
10	.	.	.	_	2	P

1	HH	hh	NNP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	supported	support	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	the	the	DT	_	8	NMOD
6	Medical	medical	NNP	_	7	NMOD
7	Research	research	NNP	_	8	NMOD
8	Council	council	NNP	_	4	PMOD
9	,	,	,	_	8	P
10	United	united	NNP	_	11	NMOD
11	Kingdom	kingdom	NNP	_	8	APPO
12	.	.	.	_	2	P

1	Competing	compete	VBG	_	2	NMOD
2	interests	interest	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	declared	declare	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	no	no	DT	_	8	NMOD
7	competing	compete	VBG	_	8	NMOD
8	interests	interest	NNS	_	9	SBJ
9	exist	exist	VBP	_	5	SUB
10	.	.	.	_	3	P

